chrom	pos	ref	alt	start	stop	strand	variation_type	variation_id	rcv	scv	allele_id	symbol	hgvs_c	hgvs_p	molecular_consequence	clinical_significance	clinical_significance_ordered	pathogenic	likely_pathogenic	uncertain_significance	likely_benign	benign	review_status	review_status_ordered	last_evaluated	all_submitters	submitters_ordered	all_traits	all_pmids	inheritance_modes	age_of_onset	prevalence	disease_mechanism	origin	xrefs	dates_ordered	gold_stars	conflicted
1	7809893	C	G	7809893	7809893	+	Haplotype	224889	RCV000210468	SCV000266565	226735	PER3	NM_001289862.1:c.1243C>G	NP_001276791.1:p.Pro415Ala	NM_001289862.1:c.1243C>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 23, 2017	OMIM	OMIM	Advanced sleep phase syndrome, familial, 3;ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3 (1 family)	26903630					germline	MedGen:C4225169;OMIM:616882;Orphanet:164736	2016-10-17	0	0
1	7809900	A	G	7809900	7809900	+	Haplotype	224889	RCV000210468	SCV000266565	226734	PER3	NM_001289862.1:c.1250A>G	NP_001276791.1:p.His417Arg	NM_001289862.1:c.1250A>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 23, 2017	OMIM	OMIM	Advanced sleep phase syndrome, familial, 3;ADVANCED SLEEP PHASE SYNDROME, FAMILIAL, 3 (1 family)	26903630					germline	MedGen:C4225169;OMIM:616882;Orphanet:164736	2016-10-17	0	0
1	7984971	G	A	7984971	7984971	+	Haplotype	446717	RCV000007484	SCV000027684	22107	PARK7	NM_007262.4:c.487G>A	NP_009193.2:p.Glu163Lys	NM_007262.4:c.487G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2005	OMIM	OMIM	Parkinson disease 7;PARKINSON DISEASE 7, AUTOSOMAL RECESSIVE EARLY-ONSET	16240358;20301402;23279440					germline	GeneReviews:NBK1223;Genetic Alliance:Parkinson+disease+7/9090;MedGen:C1853445;OMIM:602533.0001;OMIM:602533.0002;OMIM:602533.0003;OMIM:602533.0004;OMIM:602533.0005;OMIM:602533.0006;OMIM:606324;Orphanet:2828	2005-11-01	0	0
1	25301061	C	G	25301061	25301061	+	Haplotype	202166;208474	RCV000184007;RCV000190496	SCV000236501;SCV000245368	198596	RHD	NM_016124.4:c.602C>G	NP_057208.2:p.Thr201Arg	NM_016124.4:c.602C>G:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0
1	25301552	T	G	25301552	25301552	+	Haplotype	202166;208474	RCV000184007;RCV000190496	SCV000236501;SCV000245368	198597	RHD	NM_016124.4:c.667T>G	NP_057208.2:p.Phe223Val	NM_016124.4:c.667T>G:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0
1	25301582	G	C	25301582	25301582	+	Haplotype	208474	RCV000190496	SCV000245368	204995	RHD	NM_016124.4:c.697G>C	NP_057208.2:p.Glu233Gln	NM_016124.4:c.697G>C:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363	0000-00-00	0	0
1	25301618	G	C	25301618	25301618	+	Haplotype	208474	RCV000190496	SCV000245368	204996	RHD	NM_016124.4:c.733G>C	NP_057208.2:p.Val245Leu	NM_016124.4:c.733G>C:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363	0000-00-00	0	0
1	25301629	C	T	25301629	25301629	+	Haplotype	202166;208474	RCV000184007;RCV000190496	SCV000236501;SCV000245368	198598	RHD	NM_016124.4:c.744C>T	NP_057208.2:p.Ser248=	NM_016124.4:c.744C>T:synonymous variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0
1	25306613	G	A	25306613	25306613	+	Haplotype	202166	RCV000184007	SCV000236501	198599	RHD	NM_016124.4:c.957G>A	NP_057208.2:p.Val319=	NM_001127691.2:c.939+3154G>A:intron variant;NM_016124.4:c.957G>A:synonymous variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0
1	25306681	T	C	25306681	25306681	+	Haplotype	202166	RCV000184007	SCV000236501	198600	RHD	NM_001127691.2:c.939+3222T>C	NP_057208.2:p.Ile342Thr	NM_001127691.2:c.939+3222T>C:intron variant;NM_016124.4:c.1025T>C:missense variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0
1	25306719	G	A	25306719	25306719	+	Haplotype	202166	RCV000184007	SCV000236501	198601	RHD	NM_001127691.2:c.939+3260G>A	NP_057208.2:p.Gly355Ser	NM_001127691.2:c.939+3260G>A:intron variant;NM_016124.4:c.1063G>A:missense variant	risk factor	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	Sep 30, 2014	Colsan	Colsan	Weak RhD expression;Weak RhD expression	24579654					unknown	MedGen:CN231363	0000-00-00	0	0
1	25375385	C	T	25375385	25375385	+	Haplotype	208474	RCV000190496	SCV000245368	204997	RHD				-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Colsan	Colsan	Weak RhD expression;Weak RhD expression						unknown	MedGen:CN231363	0000-00-00	0	0
1	25420739	G	C	25420739	25420739	-	Haplotype	17709	RCV000019283	SCV000039571	32748	RHCE	NM_020485.5:c.48G=	NP_065231.3:p.Trp16=	NM_020485.5:c.48G=:synonymous variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Sep 01, 1993	OMIM	OMIM	RH C/c POLYMORPHISM;RH C/c POLYMORPHISM	8220426					germline	OMIM:111700.0002	1993-09-01	0	0
1	53210729	T	G	53210729	53210729	+	Haplotype	30118	RCV000023026	SCV000044317	39073	CPT2	NM_000098.2:c.1055T>G	NP_000089.1:p.Phe352Cys	NM_000098.2:c.1055T>G:missense variant	Benign/Likely benign	risk factor	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 07, 2017	OMIM	OMIM	Encephalopathy, acute, infection-induced, 4, susceptibility to;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	15811315;18306170;20934285;21697855					germline	Genetic Alliance:Encephalopathy%2C+acute%2C+infection-induced%2C+4%2C+susceptibility+to/8308;MedGen:C3280160;OMIM:614212;Orphanet:263524	2011-08-01	2	0
1	53210776	G	A	53210776	53210776	+	Haplotype	30118	RCV000023026	SCV000044317	39074	CPT2	NM_000098.2:c.1102G>A	NP_000089.1:p.Val368Ile	NM_000098.2:c.1102G>A:missense variant	Benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Encephalopathy, acute, infection-induced, 4, susceptibility to;ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4	15811315;18306170;20934285;21697855					germline	Genetic Alliance:Encephalopathy%2C+acute%2C+infection-induced%2C+4%2C+susceptibility+to/8308;MedGen:C3280160;OMIM:614212;Orphanet:263524	2011-08-01	0	0
1	53210911	CAG	C	53210913	53210914	+	Haplotype	60702	RCV000009520;RCV000202553	SCV000029738;SCV000153666	98339	CPT2	NM_000098.2:c.1239_1240delGA	NP_000089.1:p.Lys414Thrfs	NM_000098.2:c.1239_1240delGA:frameshift variant	Pathogenic	pathogenic	2	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 30, 2017	OMIM;GeneReviews	OMIM;GeneReviews	Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED;Carnitine palmitoyltransferase II deficiency	10090476;11477613;12410208;20301431;25173338					germline	GeneReviews:NBK1253;MedGen:C1833508;OMIM:255110;Orphanet:157;Orphanet:228302;MedGen:C0342790;Office of Rare Diseases:1121;SNOMED CT:238002005	2002-11-01;2014-05-15	2	0
1	53211016	T	C	53211016	53211016	+	Haplotype	60702	RCV000009520;RCV000202553	SCV000029738;SCV000153666	23999	CPT2	NM_000098.2:c.1342T>C	NP_000089.1:p.Phe448Leu	NM_000098.2:c.1342T>C:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 18, 2016	OMIM;GeneReviews	OMIM;GeneReviews	Carnitine palmitoyltransferase II deficiency, myopathic, stress-induced;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, MYOPATHIC, STRESS-INDUCED;Carnitine palmitoyltransferase II deficiency	10090476;11477613;12410208;20301431;25173338					germline	GeneReviews:NBK1253;MedGen:C1833508;OMIM:255110;Orphanet:157;Orphanet:228302;MedGen:C0342790;Office of Rare Diseases:1121;SNOMED CT:238002005	2002-11-01;2014-05-15	1	1
1	54865405	C	G	54865405	54865405	-	Haplotype	4368	RCV000004616	SCV000024790	38433	DHCR24	NM_014762.3:c.918G>C	NP_055577.1:p.Lys306Asn	NM_014762.3:c.918G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2001	OMIM	OMIM	Desmosterolosis;DESMOSTEROLOSIS	11519011					germline	GeneTests:238860;Genetic Alliance:Desmosterolosis/2221;MedGen:C1865596;OMIM:602398;Office of Rare Diseases:10283;Orphanet:35107	2001-10-01	0	0
1	54865442	T	G	54865442	54865442	-	Haplotype	4368	RCV000004616	SCV000024790	19407	DHCR24	NM_014762.3:c.881A>C	NP_055577.1:p.Asn294Thr	NM_014762.3:c.881A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2001	OMIM	OMIM	Desmosterolosis;DESMOSTEROLOSIS	11519011					germline	GeneTests:238860;Genetic Alliance:Desmosterolosis/2221;MedGen:C1865596;OMIM:602398;Office of Rare Diseases:10283;Orphanet:35107	2001-10-01	0	0
1	94001992	C	G	94001992	94001992	-	Haplotype	236131	RCV000408516	SCV000281924	22923	ABCA4	NM_000350.2:c.6148G>C	NP_000341.2:p.Val2050Leu	NM_000350.2:c.6148G>C:missense variant	Conflicting interpretations of pathogenicity	likely pathogenic	0	1	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Feb 17, 2017	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	1	1
1	94005499	C	T	94005499	94005499	-	Haplotype	236068	RCV000408532	SCV000281790	105317	ABCA4	NM_000350.2:c.6089G>A	NP_000341.2:p.Arg2030Gln	NM_000350.2:c.6089G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Jun 02, 2017	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	2	0
1	94014622	G	T	94014622	94014622	-	Haplotype	236131	RCV000408516	SCV000281924	105260	ABCA4	NM_000350.2:c.5381C>A	NP_000341.2:p.Ala1794Asp	NM_000350.2:c.5381C>A:missense variant	Likely pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0
1	94019625	A	C	94019625	94019625	-	Haplotype	236092	RCV000408474	SCV000281849	237656	ABCA4	NM_000350.2:c.5153T>G	NP_000341.2:p.Val1718Gly	NM_000350.2:c.5153T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0
1	94027417	G	A	94027417	94027417	-	Haplotype	225694	RCV000211040	SCV000267675	227509	ABCA4	NM_000350.2:c.4539+2028C>T		NM_000350.2:c.4539+2028C>T:intron variant	Uncertain significance	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	criteria provided, single submitter	Jan 01, 2016	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Stargardt disease 1	26527198;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	0000-00-00	1	0
1	94042800	T	A	94042800	94042800	-	Haplotype	236091	RCV000408579	SCV000281848	237681	ABCA4	NM_000350.2:c.3289A>T	NP_000341.2:p.Arg1097Ter	NM_000350.2:c.3289A>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 01, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	0	0
1	94043413	G	A	94043413	94043413	-	Haplotype	7901	RCV000008358;RCV000008359	SCV000028566;SCV000028567	22933	ABCA4	NM_000350.2:c.3113C>T	NP_000341.2:p.Ala1038Val	NM_000350.2:c.3113C>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	2	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 21, 2017	OMIM	OMIM	Stargardt disease 1;STARGARDT DISEASE 1;Cone-rod dystrophy 3	10958761;10958763;12796258;16103129;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827;Genetic Alliance:Cone-Rod+Dystrophy+3/1769;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1858806;OMIM:604116;Office of Rare Diseases:10653;Orphanet:1872	2005-10-01	2	0
1	94051698	C	G	94051698	94051698	-	Haplotype	236091;236092	RCV000408579;RCV000408474	SCV000281848;SCV000281849	22918	ABCA4	NM_000350.2:c.2588G>C	NP_000341.2:p.Gly863Ala	NM_000350.2:c.2588G>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Oct 19, 2017	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	1	1
1	94063250	A	G	94063250	94063250	-	Haplotype	7901	RCV000008358;RCV000008359	SCV000028566;SCV000028567	22940	ABCA4	NM_000350.2:c.1622T>C	NP_000341.2:p.Leu541Pro	NM_000350.2:c.1622T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 12, 2017	OMIM	OMIM	Stargardt disease 1;STARGARDT DISEASE 1;Cone-rod dystrophy 3	10958761;10958763;12796258;16103129;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827;Genetic Alliance:Cone-Rod+Dystrophy+3/1769;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1858806;OMIM:604116;Office of Rare Diseases:10653;Orphanet:1872	2005-10-01	0	1
1	94111370	G	A	94111370	94111370	-	Haplotype	225694	RCV000211040	SCV000267675	227508	ABCA4	NM_000350.2:c.302+68C>T		NM_000350.2:c.302+68C>T:intron variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Stargardt disease 1	26527198;28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	0000-00-00	0	0
1	94121045	T	C	94121045	94121045	-	Haplotype	236068	RCV000408532	SCV000281790	104999	ABCA4	NM_000350.2:c.1A>G	NP_000341.2:p.Met1Val	NM_000350.2:c.1A>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Sep 23, 2016	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Institute of Human Genetics, Univ. Regensburg,Univ. Regensburg	Stargardt disease 1	28118664					germline	Genetic Alliance:Stargardt+disease+1/9354;Genetics Home Reference:stargardt-macular-degeneration;MeSH:C535804;MedGen:C1855465;OMIM:248200;OMIM:601691.0026;Orphanet:827	2016-01-01	2	0
1	115726998	T	C	115726998	115726998	-	Haplotype	228471	RCV000217394	SCV000271536	44436	CASQ2	NM_001232.3:c.731A>G	NP_001223.2:p.His244Arg	NM_001232.3:c.731A>G:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Jul 28, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-02-05	1	1
1	115726999	G	A	115726999	115726999	-	Haplotype	228471	RCV000217394	SCV000271536	228262	CASQ2	NM_001232.3:c.730C>T	NP_001223.2:p.His244Tyr	NM_001232.3:c.730C>T:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Jul 21, 2016	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-02-05	0	1
1	155235203	C	G	155235203	155235203	-	Haplotype	4297	RCV000004533;RCV000004534;RCV000004535;RCV000004536	SCV000024707;SCV000024708;SCV000024709;SCV000024710	38385	GBA	NM_001005741.2:c.1497G>C	NP_001005741.1:p.Val499=	NM_001005741.2:c.1497G>C:synonymous variant	Benign/Likely benign	pathogenic	4	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 21, 2017	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease, perinatal lethal	10685993;1437405;1594045;18197057;1899336;1972019;19888064;20301446;7857677;8118460;8929950					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:77261;SNOMED CT:5963005;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;MedGen:C1842704;OMIM:608013	2000-03-01	2	0
1	155235217	C	G	155235217	155235217	-	Haplotype	4297	RCV000004533;RCV000004534;RCV000004535;RCV000004536	SCV000024707;SCV000024708;SCV000024709;SCV000024710	38384	GBA	NM_001005741.2:c.1483G>C	NP_001005741.1:p.Ala495Pro	NM_001005741.2:c.1483G>C:missense variant	Benign	pathogenic	4	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 24, 2012	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease, perinatal lethal	10685993;1437405;1594045;18197057;1899336;1972019;19888064;20301446;7857677;8118460;8929950					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:77261;SNOMED CT:5963005;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;MedGen:C1842704;OMIM:608013	2000-03-01	1	0
1	155235252	A	G	155235252	155235252	-	Haplotype	4297	RCV000004533;RCV000004534;RCV000004535;RCV000004536	SCV000024707;SCV000024708;SCV000024709;SCV000024710	19327	GBA	NM_001005741.2:c.1448T>C	NP_001005741.1:p.Leu483Pro	NM_001005741.2:c.1448T>C:missense variant	Pathogenic, risk factor	pathogenic	4	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 23, 2016	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I;Acute neuronopathic Gaucher's disease;Subacute neuronopathic Gaucher's disease;Gaucher disease, perinatal lethal	10685993;1437405;1594045;18197057;1899336;1972019;19888064;20301446;7857677;8118460;8929950					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:77261;SNOMED CT:5963005;Genetic Alliance:Gaucher+Disease+Perinatal+Lethal/3001;MedGen:C1842704;OMIM:608013	2000-03-01	0	0
1	155235727	C	G	155235727	155235727	-	Haplotype	4334	RCV000004580;RCV000004581	SCV000024754;SCV000024755	19332	GBA	NM_001005741.2:c.1342G>C	NP_001005741.1:p.Asp448His	NM_001005741.2:c.1342G>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	2	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 29, 2016	OMIM	OMIM	Acute neuronopathic Gaucher's disease;GAUCHER DISEASE, TYPE II;Subacute neuronopathic Gaucher's disease	15690354;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:355;Orphanet:77261;SNOMED CT:5963005	2005-04-01	2	0
1	155236376	C	T	155236376	155236376	-	Haplotype	4299	RCV000004538	SCV000024712	38432	GBA	NM_001005741.2:c.1093G>A	NP_001005741.1:p.Glu365Lys	NM_001005741.2:c.1093G>A:missense variant	Conflicting interpretations of pathogenicity, risk factor	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 28, 2017	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10079102;11903352;15146461;18197057;1864608;19888064;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009	2004-06-01	0	1
1	155237458	A	C	155237458	155237458	-	Haplotype	4334	RCV000004580;RCV000004581	SCV000024754;SCV000024755	19373	GBA	NM_001005741.2:c.882T>G	NP_001005741.1:p.His294Gln	NM_001005741.2:c.882T>G:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2005	OMIM	OMIM	Acute neuronopathic Gaucher's disease;GAUCHER DISEASE, TYPE II;Subacute neuronopathic Gaucher's disease	15690354;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+2/3003;MedGen:C0268250;OMIM:230900;OMIM:606463.0001;OMIM:606463.0002;OMIM:606463.0006;OMIM:606463.0008;OMIM:606463.0009;OMIM:606463.0013;OMIM:606463.0015;OMIM:606463.0017;OMIM:606463.0030;OMIM:606463.0031;OMIM:606463.0047;SNOMED CT:12246008;Genetic Alliance:Gaucher+Disease+Type+3/3004;MedGen:C0268251;OMIM:231000;OMIM:606463.0005;OMIM:606463.0007;OMIM:606463.0026;OMIM:606463.0035;OMIM:606463.0040;OMIM:606463.0043;Orphanet:355;Orphanet:77261;SNOMED CT:5963005	2005-04-01	0	0
1	155238570	C	G	155238570	155238570	-	Haplotype	4299	RCV000004538	SCV000024712	19338	GBA	NM_001005741.2:c.535G>C	NP_001005741.1:p.Asp179His	NM_001005741.2:c.535G>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 28, 2017	OMIM	OMIM	Gaucher's disease, type 1;GAUCHER DISEASE, TYPE I	10079102;11903352;15146461;18197057;1864608;19888064;20301446					germline	GeneReviews:NBK1269;Genetic Alliance:Gaucher+Disease+Type+1/3002;MedGen:C1961835;OMIM:230800;Orphanet:355;Orphanet:77259;SNOMED CT:62201009	2004-06-01	1	0
1	156860959	C	T	156860959	156860959	+	Haplotype	12304	RCV000030667	SCV000033344	27343	NTRK1	NM_002529.3:c.25C>T	NP_002520.2:p.Gln9Ter	NM_001007792.1:c.123-3395C>T:intron variant;NM_001012331.1:c.25C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 05, 2008	OMIM	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344;11159935;20301726					germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007	2001-02-01	0	0
1	156879126	C	T	156879126	156879126	+	Haplotype	12304	RCV000030667	SCV000033344	38397	NTRK1	NM_002529.3:c.1810C>T	NP_002520.2:p.His604Tyr	NM_001007792.1:c.1702C>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 08, 2017	OMIM	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344;11159935;20301726					germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007	2001-02-01	0	1
1	156879154	G	T	156879154	156879154	+	Haplotype	12304	RCV000030667	SCV000033344	27347	NTRK1	NM_002529.3:c.1838G>T	NP_002520.2:p.Gly613Val	NM_001007792.1:c.1730G>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 08, 2017	OMIM	OMIM	Hereditary insensitivity to pain with anhidrosis;INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS	10330344;11159935;20301726					germline	GeneReviews:NBK1769;Genetic Alliance:Insensitivity+to+pain%2C+congenital%2C+with+anhidrosis/3832;MedGen:C0020074;OMIM:256800;Office of Rare Diseases:3006;Orphanet:642;SNOMED CT:62985007	2001-02-01	1	1
1	161306427	G	C	161306427	161306427	-	Haplotype	14182	RCV000015246	SCV000035505	38403	MPZ	NM_000530.7:c.486C>G	NP_000521.2:p.Ile162Met	NM_000530.7:c.486C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 2002	OMIM	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375;20301462;9222756					germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942	2002-02-01	0	0
1	161306774	C	T	161306774	161306774	-	Haplotype	14180	RCV000015243	SCV000035502	38402	MPZ	NM_000530.7:c.382G>A	NP_000521.2:p.Asp128Asn	NM_000530.7:c.382G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1997	OMIM	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265	1997-01-01	0	0
1	161306810	T	G	161306810	161306810	-	Haplotype	14180	RCV000015243	SCV000035502	38401	MPZ	NM_000530.7:c.346A>C	NP_000521.2:p.Asn116His	NM_000530.7:c.346A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1997	OMIM	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265	1997-01-01	0	0
1	161306815	A	G	161306815	161306815	-	Haplotype	14180	RCV000015243	SCV000035502	29219	MPZ	NM_000530.7:c.341T>C	NP_000521.2:p.Ile114Thr	NM_000530.7:c.341T>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 25, 2017	OMIM	OMIM	Dejerine-sottas syndrome, sporadic;DEJERINE-SOTTAS SYNDROME, SPORADIC	9222756					germline	MedGen:C4016265	1997-01-01	0	0
1	161306819	C	A	161306819	161306819	-	Haplotype	208147	RCV000194363	SCV000243903	49442	MPZ	NM_000530.7:c.337G>T	NP_000521.2:p.Val113Phe	NM_000530.7:c.337G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 26, 2015	GeneReviews	GeneReviews	Charcot-Marie-Tooth disease, demyelinating, type 1b;Charcot-Marie-Tooth disease, type IB	20301384					germline	GeneReviews:NBK1205;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+1B/1285;MedGen:C0270912;OMIM:118200;Office of Rare Diseases:1246;Orphanet:101082;SNOMED CT:42986003	2015-03-26	0	0
1	161306882	C	T	161306882	161306882	-	Haplotype	14182	RCV000015246	SCV000035505	38404	MPZ	NM_000530.7:c.274G>A	NP_000521.2:p.Val92Met	NM_000530.7:c.274G>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 21, 2017	OMIM	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375;20301462;9222756					germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942	2002-02-01	0	0
1	161306890	A	T	161306890	161306890	-	Haplotype	14182	RCV000015246	SCV000035505	29221	MPZ	NM_000530.7:c.266T>A	NP_000521.2:p.Ile89Asn	NM_000530.7:c.266T>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 21, 2017	OMIM	OMIM	Charcot-Marie-Tooth disease type 2I;CHARCOT-MARIE-TOOTH DISEASE, TYPE 2I	11835375;20301462;9222756					germline	GeneReviews:NBK1285;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+2I/1300;MedGen:C1843251;OMIM:607677;Office of Rare Diseases:9197;Orphanet:99942	2002-02-01	0	0
1	161306915	G	A	161306915	161306915	-	Haplotype	208147	RCV000194363	SCV000243903	49438	MPZ	NM_000530.7:c.241C>T	NP_000521.2:p.His81Tyr	NM_000530.7:c.241C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 26, 2015	GeneReviews	GeneReviews	Charcot-Marie-Tooth disease, demyelinating, type 1b;Charcot-Marie-Tooth disease, type IB	20301384					germline	GeneReviews:NBK1205;Genetic Alliance:Charcot-Marie-Tooth+Disease+Type+1B/1285;MedGen:C0270912;OMIM:118200;Office of Rare Diseases:1246;Orphanet:101082;SNOMED CT:42986003	2015-03-26	0	0
1	161629903	T	C	161629903	161629903	-	Haplotype	36924	RCV000030607	SCV000053285	45587	FCGR3B	NM_000570.4:c.194A>G	NP_000561.3:p.Asn65Ser	NM_000570.4:c.194A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 1989	OMIM	OMIM	Neutrophil-specific antigens na1/na2;NEUTROPHIL-SPECIFIC ANTIGENS NA1/NA2	2478590					germline	MedGen:C4017227	1989-11-01	0	0
1	171107825	G	A	171107825	171107825	+	Haplotype	16318;217371	RCV000017711;RCV000201276;RCV000201278	SCV000037988;SCV000256060;SCV000256061	38476	FMO3	NM_006894.5:c.472G>A	NP_008825.4:p.Glu158Lys	NM_001002294.2:c.472G>A:missense variant	Benign	pathogenic;likely pathogenic	2	1	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 14, 2016	OMIM;GeneReviews	OMIM;GeneReviews	Trimethylaminuria, mild;TRIMETHYLAMINURIA, MILD;Trimethylaminuria	10485731;10896299;11809920;20301282;22126753;19321370				loss of function	germline	MedGen:C4016101;GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005	1999-09-04;2015-10-01	2	0
1	171108154	T	C	171108154	171108154	+	Haplotype	217371	RCV000201278	SCV000256061	214011	FMO3	NM_006894.5:c.560T>C	NP_008825.4:p.Val187Ala	NM_001002294.2:c.560T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2015	GeneReviews	GeneReviews	Trimethylaminuria	19321370;20301282;22126753				loss of function	germline	GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005	2015-10-01	0	0
1	171114102	A	G	171114102	171114102	+	Haplotype	16318	RCV000017711;RCV000201276	SCV000037988;SCV000256060	31357	FMO3	NM_006894.5:c.923A>G	NP_008825.4:p.Glu308Gly	NM_001002294.2:c.923A>G:missense variant	Benign	pathogenic;likely pathogenic	1	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM;GeneReviews	OMIM;GeneReviews	Trimethylaminuria, mild;TRIMETHYLAMINURIA, MILD;Trimethylaminuria	10485731;10896299;11809920;20301282;22126753				loss of function	germline	MedGen:C4016101;GeneReviews:NBK1103;Genetic Alliance:Trimethylaminuria/7223;Genetic Testing Registry (GTR):GTR000505067;Genetic Testing Registry (GTR):GTR000518973;Genetic Testing Registry (GTR):GTR000520120;MedGen:C0342739;OMIM:602079;Office of Rare Diseases:6447;SNOMED CT:237959005	1999-09-04;2015-10-01	0	0
1	179575915	C	A	179575915	179575915	-	Haplotype	225143	RCV000210779	SCV000266491	227036	NPHS2	NM_014625.3:c.-51G>T		NM_014625.3:c.-51G>T:5 prime UTR variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	Human Genetics Disease in Children – Taif University,Taif University	Human Genetics Disease in Children – Taif University,Taif University	Nephrotic syndrome, idiopathic, steroid-resistant						unknown	Genetic Alliance:Nephrotic+syndrome%2C+idiopathic%2C+steroid-resistant/5149;MedGen:C1868672;OMIM:600995;Office of Rare Diseases:3946;Orphanet:656	2016-01-01	0	1
1	179575916	G	C	179575916	179575916	-	Haplotype	225143	RCV000210779	SCV000266491	227037	NPHS2	NM_014625.3:c.-52C>G		NM_014625.3:c.-52C>G:5 prime UTR variant	Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	Human Genetics Disease in Children – Taif University,Taif University	Human Genetics Disease in Children – Taif University,Taif University	Nephrotic syndrome, idiopathic, steroid-resistant						unknown	Genetic Alliance:Nephrotic+syndrome%2C+idiopathic%2C+steroid-resistant/5149;MedGen:C1868672;OMIM:600995;Office of Rare Diseases:3946;Orphanet:656	2016-01-01	0	0
1	183574507	T	C	183574507	183574507	-	Haplotype	2240	RCV000002328	SCV000022486	38423	NCF2	NM_000433.3:c.481A>G	NP_000424.2:p.Lys161Glu	NM_000433.3:c.481A>G:missense variant;NM_001190789.1:c.366+3092A>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 24, 1997	OMIM	OMIM	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2;GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	22876374;9070911					germline	GeneReviews:NBK99496;Genetic Alliance:Chronic+granulomatous+disease%2C+autosomal+recessive+cytochrome+b-positive%2C+type+II/7977;MedGen:C1856245;OMIM:233710;Orphanet:379	1997-02-24	0	0
1	183574509	T	A	183574509	183574509	-	Haplotype	2240	RCV000002328	SCV000022486	17279	NCF2	NM_000433.3:c.479A>T	NP_000424.2:p.Asp160Val	NM_000433.3:c.479A>T:missense variant;NM_001190789.1:c.366+3090A>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 24, 1997	OMIM	OMIM	Chronic granulomatous disease, autosomal recessive cytochrome b-positive, type 2;GRANULOMATOUS DISEASE, CHRONIC, AUTOSOMAL RECESSIVE, CYTOCHROME b-POSITIVE, TYPE II	22876374;9070911					germline	GeneReviews:NBK99496;Genetic Alliance:Chronic+granulomatous+disease%2C+autosomal+recessive+cytochrome+b-positive%2C+type+II/7977;MedGen:C1856245;OMIM:233710;Orphanet:379	1997-02-24	0	0
1	207454348	T	C	207454348	207454348	+	Haplotype	17065	RCV000018594	SCV000038877	472254	CR2	NM_001006658.2:c.-71T>C			-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 06, 2007	OMIM	OMIM	Systemic lupus erythematosus 9;SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	17360460					germline	Genetics Home Reference:systemic-lupus-erythematosus;MedGen:C1970455;OMIM:120650.0001;OMIM:610927	2007-03-06	0	0
1	207472977	G	A	207472977	207472977	+	Haplotype	17065	RCV000018594	SCV000038877	389365	CR2	NM_001006658.2:c.1776G>A	NP_001006659.1:p.Leu592=	NM_001006658.2:c.1776G>A:synonymous variant	Benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 28, 2016	OMIM	OMIM	Systemic lupus erythematosus 9;SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	17360460					germline	Genetics Home Reference:systemic-lupus-erythematosus;MedGen:C1970455;OMIM:120650.0001;OMIM:610927	2007-03-06	0	0
1	207473117	G	A	207473117	207473117	+	Haplotype	17065	RCV000018594	SCV000038877	389363	CR2	NM_001006658.2:c.1916G>A	NP_001006659.1:p.Ser639Asn	NM_001006658.2:c.1916G>A:missense variant	Benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 28, 2016	OMIM	OMIM	Systemic lupus erythematosus 9;SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 9	17360460					germline	Genetics Home Reference:systemic-lupus-erythematosus;MedGen:C1970455;OMIM:120650.0001;OMIM:610927	2007-03-06	0	0
1	209706871	C	CA	209706873	209706873	+	Haplotype	8911	RCV000009466	SCV000029684	23950	HSD11B1	NM_181755.2:c.331+53_331+54insA		NM_181755.2:c.331+53_331+54insA:intron variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Cortisone reductase deficiency 2;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	12858176;15827106;16091483;16817821;17062770					germline	Genetic Alliance:CORTISONE+REDUCTASE+DEFICIENCY+2/8103;MedGen:C3553382;OMIM:614662;Orphanet:168588	2007-01-01	0	0
1	209706914	T	G	209706914	209706914	+	Haplotype	8911	RCV000009466	SCV000029684	76328	HSD11B1	NM_181755.2:c.332-29T>G		NM_181755.2:c.332-29T>G:intron variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Cortisone reductase deficiency 2;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	12858176;15827106;16091483;16817821;17062770					germline	Genetic Alliance:CORTISONE+REDUCTASE+DEFICIENCY+2/8103;MedGen:C3553382;OMIM:614662;Orphanet:168588	2007-01-01	0	0
1	210919955	C	G	210919955	210919955	-	Haplotype	203434	RCV000185594	SCV000238503	181518	KCNH1	NM_172362.2:c.1147G>C	NP_758872.1:p.Val383Leu	NM_172362.2:c.1147G>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jun 01, 2015	OMIM	OMIM	Zimmermann-Laband syndrome 1;ZIMMERMANN-LABAND SYNDROME 1	18541964;25915598					germline	Gene:353173;Genetic Alliance:Laband+syndrome/4062;MedGen:CN032818;OMIM:135500;Orphanet:3473	2015-06-01	0	0
1	210920047	G	T	210920047	210920047	-	Haplotype	203434	RCV000185594	SCV000238503	181521	KCNH1	NM_002238.3:c.974C>A	NP_758872.1:p.Ser352Tyr	NM_172362.2:c.1055C>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2015	OMIM	OMIM	Zimmermann-Laband syndrome 1;ZIMMERMANN-LABAND SYNDROME 1	18541964;25915598					germline	Gene:353173;Genetic Alliance:Laband+syndrome/4062;MedGen:CN032818;OMIM:135500;Orphanet:3473	2015-06-01	0	0
1	226982996	C	T	226982996	226982996	+	Haplotype	217876	RCV000201953	SCV000256872	214530	COQ8A	NM_020247.4:c.1042C>T	NP_064632.2:p.Arg348Ter	NM_020247.4:c.1042C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Coenzyme Q10 deficiency, primary, 4	18319072;20580948;28125198					germline	GeneReviews:NBK410087;Genetic Alliance:Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342;MedGen:C2677589;OMIM:612016;Orphanet:139485	2014-06-16	0	0
1	226985332	G	A	226985332	226985332	+	Haplotype	217876	RCV000201953	SCV000256872	18675	COQ8A	NM_020247.4:c.1651G>A	NP_064632.2:p.Glu551Lys	NM_020247.4:c.1651G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Oct 11, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Coenzyme Q10 deficiency, primary, 4	18319072;20580948;28125198					germline	GeneReviews:NBK410087;Genetic Alliance:Spinocerebellar+ataxia%2C+autosomal+recessive+9/9342;MedGen:C2677589;OMIM:612016;Orphanet:139485	2014-06-16	1	0
1	229432787	G	A	229432787	229432787	-	Haplotype	18293	RCV000019955	SCV000040253	38498	ACTA1	NM_001100.3:c.223C>T	NP_001091.1:p.His75Tyr	NM_001100.3:c.223C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2009	OMIM	OMIM	Nemaline myopathy 3;NEMALINE MYOPATHY 3	19553116;20301465;22510848					germline	GeneReviews:NBK1288;Genetic Alliance:Nemaline+myopathy+3/5125;MedGen:C1834336;OMIM:161800;Office of Rare Diseases:10111	2009-07-01	0	0
1	229432788	C	A	229432788	229432788	-	Haplotype	18293	RCV000019955	SCV000040253	33332	ACTA1	NM_001100.3:c.222G>T	NP_001091.1:p.Glu74Asp	NM_001100.3:c.222G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2009	OMIM	OMIM	Nemaline myopathy 3;NEMALINE MYOPATHY 3	19553116;20301465;22510848					germline	GeneReviews:NBK1288;Genetic Alliance:Nemaline+myopathy+3/5125;MedGen:C1834336;OMIM:161800;Office of Rare Diseases:10111	2009-07-01	0	0
1	231421509	C	G	231421509	231421509	-	Haplotype	156155	RCV000144173	SCV000189250	165954	EGLN1	NM_022051.2:c.380G>C	NP_071334.1:p.Cys127Ser	NM_022051.2:c.380G>C:missense variant	Benign, Affects	affects	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Hemoglobin, high altitude adaptation;HEMOGLOBIN, HIGH ALTITUDE ADAPTATION	25129147					germline	MedGen:C1836778;OMIM:609070	2014-09-01	0	0
1	231421877	G	C	231421877	231421877	-	Haplotype	156155	RCV000144173	SCV000189250	227498	EGLN1	NM_022051.2:c.12C>G	NP_071334.1:p.Asp4Glu	NM_022051.2:c.12C>G:missense variant	Benign/Likely benign	affects	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Apr 12, 2017	OMIM	OMIM	Hemoglobin, high altitude adaptation;HEMOGLOBIN, HIGH ALTITUDE ADAPTATION	25129147					germline	MedGen:C1836778;OMIM:609070	2014-09-01	2	0
2	44942310	G	A	44942310	44942310	+	Haplotype	441532	RCV000006470	SCV000026653	21137	SIX3	NM_005413.3:c.206G>A	NP_005404.1:p.Gly69Asp	NM_005413.3:c.206G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2006	OMIM	OMIM	Holoprosencephaly 2;HOLOPROSENCEPHALY 2	17001667;20301702					germline	GeneReviews:NBK1530;Genetic Alliance:Holoprosencephaly+2/8559;MedGen:C1834877;OMIM:157170;Orphanet:2162	2006-12-01	0	0
2	47046329	A	G	47046329	47046329	+	Haplotype	190388	RCV000170526	SCV000223091	188215	TTC7A	NM_020458.3:c.1817A>G	NP_065191.2:p.Lys606Arg	NM_001288953.1:c.1715A>G:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Multiple gastrointestinal atresias;GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME	23830146					germline	MedGen:C0220744;OMIM:243150;OMIM:609332.0001;OMIM:609332.0002;OMIM:609332.0003;OMIM:609332.0004;OMIM:609332.0005;OMIM:609332.0006;OMIM:609332.0007;OMIM:609332.0008;OMIM:609332.0009;OMIM:609332.0010;OMIM:609332.0011;OMIM:609332.0012;OMIM:609332.0013;OMIM:609332.0014;OMIM:609332.0015;Office of Rare Diseases:3013;Orphanet:2300;Orphanet:436252;SNOMED CT:95472001	2013-09-01	0	1
2	47050043	T	C	47050043	47050043	+	Haplotype	190388	RCV000170526	SCV000223091	188216	TTC7A	NM_020458.3:c.2014T>C	NP_065191.2:p.Ser672Pro	NM_001288953.1:c.1912T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Multiple gastrointestinal atresias;GASTROINTESTINAL DEFECTS AND IMMUNODEFICIENCY SYNDROME	23830146					germline	MedGen:C0220744;OMIM:243150;OMIM:609332.0001;OMIM:609332.0002;OMIM:609332.0003;OMIM:609332.0004;OMIM:609332.0005;OMIM:609332.0006;OMIM:609332.0007;OMIM:609332.0008;OMIM:609332.0009;OMIM:609332.0010;OMIM:609332.0011;OMIM:609332.0012;OMIM:609332.0013;OMIM:609332.0014;OMIM:609332.0015;Office of Rare Diseases:3013;Orphanet:2300;Orphanet:436252;SNOMED CT:95472001	2013-09-01	0	1
2	74464919	C	T	74464919	74464919	-	Haplotype	375688	RCV000114957	SCV000148867	214379	MOGS	NM_006302.2:c.329G>A	NP_006293.2:p.Arg110His	NM_006302.2:c.329G>A:missense variant	Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2015	OMIM	OMIM	Congenital disorder of glycosylation type 2B;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	20301507;24716661					germline	Genetic Alliance:CONGENITAL+DISORDER+OF+GLYCOSYLATION%2C+TYPE+IIb/8057;MedGen:C1853736;OMIM:606056;Office of Rare Diseases:10767;Orphanet:79330	2014-04-24	0	0
2	74465183	G	T	74465183	74465183	-	Haplotype	375688	RCV000114957	SCV000148867	132608	MOGS	NM_006302.2:c.65C>A	NP_006293.2:p.Ala22Glu	NM_001146158.1:c.-59+131C>A:intron variant;NM_006302.2:c.65C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 24, 2014	OMIM	OMIM	Congenital disorder of glycosylation type 2B;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIb	20301507;24716661					germline	Genetic Alliance:CONGENITAL+DISORDER+OF+GLYCOSYLATION%2C+TYPE+IIb/8057;MedGen:C1853736;OMIM:606056;Office of Rare Diseases:10767;Orphanet:79330	2014-04-24	0	0
2	86217101	T	C	86217101	86217101	-	Distinct chromosomes	157528	RCV000144873	SCV000172145	167389	REEP1	NM_001164730.1:c.626A>G	NP_001158202.1:p.Ter209Trp	NM_001164730.1:c.626A>G:stop lost;NM_001164732.1:c.370A>G:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2013	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type|spasticity;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	0	0
2	127654493	G	A	127654493	127654493	-	Haplotype	222901	RCV000208555	SCV000264322	224616	LIMS2	NM_001161404.1:c.275C>T	NP_001154876.1:p.Pro92Leu	NM_001161404.1:c.275C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 12, 2016	OMIM	OMIM	Muscular dystrophy, limb-girdle, type 2W;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W (1 family)	25589244					germline	MedGen:C4225192;OMIM:616827	2016-08-12	0	0
2	127654507	G	C	127654507	127654507	-	Haplotype	222901	RCV000208555	SCV000264322	224615	LIMS2	NM_001136037.2:c.342C>G	NP_001154876.1:p.Asn87Lys	NM_001161404.1:c.261C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 12, 2016	OMIM	OMIM	Muscular dystrophy, limb-girdle, type 2W;MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 2W (1 family)	25589244					germline	MedGen:C4225192;OMIM:616827	2016-08-12	0	0
2	166272746	C	A	166272746	166272746	-	Haplotype	441531	RCV000023304	SCV000044595	39316	SCN9A	NM_002977.3:c.2971G>T	NP_002968.1:p.Val991Leu	NM_002977.3:c.2971G>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 22, 2017	OMIM	OMIM	Small fiber neuropathy;NEUROPATHY, SMALL FIBER	21698661					germline	GeneTests:320010;Genetics Home Reference:small-fiber-neuropathy;MedGen:C3276709;OMIM:133020	2012-01-01	1	1
2	166277030	T	G	166277030	166277030	-	Haplotype	441531	RCV000023304	SCV000044595	39315	SCN9A	NM_002977.3:c.2794A>C	NP_002968.1:p.Met932Leu	NM_002977.3:c.2794A>C:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 22, 2017	OMIM	OMIM	Small fiber neuropathy;NEUROPATHY, SMALL FIBER	21698661					germline	GeneTests:320010;Genetics Home Reference:small-fiber-neuropathy;MedGen:C3276709;OMIM:133020	2012-01-01	2	0
2	178530595	AC	A	178530596	178530596	-	Haplotype	178839	RCV000155611	SCV000205319	172806	TTN	NM_133378.4:c.98315delG	NP_001254479.2:p.Gly35340Valfs	NM_001267550.2:c.106019delG:frameshift variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Sep 27, 2013	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Autosomal recessive centronuclear myopathy	22617344;23975875;24033266					germline	Genetic Alliance:Autosomal+recessive+centronuclear+myopathy/7787;Genetics Home Reference:centronuclear-myopathy;MedGen:C0410204;OMIM:255200;Orphanet:169186;Orphanet:ORPHA169186;SNOMED CT:240081004	2013-09-27	0	0
2	178569735	ATGTT	A	178569736	178569739	-	Haplotype	178839	RCV000155611	SCV000205319	172708	TTN	NM_001267550.2:c.76393_76396delAACA	NP_001254479.2:p.Asn25465Terfs	NM_001267550.2:c.76393_76396delAACA:frameshift variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Sep 27, 2013	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Autosomal recessive centronuclear myopathy	22617344;23975875;24033266					germline	Genetic Alliance:Autosomal+recessive+centronuclear+myopathy/7787;Genetics Home Reference:centronuclear-myopathy;MedGen:C0410204;OMIM:255200;Orphanet:169186;Orphanet:ORPHA169186;SNOMED CT:240081004	2013-09-27	0	0
2	178607565	T	A	178607565	178607565	-	Haplotype	179465	RCV000156254	SCV000205970	56237	TTN	NM_001267550.2:c.53123A>T	NP_597676.3:p.Lys8768Ile	NM_001267550.2:c.53123A>T:missense variant	Benign/Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Aug 08, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-03-04	0	0
2	178607566	T	C	178607566	178607566	-	Haplotype	179465	RCV000156254	SCV000205970	173874	TTN	NM_001267550.2:c.53122A>G	NP_001254479.2:p.Lys17708Glu	NM_001267550.2:c.53122A>G:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Aug 31, 2016	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-03-04	1	1
2	188997189	C	T	188997189	188997189	+	Haplotype	101229	RCV000087466	SCV000120353	106974	COL3A1	NM_000090.3:c.1786C>T	NP_000081.1:p.Arg596Ter	NM_000090.3:c.1786C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 19, 2017	Collagen Diagnostic Laboratory	Collagen Diagnostic Laboratory	Ehlers-Danlos syndrome, type 4;Ehlers-Danlos syndrome, type 4	20301667;23788249;24882528;25173340;25355838;25356965;27854360					germline	GeneReviews:NBK1494;Genetic Alliance:Ehlers-Danlos+Syndrome+Vascular+Type/2491;MedGen:C0268338;OMIM:130050;Orphanet:286;SNOMED CT:17025000	0000-00-00	1	0
2	189010205	G	A	189010205	189010205	+	Haplotype	101229	RCV000087466	SCV000120353	106975	COL3A1	NM_000090.3:c.3851G>A	NP_000081.1:p.Gly1284Glu	NM_000090.3:c.3851G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Collagen Diagnostic Laboratory	Collagen Diagnostic Laboratory	Ehlers-Danlos syndrome, type 4;Ehlers-Danlos syndrome, type 4	20301667;23788249;24882528;25173340;25355838;25356965;27854360					germline	GeneReviews:NBK1494;Genetic Alliance:Ehlers-Danlos+Syndrome+Vascular+Type/2491;MedGen:C0268338;OMIM:130050;Orphanet:286;SNOMED CT:17025000	0000-00-00	0	0
2	200571795	CAG	C	200571799	200571800		Haplotype	375673	RCV000417144	SCV000494729	362513	CLDN14	NM_152524.5:c.1453_1454delGA	NP_689737.4:p.Glu485Lysfs	NM_152524.5:c.1453_1454delGA:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 30, 2016	Laboratory of Molecular Genetics,National Institutes of Health	Laboratory of Molecular Genetics,National Institutes of Health	Perrault Syndrome;Deafness;Primary ovarian insufficiency;Perrault Syndrome						germline	Illumina Clinical Services Laboratory,Illumina:37522;MedGen:CN239459	2016-08-30	0	0
2	201709900	G	A	201709900	201709900	-	Haplotype	217879	RCV000201952	SCV000256875	214531	ALS2	NM_020919.3:c.4261C>T	NP_065970.2:p.Arg1421Ter	NM_020919.3:c.4261C>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 14, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Infantile-onset ascending hereditary spastic paralysis	12919135;18394004;20301421				loss of function	germline	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2014-07-14	0	0
2	201723325	C	G	201723325	201723325	-	CompoundHeterozygote	42162	RCV000034989	SCV000058622	205072	ALS2	NM_020919.3:c.3624+5G>C		NM_020919.3:c.3624+5G>C:intron variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Amyotrophic lateral sclerosis type 2;ALS2-Related Disorders	20018642;20301421;20301623					not provided	GeneReviews:NBK1243;Genetic Alliance:Amyotrophic+Lateral+Sclerosis+Type+2/404;MedGen:C1859807;OMIM:205100;OMIM:606352.0001;OMIM:606352.0011;OMIM:606352.0016;OMIM:606352.0017;Office of Rare Diseases:9470;Orphanet:300605	2011-02-10	0	0
2	201723388	AC	A	201723389	201723389	-	CompoundHeterozygote	42162	RCV000034989	SCV000058622	51328	ALS2	NM_020919.3:c.3565delG	NP_065970.2:p.Val1189Trpfs	NM_020919.3:c.3565delG:frameshift variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Amyotrophic lateral sclerosis type 2;ALS2-Related Disorders	20018642;20301421;20301623					not provided	GeneReviews:NBK1243;Genetic Alliance:Amyotrophic+Lateral+Sclerosis+Type+2/404;MedGen:C1859807;OMIM:205100;OMIM:606352.0001;OMIM:606352.0011;OMIM:606352.0016;OMIM:606352.0017;Office of Rare Diseases:9470;Orphanet:300605	2011-02-10	0	0
2	201723425	C	A	201723425	201723425	-	CompoundHeterozygote	42138	RCV000034965	SCV000058589	205071	ALS2	NM_020919.3:c.3529G>T	NP_065970.2:p.Gly1177Ter	NM_020919.3:c.3529G>T:nonsense	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Infantile-onset ascending hereditary spastic paralysis;ALS2-Related Disorders	18394004;20301421				loss of function	not provided	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2011-02-10	0	0
2	201746653	G	T	201746653	201746653	-	Haplotype	217879	RCV000201952	SCV000256875	214532	ALS2	NM_020919.3:c.1911C>A	NP_065970.2:p.Tyr637Ter	NM_020919.3:c.1911C>A:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 14, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Infantile-onset ascending hereditary spastic paralysis	12919135;18394004;20301421				loss of function	germline	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2014-07-14	0	0
2	201746738	T	TCACTG	201746739	201746743	-	CompoundHeterozygote	42138	RCV000034965	SCV000058589	51304	ALS2	NM_020919.3:c.1821_1825dupCAGTG	NP_065970.2:p.Glu609Alafs	NM_020919.3:c.1821_1825dupCAGTG:frameshift variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2011	GeneReviews	GeneReviews	Infantile-onset ascending hereditary spastic paralysis;ALS2-Related Disorders	18394004;20301421				loss of function	not provided	GeneReviews:NBK1243;Genetic Alliance:Infantile-onset+ascending+hereditary+spastic+paralysis/3819;Genetic Testing Registry (GTR):GTR000249543;Genetic Testing Registry (GTR):GTR000514976;Genetic Testing Registry (GTR):GTR000528540;MedGen:C1846588;OMIM:607225;Office of Rare Diseases:4914;Orphanet:293168	2011-02-10	0	0
2	227273090	G	A	227273090	227273090	+	Haplotype	397582	RCV000449541	SCV000537787	384474	COL4A3	NM_000091.4:c.1900G>A	NP_000082.2:p.Gly634Arg	NM_000091.4:c.1900G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Alport syndrome, autosomal recessive	20301386;22166944					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome+Recessive+Type/337;MedGen:C1567744;OMIM:203780;Orphanet:63;Orphanet:88919	0000-00-00	0	0
2	227273117	G	A	227273117	227273117	+	Haplotype	397582	RCV000449541	SCV000537787	285718	COL4A3	NM_000091.4:c.1927G>A	NP_000082.2:p.Gly643Ser	NM_000091.4:c.1927G>A:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 14, 2016	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Alport syndrome, autosomal recessive	20301386;22166944					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome+Recessive+Type/337;MedGen:C1567744;OMIM:203780;Orphanet:63;Orphanet:88919	0000-00-00	1	0
2	232484156	G	A	232484156	232484156	-	Haplotype	235817	RCV000224367	SCV000281670	48091	ECEL1	NM_004826.3:c.1252C>T	NP_004817.2:p.Arg418Cys	NM_004826.3:c.1252C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	232484156	G	T	232484156	232484156	-	Haplotype	235818	RCV000224716	SCV000281671	48089	ECEL1	NM_004826.3:c.1252C>A	NP_004817.2:p.Arg418Ser	NM_004826.3:c.1252C>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	232484469	T	A	232484469	232484469	-	Haplotype	235818	RCV000224716	SCV000281671	48090	ECEL1	NM_004826.3:c.1184+3A>T		NM_004826.3:c.1184+3A>T:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	232485078	T	C	232485078	232485078	-	Haplotype	235820	RCV000224404	SCV000281673	237475	ECEL1	NM_004826.3:c.869A>G	NP_004817.2:p.Tyr290Cys	NM_004826.3:c.869A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	232485253	CCCAT	AGC	232485253	232485257	-	Haplotype	235820	RCV000224404	SCV000281673	237476	ECEL1	NM_004826.3:c.797_801delATGGGinsGCT	NP_004817.2:p.Asp266Glyfs	NM_004826.3:c.797_801delATGGGinsGCT:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	232485937	G	GT	232485938	232485938	-	Haplotype	235821	RCV000224209	SCV000281675	48087	ECEL1	NM_004826.3:c.716dupA	NP_004817.2:p.Tyr239Terfs	NM_004826.3:c.716dupA:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	1	0
2	232486064	C	T	232486064	232486064	-	Haplotype	235817	RCV000224367	SCV000281670	48092	ECEL1	NM_004826.3:c.590G>A	NP_004817.2:p.Gly197Asp	NM_004826.3:c.590G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	232486298	CTGGCGTCCAGGT	C	232486299	232486310	-	Haplotype	235821	RCV000224209	SCV000281675	48088	ECEL1	NM_004826.3:c.344_355delACCTGGACGCCA	NP_004817.2:p.Asn115_Ala118del	NM_004826.3:c.344_355delACCTGGACGCCA:inframe_variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Arthrogryposis, distal, type 5d	23261301					inherited	MedGen:C3554415;OMIM:615065;Orphanet:329457	2013-01-08	0	0
2	240869302	T	TTCCTGGTTG	240869303	240869311	+	Haplotype	204181	RCV000186388	SCV000239738	200465	AGXT	NM_000030.2:c.299_307dupTCCTGGTTG	NP_000021.1:p.Val102_Gly103insValLeuVal	NM_000030.2:c.299_307dupTCCTGGTTG:inframe_variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	17460142;20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0
2	240869312	G	A	240869312	240869312	+	Haplotype	204181	RCV000186388	SCV000239738	200466	AGXT	NM_000030.2:c.308G>A	NP_000021.1:p.Gly103Glu	NM_000030.2:c.308G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	17460142;20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0
2	240875986	G	GA	240875987	240875988	+	Haplotype	204202	RCV000186409	SCV000239759	200559	AGXT	NM_000030.2:c.829_830insA	NP_000021.1:p.Ala277Aspfs	NM_000030.2:c.829_830insA:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0
2	240875988	C	A	240875988	240875988	+	Haplotype	204202	RCV000186409	SCV000239759	200560	AGXT	NM_000030.2:c.830C>A	NP_000021.1:p.Ala277Asp	NM_000030.2:c.830C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type I;Primary hyperoxaluria, type I	20301460;22547750				loss of function	germline	GeneReviews:NBK1283;Genetic Alliance:Primary+hyperoxaluria+type+1/5947;Genetic Testing Registry (GTR):GTR000118454;Genetic Testing Registry (GTR):GTR000507681;Genetic Testing Registry (GTR):GTR000514623;Genetic Testing Registry (GTR):GTR000515735;Genetic Testing Registry (GTR):GTR000515765;Genetic Testing Registry (GTR):GTR000521390;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268164;OMIM:259900;Office of Rare Diseases:2835;Orphanet:416;Orphanet:93598;SNOMED CT:65520001	2014-11-27	0	0
3	15635477	GCGGCTG	TCC	15635477	15635483	+	Haplotype	38562	RCV000021886	SCV000042553	16934	BTD	NM_000060.4:c.98_104delGCGGCTGinsTCC	NP_000051.1:p.Cys33Phefs	NM_000060.4:c.98_104delGCGGCTGinsTCC:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Apr 19, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518;15776412;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	2	0
3	15635512	G	A	15635512	15635512	+	Haplotype	24975;38563	RCV000021890;RCV000021889	SCV000042558;SCV000042557	36313	BTD	NM_000060.4:c.133G>A	NP_000051.1:p.Gly45Arg	NM_000060.4:c.133G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 03, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	10400129;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	1	1
3	15635538	C	A	15635538	15635538	+	Haplotype	24977	RCV000021892	SCV000042560	36316	BTD	NM_000060.4:c.159C>A	NP_000051.1:p.His53Gln	NM_000060.4:c.159C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15635539	G	T	15635539	15635539	+	Haplotype	24977	RCV000021892	SCV000042560	36317	BTD	NM_000060.4:c.160G>T	NP_000051.1:p.Glu54Ter	NM_000060.4:c.160G>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15635591	T	C	15635591	15635591	+	Haplotype	38562;38564	RCV000021886;RCV000021901	SCV000042553;SCV000042569	47043	BTD	NM_000060.4:c.212T>C	NP_000051.1:p.Leu71Pro	NM_000060.4:c.212T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	2	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 09, 2016	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	14707518;15776412;20301497;22378278;22475884;9396567;15060693					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	1	1
3	15635614	C	T	15635614	15635614	+	Haplotype	38565;38566	RCV000021903;RCV000032009	SCV000042572;SCV000042573	16944	BTD	NM_000060.4:c.235C>T	NP_000051.1:p.Arg79Cys	NM_000060.4:c.235C>T:missense variant	Pathogenic	pathogenic	2	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Sep 28, 2016	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	10801053;15776412;16435182;20301497;22378278;22475884;10400129;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	1	0
3	15635615	G	A	15635615	15635615	+	Haplotype	38564	RCV000021901	SCV000042569	46851	BTD	NM_000060.4:c.236G>A	NP_000051.1:p.Arg79His	NM_000060.4:c.236G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	14707518;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15635662	C	T	15635662	15635662	+	Haplotype	24994	RCV000021912	SCV000042581	36332	BTD	NM_000060.4:c.283C>T	NP_000051.1:p.Gln95Ter	NM_000060.4:c.283C>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15644326	G	A	15644326	15644326	+	Haplotype	38566;38568	RCV000032009;RCV000021933	SCV000042573;SCV000042602	46845	BTD	NM_000060.4:c.470G>A	NP_000051.1:p.Arg157His	NM_000060.4:c.470G>A:missense variant	Pathogenic	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 25, 2016	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency	10400129;10801053;15776412;16435182;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15644367	G	A	15644367	15644367	+	Haplotype	25016	RCV000021936	SCV000022135;SCV000042605	36353	BTD	NM_000060.4:c.511G>A	NP_000051.1:p.Ala171Thr	NM_000060.4:c.511G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;no assertion criteria provided	May 18, 2017	OMIM;ARUP Institute,ARUP Laboratories	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129;15776412;20301497;21228398;22378278;22475884;7509806;9375914;9654207					germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2011-01-12;2012-12-04	0	1
3	15644497	A	G	15644497	15644497	+	Haplotype	25030	RCV000021952	SCV000042621	36367	BTD	NM_000060.4:c.641A>G	NP_000051.1:p.Asn214Ser	NM_000060.4:c.641A>G:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	1
3	15644650	A	T	15644650	15644650	+	Haplotype	25042	RCV000021964	SCV000042634	36378	BTD	NM_000060.4:c.794A>T	NP_000051.1:p.His265Leu	NM_000060.4:c.794A>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	12359137;20083419;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15644721	G	C	15644721	15644721	+	Haplotype	38563	RCV000021889	SCV000042557	46848	BTD	NM_000060.4:c.865G>C	NP_000051.1:p.Ala289Pro	NM_000060.4:c.865G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15644789	T	G	15644789	15644789	+	Haplotype	25042	RCV000021964	SCV000042634	36379	BTD	NM_000060.4:c.933T>G	NP_000051.1:p.Ser311Arg	NM_000060.4:c.933T>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	12359137;20083419;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15645027	C	T	15645027	15645027	+	Haplotype	38571	RCV000021985	SCV000042655	46849	BTD	NM_001281724.2:c.1177C>T	NP_001268653.1:p.Pro393Ser	NM_000060.4:c.1171C>T:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Apr 18, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	11668630;15776412;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	2	0
3	15645063	T	G	15645063	15645063	+	Haplotype	1904	RCV000001981	SCV000022139;SCV000042659	16943	BTD	NM_000060.4:c.1207T>G	NP_000051.1:p.Phe403Val	NM_000060.4:c.1207T>G:missense variant	Pathogenic	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;no assertion criteria provided	Apr 29, 2016	OMIM;ARUP Institute,ARUP Laboratories	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY;Biotinidase deficiency	10400129;15776412;20301497;22378278;22475884					germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	1999-07-01;2012-12-04	0	0
3	15645127	G	C	15645127	15645127	+	Haplotype	24975	RCV000021890	SCV000042558	36314	BTD	NM_000060.4:c.1271G>C	NP_000051.1:p.Cys424Ser	NM_000060.4:c.1271G>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10400129;15060693;15776412;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15645186	G	C	15645186	15645186	+	Haplotype	1904;24994;25016;25030;38568	RCV000001981;RCV000021912;RCV000021936;RCV000021952;RCV000021933	SCV000022139;SCV000042659;SCV000042581;SCV000022135;SCV000042605;SCV000042621;SCV000042602	16939	BTD	NM_001281724.2:c.1336G>C	NP_001268653.1:p.Asp446His	NM_000060.4:c.1330G>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	7	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 18, 2017	OMIM;ARUP Institute,ARUP Laboratories	OMIM;ARUP Institute,ARUP Laboratories	Biotinidase deficiency;BIOTINIDASE DEFICIENCY	10400129;15776412;20301497;22378278;22475884;21228398;7509806;9375914;9654207;16435182;9396567					germline;not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	1999-07-01;2012-12-04;2011-01-12	2	0
3	15645190	G	T	15645190	15645190	+	Haplotype	38571	RCV000021985	SCV000042655	36396	BTD	NM_000060.4:c.1334G>T	NP_000051.1:p.Gly445Val	NM_000060.4:c.1334G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 10, 2017	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	11668630;15776412;20301497;22378278;22475884;9396567					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	15645217	A	C	15645217	15645217	+	Haplotype	38565	RCV000021903	SCV000042572	36326	BTD	NM_000060.4:c.1361A>C	NP_000051.1:p.Tyr454Ser	NM_000060.4:c.1361A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 04, 2012	ARUP Institute,ARUP Laboratories	ARUP Institute,ARUP Laboratories	Biotinidase deficiency;Biotinidase deficiency	10801053;15776412;16435182;20301497;22378278;22475884					not provided	GeneReviews:NBK1322;Genetic Alliance:Biotinidase+Deficiency/846;MedGen:C0220754;OMIM:253260;OMIM:609019;Office of Rare Diseases:894;Orphanet:79241;SNOMED CT:8808004	2012-12-04	0	0
3	33018510	G	A	33018510	33018510	-	Haplotype	208495	RCV000190508	SCV000245394	205010	GLB1	NM_000404.3:c.1285C>T	NP_000395.2:p.Pro429Ser	NM_000404.3:c.1285C>T:missense variant	Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 18, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Mucopolysaccharidosis, MPS-IV-B	24156116					germline	GeneReviews:NBK164500;Genetic Alliance:Morquio+syndrome+B/4877;MedGen:C0086652;OMIM:253010;Orphanet:582;SNOMED CT:238044004	2016-05-13	0	0
3	33024297	G	T	33024297	33024297	-	Haplotype	208495	RCV000190508	SCV000245394	205011	GLB1	NM_000404.3:c.1097C>A	NP_000395.2:p.Pro366His	NM_000404.3:c.1097C>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	May 13, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Mucopolysaccharidosis, MPS-IV-B	24156116					germline	GeneReviews:NBK164500;Genetic Alliance:Morquio+syndrome+B/4877;MedGen:C0086652;OMIM:253010;Orphanet:582;SNOMED CT:238044004	2016-05-13	0	0
3	38551513	G	A	38551513	38551513	-	Haplotype	440848	RCV000009965	SCV000030186	38446	SCN5A	NM_198056.2:c.4859C>T	NP_932173.1:p.Thr1620Met	NM_000335.4:c.4856C>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 28, 2017	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10618304;19251209;20129283;20301690;21321465;21810866;23788249;25356965;27854360;9521325					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2000-01-04	0	0
3	38562456	G	A	38562456	38562456	-	Haplotype	440850	RCV000010010	SCV000030231	38448	SCN5A	NM_198056.2:c.3922C>T	NP_932173.1:p.Leu1308Phe	NM_000335.4:c.3919C>T:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 31, 2017	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10532948;15851227;18599870;19841300;20129283;20301690;21810866;23788249;25356965;27854360					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2008-08-15	2	0
3	38566555	G	A	38566555	38566555	-	Haplotype	440848	RCV000009965	SCV000030186	24410	SCN5A	NM_198056.2:c.3694C>T	NP_932173.1:p.Arg1232Trp	NM_000335.4:c.3691C>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Sep 03, 2015	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10618304;19251209;20129283;20301690;21321465;21810866;23788249;25356965;27854360;9521325					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2000-01-04	1	1
3	38603929	T	C	38603929	38603929	-	Haplotype	440849	RCV000010000	SCV000030221	38447	SCN5A	NM_198056.2:c.1673A>G	NP_932173.1:p.His558Arg	NM_000335.4:c.1673A>G:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Progressive familial heart block type 1A;PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	10807545;11463728;11997281;12569159;12639704;14760;18378609;23788249;23994779;27854360					germline	Genetic Alliance:Progressive+familial+heart+block+type+1A/5978;Genetics Home Reference:progressive-familial-heart-block;MedGen:C1879286;OMIM:113900;OMIM:600163.0009;OMIM:600163.0017;OMIM:600163.0018;OMIM:600163.0031;Office of Rare Diseases:1093;Orphanet:871	2008-04-15	0	0
3	38604067	G	A	38604067	38604067	-	Haplotype	440849	RCV000010000	SCV000030221	24437	SCN5A	NM_198056.2:c.1535C>T	NP_932173.1:p.Thr512Ile	NM_198056.2:c.1535C>T:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Mar 27, 2016	OMIM	OMIM	Progressive familial heart block type 1A;PROGRESSIVE FAMILIAL HEART BLOCK, TYPE IA	10807545;11463728;11997281;12569159;12639704;14760;18378609;23788249;23994779;27854360					germline	Genetic Alliance:Progressive+familial+heart+block+type+1A/5978;Genetics Home Reference:progressive-familial-heart-block;MedGen:C1879286;OMIM:113900;OMIM:600163.0009;OMIM:600163.0017;OMIM:600163.0018;OMIM:600163.0031;Office of Rare Diseases:1093;Orphanet:871	2008-04-15	1	1
3	38613752	C	T	38613752	38613752	-	Haplotype	440850	RCV000010010	SCV000030231	24446	SCN5A	NM_001099404.1:c.703+223G>A	NP_932173.1:p.Val232Ile	NM_000335.4:c.694G>A:missense variant;NM_001099404.1:c.703+223G>A:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Apr 21, 2017	OMIM	OMIM	Brugada syndrome 1;BRUGADA SYNDROME 1	10532948;15851227;18599870;19841300;20129283;20301690;21810866;23788249;25356965;27854360					germline	GeneReviews:NBK1517;MedGen:CN029323;OMIM:601144;Orphanet:130	2008-08-15	1	1
3	39265671	G	A	39265671	39265671	-	Haplotype	8152	RCV000008629;RCV000008630;RCV000023109	SCV000028837;SCV000028838;SCV000044400	36774	CX3CR1	NM_001171174.1:c.935C>T	NP_001164645.1:p.Thr312Met	NM_001171174.1:c.935C>T:missense variant	-	pathogenic;protective;risk factor	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Human immunodeficiency virus type 1, rapid progression to AIDS;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS;Coronary artery disease, resistance to;MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO	10731151;11264153;12697743;15208270;17909628;23716478					germline	MedGen:C4016733;MedGen:C1832288;OMIM:601470.0001	2014-09-05;2015-05-18;2013-12-01	0	0
3	39265765	C	T	39265765	39265765	-	Haplotype	8152	RCV000008629;RCV000008630;RCV000023109	SCV000028837;SCV000028838;SCV000044400	23191	CX3CR1	NM_001171174.1:c.841G>A	NP_001164645.1:p.Val281Ile	NM_001171174.1:c.841G>A:missense variant	-	pathogenic;protective;risk factor	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Human immunodeficiency virus type 1, rapid progression to AIDS;HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, RAPID PROGRESSION TO AIDS;Coronary artery disease, resistance to;MACULAR DEGENERATION, AGE-RELATED, 12, SUSCEPTIBILITY TO	10731151;11264153;12697743;15208270;17909628;23716478					germline	MedGen:C4016733;MedGen:C1832288;OMIM:601470.0001	2014-09-05;2015-05-18;2013-12-01	0	0
3	42691976	T	C	42691976	42691976	+	Haplotype	228777	RCV000213109	SCV000271889	229063	KLHL40	NM_152393.3:c.1849T>C	NP_689606.2:p.Cys617Arg	NM_152393.3:c.1849T>C:missense variant	Benign	uncertain significance	0	0	1	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Jan 05, 2016	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-18	2	0
3	42691977	G	A	42691977	42691977	+	Haplotype	228777	RCV000213109	SCV000271889	229064	KLHL40	NM_152393.3:c.1850G>A	NP_689606.2:p.Cys617Tyr	NM_152393.3:c.1850G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 18, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-18	0	0
3	49123179	G	A	49123179	49123179	-	Haplotype	14535	RCV000015634	SCV000035899	38466	LAMB2	NM_002292.3:c.4177C>T	NP_002283.3:p.Leu1393Phe	NM_002292.3:c.4177C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2006	OMIM	OMIM	Nephrotic syndrome, type 5, with or without ocular abnormalities;NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	16912710					germline	Genetic Alliance:Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989;MedGen:C3280113;OMIM:150325.0006;OMIM:150325.0007;OMIM:150325.0008;OMIM:150325.0009;OMIM:150325.0010;OMIM:150325.0011;OMIM:614199;Orphanet:306507	2006-09-01	0	0
3	49123216	G	T	49123216	49123216	-	Haplotype	14535	RCV000015634	SCV000035899	29574	LAMB2	NM_002292.3:c.4140C>A	NP_002283.3:p.Asn1380Lys	NM_002292.3:c.4140C>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Apr 25, 2017	OMIM	OMIM	Nephrotic syndrome, type 5, with or without ocular abnormalities;NEPHROTIC SYNDROME, TYPE 5, WITH OCULAR ABNORMALITIES	16912710					germline	Genetic Alliance:Nephrotic+syndrome%2C+type+5%2C+with+or+without+ocular+abnormalities/8989;MedGen:C3280113;OMIM:150325.0006;OMIM:150325.0007;OMIM:150325.0008;OMIM:150325.0009;OMIM:150325.0010;OMIM:150325.0011;OMIM:614199;Orphanet:306507	2006-09-01	1	0
3	52786965	A	T	52786965	52786965	+	Haplotype	14798	RCV000015921	SCV000036188	29837	ITIH1	NM_002215.3:c.1754A>T	NP_002206.2:p.Glu585Val	NM_002215.3:c.1754A>T:missense variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1995	OMIM	OMIM	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM;INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	7535743					germline	OMIM:147270.0001;OMIM:147270.0002;OMIM:147270.0003	1995-04-01	0	0
3	52786995	A	G	52786995	52786995	+	Haplotype	14798;14799	RCV000015921;RCV000015922	SCV000036188;SCV000036189	29838	ITIH1	NM_002215.3:c.1784A>G	NP_002206.2:p.Gln595Arg	NM_002215.3:c.1784A>G:missense variant	-	benign	0	0	0	0	2	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1995	OMIM	OMIM	INTER-ALPHA-TRYPSIN INHIBITOR, HEAVY CHAIN 1 POLYMORPHISM	7535743					germline	OMIM:147270.0001;OMIM:147270.0002;OMIM:147270.0003	1995-04-01	0	0
3	64157305	C	T	64157305	64157305	-	Haplotype	30731	RCV000023709	SCV000045000	39689	PRICKLE2	NM_198859.3:c.457G>A	NP_942559.1:p.Val153Ile	NM_198859.3:c.457G>A:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 21, 2016	OMIM	OMIM	Epilepsy, progressive myoclonic 5;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	21276947;26942291;26942292;632821					germline	Genetic Alliance:Epilepsy%2C+progressive+myoclonic+5/8335;MedGen:CN226157;OMIM:613832;Orphanet:402082	2011-02-11	0	1
3	64157319	C	T	64157319	64157319	-	Haplotype	30731	RCV000023709	SCV000045000	39688	PRICKLE2	NM_198859.3:c.443G>A	NP_942559.1:p.Arg148His	NM_198859.3:c.443G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 20, 2015	OMIM	OMIM	Epilepsy, progressive myoclonic 5;RECLASSIFIED - VARIANT OF UNKNOWN SIGNIFICANCE	21276947;26942291;26942292;632821					germline	Genetic Alliance:Epilepsy%2C+progressive+myoclonic+5/8335;MedGen:CN226157;OMIM:613832;Orphanet:402082	2011-02-11	0	0
3	114339010	C	T	114339010	114339010	-	Haplotype	253111	RCV000239523	SCV000297909	247522	ZBTB20	NM_001164342.2:c.2221G>A	NP_001157814.1:p.Gly741Arg	NM_001164342.2:c.2221G>A:missense variant;NR_121662.1:n.883G>A:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 08, 2016	OMIM	OMIM	Primrose syndrome;PRIMROSE SYNDROME	27061120					germline	Genetic Alliance:Primrose+syndrome/5964;MedGen:C0796121;OMIM:259050;Office of Rare Diseases:4488	2016-08-08	0	0
3	114339384	G	A	114339384	114339384	-	Haplotype	253111	RCV000239523	SCV000297909	247523	ZBTB20	NM_001164342.2:c.1847C>T	NP_001157814.1:p.Ser616Phe	NM_001164342.2:c.1847C>T:missense variant;NR_121662.1:n.509C>T:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 08, 2016	OMIM	OMIM	Primrose syndrome;PRIMROSE SYNDROME	27061120					germline	Genetic Alliance:Primrose+syndrome/5964;MedGen:C0796121;OMIM:259050;Office of Rare Diseases:4488	2016-08-08	0	0
3	124735222	A	G	124735222	124735222	+	Haplotype	11906	RCV000012681	SCV000032916	26945	UMPS	NM_000373.3:c.286A>G	NP_000364.1:p.Arg96Gly	NM_000373.3:c.286A>G:missense variant;NR_033434.1:n.263-2346A>G:intron variant;NR_033437.1:n.491A>G:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 1997	OMIM	OMIM	Orotic aciduria;OROTIC ACIDURIA	9042911					germline	Genetic Alliance:Orotic+aciduria+hereditary/5431;MedGen:C0268128;OMIM:258900;OMIM:258920;Orphanet:30;SNOMED CT:47641009;SNOMED CT:90093009	1997-03-01	0	0
3	124743926	G	C	124743926	124743926	+	Haplotype	11906	RCV000012681	SCV000032916	38455	UMPS	NM_000373.3:c.1285G>C	NP_000364.1:p.Gly429Arg	NM_000373.3:c.1285G>C:missense variant;NR_033434.1:n.1237G>C:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 1997	OMIM	OMIM	Orotic aciduria;OROTIC ACIDURIA	9042911					germline	Genetic Alliance:Orotic+aciduria+hereditary/5431;MedGen:C0268128;OMIM:258900;OMIM:258920;Orphanet:30;SNOMED CT:47641009;SNOMED CT:90093009	1997-03-01	0	0
3	179218304	A	C	179218304	179218304	+	Haplotype	222469	RCV000144511	SCV000189830	28698	PIK3CA	NM_006218.3:c.1634A>C	NP_006209.2:p.Glu545Ala	NM_006218.3:c.1634A>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 31, 2016	OMIM	OMIM	Cowden syndrome 5;COWDEN SYNDROME 5	23246288					germline	MedGen:C3554518;OMIM:615108;Orphanet:201	2013-01-10	0	0
3	179218328	GT	C	179218328	179218329	+	Haplotype	222469	RCV000144511	SCV000189830	166223	PIK3CA	NM_006218.3:c.1658_1659delGTinsC	NP_006209.2:p.Ser553Thrfs	NM_006218.3:c.1658_1659delGTinsC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 10, 2013	OMIM	OMIM	Cowden syndrome 5;COWDEN SYNDROME 5	23246288					germline	MedGen:C3554518;OMIM:615108;Orphanet:201	2013-01-10	0	0
3	193637313	T	C	193637313	193637313	+	Haplotype	5089	RCV000005394	SCV000025574	101627	OPA1	NM_015560.2:c.870+32T>C		NM_015560.2:c.870+32T>C:intron variant	Benign	risk factor	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 22, 2013	OMIM	OMIM	Glaucoma, normal tension, susceptibility to;GLAUCOMA, NORMAL TENSION, SUSCEPTIBILITY TO	11810296;12073024;17188046;19581274					germline	Genetic Alliance:Glaucoma%2C+normal+tension%2C+susceptibility+to/8467;MedGen:C1847730;OMIM:606657	2010-02-01	1	0
4	1002767	G	C	1002767	1002767	+	Haplotype	11911	RCV000012686	SCV000032921	26950	IDUA	NM_000203.4:c.1225G>C	NP_000194.2:p.Gly409Arg	NM_000203.4:c.1225G>C:missense variant;NR_110313.1:n.1313G>C:non-coding transcript variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Sep 08, 2016	OMIM	OMIM	Hurler syndrome;HURLER SYNDROME	20301341;8328452					germline	GeneReviews:NBK1162;Genetic Alliance:Mucopolysaccharidosis+type+I/4912;MedGen:C0086795;OMIM:607014	1993-08-01	1	1
4	1004393	A	T	1004393	1004393	+	Haplotype	11911	RCV000012686	SCV000032921	38456	IDUA	NM_000203.4:c.1962A>T	NP_000194.2:p.Ter654Cys	NM_000203.4:c.1962A>T:stop lost;NR_110313.1:n.2054A>T:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1993	OMIM	OMIM	Hurler syndrome;HURLER SYNDROME	20301341;8328452					germline	GeneReviews:NBK1162;Genetic Alliance:Mucopolysaccharidosis+type+I/4912;MedGen:C0086795;OMIM:607014	1993-08-01	0	0
4	1804384	T	G	1804384	1804384	+	Haplotype	441276	RCV000017763	SCV000038041	38477	FGFR3	NM_022965.3:c.931-440T>G	NP_001156685.1:p.Leu379Arg	NM_000142.4:c.1130T>G:missense variant;NM_022965.3:c.931-440T>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 2006	OMIM	OMIM	Achondroplasia;ACHONDROPLASIA	16411219;20301331				gain of function	germline	GeneReviews:NBK1152;GeneTests:2789;Genetic Alliance:Achondroplasia/113;Genetic Testing Registry (GTR):GTR000017792;Genetic Testing Registry (GTR):GTR000193973;Genetic Testing Registry (GTR):GTR000226127;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000325183;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000332463;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000500431;Genetic Testing Registry (GTR):GTR000501373;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508972;Genetic Testing Registry (GTR):GTR000510685;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000523319;Genetic Testing Registry (GTR):GTR000529586;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552209;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;Genetic Testing Registry (GTR):GTR000556521;MedGen:C0001080;OMIM:100800;Office of Rare Diseases:8173;Orphanet:15;SNOMED CT:86268005	2006-02-01	0	0
4	1804392	G	A	1804392	1804392	+	Haplotype	441276	RCV000017763	SCV000038041	31366	FGFR3	NM_022965.3:c.931-432G>A	NP_001156685.1:p.Gly382Arg	NM_000142.4:c.1138G>A:missense variant;NM_022965.3:c.931-432G>A:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	Achondroplasia;ACHONDROPLASIA	16411219;20301331				gain of function	germline	GeneReviews:NBK1152;GeneTests:2789;Genetic Alliance:Achondroplasia/113;Genetic Testing Registry (GTR):GTR000017792;Genetic Testing Registry (GTR):GTR000193973;Genetic Testing Registry (GTR):GTR000226127;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000325183;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000332463;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000500431;Genetic Testing Registry (GTR):GTR000501373;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508972;Genetic Testing Registry (GTR):GTR000510685;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000523319;Genetic Testing Registry (GTR):GTR000529586;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000552209;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;Genetic Testing Registry (GTR):GTR000556521;MedGen:C0001080;OMIM:100800;Office of Rare Diseases:8173;Orphanet:15;SNOMED CT:86268005	2006-02-01	0	0
4	1805396	A	G	1805396	1805396	+	Haplotype	441277	RCV000017771	SCV000038050	38478	FGFR3	NM_001163213.1:c.1460A>G	NP_001156685.1:p.Gln487Arg	NM_000142.4:c.1454A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2009	OMIM	OMIM	Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA, TYPE I	19449430;20301540				gain of function	germline	GeneReviews:NBK1366;Genetic Alliance:Thanatophoric+dysplasia+type+1/7051;Genetic Testing Registry (GTR):GTR000226129;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000327813;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508990;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000530324;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;MedGen:C1868678;OMIM:187600;Office of Rare Diseases:9295;Orphanet:1860;Orphanet:2655	2009-06-01	0	0
4	1805644	C	A	1805644	1805644	+	Haplotype	441277	RCV000017771	SCV000038050	31376	FGFR3	NM_001163213.1:c.1626C>A	NP_001156685.1:p.Asn542Lys	NM_000142.4:c.1620C>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 16, 2017	OMIM	OMIM	Thanatophoric dysplasia type 1;THANATOPHORIC DYSPLASIA, TYPE I	19449430;20301540				gain of function	germline	GeneReviews:NBK1366;Genetic Alliance:Thanatophoric+dysplasia+type+1/7051;Genetic Testing Registry (GTR):GTR000226129;Genetic Testing Registry (GTR):GTR000320916;Genetic Testing Registry (GTR):GTR000327662;Genetic Testing Registry (GTR):GTR000327663;Genetic Testing Registry (GTR):GTR000327813;Genetic Testing Registry (GTR):GTR000333529;Genetic Testing Registry (GTR):GTR000508438;Genetic Testing Registry (GTR):GTR000508854;Genetic Testing Registry (GTR):GTR000508990;Genetic Testing Registry (GTR):GTR000510735;Genetic Testing Registry (GTR):GTR000512698;Genetic Testing Registry (GTR):GTR000514902;Genetic Testing Registry (GTR):GTR000515562;Genetic Testing Registry (GTR):GTR000518899;Genetic Testing Registry (GTR):GTR000522269;Genetic Testing Registry (GTR):GTR000522270;Genetic Testing Registry (GTR):GTR000522271;Genetic Testing Registry (GTR):GTR000522272;Genetic Testing Registry (GTR):GTR000530324;Genetic Testing Registry (GTR):GTR000552289;Genetic Testing Registry (GTR):GTR000553542;MedGen:C1868678;OMIM:187600;Office of Rare Diseases:9295;Orphanet:1860;Orphanet:2655	2009-06-01	2	0
4	70033186	G	A	70033186	70033186	+	Haplotype	14913	RCV000016048	SCV000036315	38467	HTN3	NM_000200.2:c.122G>A	NP_000191.1:p.Arg41Gln	NM_000200.2:c.122G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1994	OMIM	OMIM	HIS2*1/HIS2*2 POLYMORPHISM;HIS2*1/HIS2*2 POLYMORPHISM	7951254					germline	OMIM:142702.0001	1994-01-01	0	0
4	70033205	T	A	70033205	70033205	+	Haplotype	14913	RCV000016048	SCV000036315	29952	HTN3	NM_000200.2:c.141T>A	NP_000191.1:p.Tyr47Ter	NM_000200.2:c.141T>A:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1994	OMIM	OMIM	HIS2*1/HIS2*2 POLYMORPHISM;HIS2*1/HIS2*2 POLYMORPHISM	7951254					germline	OMIM:142702.0001	1994-01-01	0	0
4	102267916	C	G	102267916	102267916	-	Haplotype	218898	RCV000203237	SCV000258313	215658	SLC39A8	NM_022154.5:c.1004G>C	NP_071437.3:p.Ser335Thr	NM_022154.5:c.1004G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 03, 2015	OMIM	OMIM	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	26637979					germline	MedGen:C4225234;OMIM:608732.0001;OMIM:608732.0002;OMIM:608732.0003;OMIM:608732.0004;OMIM:616721	2015-12-03	0	0
4	102344566	C	T	102344566	102344566	-	Haplotype	218898	RCV000203237	SCV000258313	215659	SLC39A8	NM_022154.5:c.97G>A	NP_071437.3:p.Val33Met	NM_022154.5:c.97G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 03, 2015	OMIM	OMIM	CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn;CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIn	26637979					germline	MedGen:C4225234;OMIM:608732.0001;OMIM:608732.0002;OMIM:608732.0003;OMIM:608732.0004;OMIM:616721	2015-12-03	0	0
4	108167587	A	G	108167587	108167587	-	Haplotype	14382	RCV000015459	SCV000035724	38464	LEF1	NM_016269.4:c.181T>C	NP_057353.1:p.Ser61Pro	NM_001166119.1:c.-1307T>C:2KB upstream variant;NM_016269.4:c.181T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2006	OMIM	OMIM	Sebaceous tumors, somatic;SEBACEOUS TUMORS, SOMATIC	16565724					somatic	MedGen:C1835244	2006-04-01	0	0
4	108167635	C	T	108167635	108167635	-	Haplotype	14382	RCV000015459	SCV000035724	29421	LEF1	NM_016269.4:c.133G>A	NP_057353.1:p.Glu45Lys	NM_001166119.1:c.-1355G>A:2KB upstream variant;NM_016269.4:c.133G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2006	OMIM	OMIM	Sebaceous tumors, somatic;SEBACEOUS TUMORS, SOMATIC	16565724					somatic	MedGen:C1835244	2006-04-01	0	0
5	225434	G	C	225434	225434	+	Haplotype	190221	RCV000170440	SCV000222878	188048	SDHA	NM_004168.3:c.328G>C	NP_004159.2:p.Ala110Pro	NM_001294332.1:c.313-449G>C:intron variant;NM_004168.3:c.328G>C:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 10, 2015	Mendelics Analise Genomica	Mendelics Analise Genomica	Mitochondrial complex II deficiency;Mitochondrial complex II deficiency	10746566;22972948					germline	Genetic Alliance:Mitochondrial+complex+II+deficiency/4824;MedGen:C1855008;OMIM:252011;Office of Rare Diseases:5053;Orphanet:3208	2015-03-10	0	0
5	240474	A	G	240474	240474	+	Haplotype	190221	RCV000170440	SCV000222878	188049	SDHA	NM_004168.3:c.1549A>G	NP_004159.2:p.Lys517Glu	NM_004168.3:c.1549A>G:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 10, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Mitochondrial complex II deficiency;Mitochondrial complex II deficiency	10746566;22972948					germline	Genetic Alliance:Mitochondrial+complex+II+deficiency/4824;MedGen:C1855008;OMIM:252011;Office of Rare Diseases:5053;Orphanet:3208	2015-03-10	0	0
5	1266519	C	T	1266519	1266519	-	Haplotype	36946	RCV000030627	SCV000053305	45604	TERT	NM_198253.2:c.2599G>A	NP_937983.2:p.Val867Met	NM_198253.2:c.2599G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2011	OMIM	OMIM	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1;PULMONARY FIBROSIS, TELOMERE-RELATED, 1	21483807					germline	MedGen:C3553617;OMIM:187270.0001;OMIM:187270.0002;OMIM:187270.0003;OMIM:187270.0004;OMIM:187270.0005;OMIM:187270.0008;OMIM:187270.0009;OMIM:187270.0010;OMIM:187270.0015;OMIM:187270.0016;OMIM:187270.0017;OMIM:614742;Orphanet:88	2011-03-01	0	0
5	1272196	C	T	1272196	1272196	-	Haplotype	36946	RCV000030627	SCV000053305	45603	TERT	NM_198253.2:c.2371G>A	NP_937983.2:p.Val791Ile	NM_198253.2:c.2371G>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 18, 2017	OMIM	OMIM	Pulmonary fibrosis and/or bone marrow failure, telomere-related, 1;PULMONARY FIBROSIS, TELOMERE-RELATED, 1	21483807					germline	MedGen:C3553617;OMIM:187270.0001;OMIM:187270.0002;OMIM:187270.0003;OMIM:187270.0004;OMIM:187270.0005;OMIM:187270.0008;OMIM:187270.0009;OMIM:187270.0010;OMIM:187270.0015;OMIM:187270.0016;OMIM:187270.0017;OMIM:614742;Orphanet:88	2011-03-01	1	0
5	41853435	A	T	41853435	41853435	-	Haplotype	8165	RCV000008643	SCV000028852	38389	OXCT1	NM_000436.3:c.398T>A	NP_000427.1:p.Val133Glu	NM_000436.3:c.398T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1998	OMIM	OMIM	Succinyl-CoA acetoacetate transferase deficiency;SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	9671268					germline	Genetic Alliance:Succinyl-CoA+acetoacetate+transferase+deficiency/6918;MedGen:C0342792;OMIM:245050;Office of Rare Diseases:5057;Orphanet:832;SNOMED CT:238004006	1998-01-01	0	0
5	41862656	G	A	41862656	41862656	-	Haplotype	8165	RCV000008643	SCV000028852	23204	OXCT1	NM_000436.3:c.173C>T	NP_000427.1:p.Thr58Met	NM_000436.3:c.173C>T:missense variant	Benign	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 31, 2017	OMIM	OMIM	Succinyl-CoA acetoacetate transferase deficiency;SUCCINYL-CoA:3-OXOACID-CoA TRANSFERASE DEFICIENCY	9671268					germline	Genetic Alliance:Succinyl-CoA+acetoacetate+transferase+deficiency/6918;MedGen:C0342792;OMIM:245050;Office of Rare Diseases:5057;Orphanet:832;SNOMED CT:238004006	1998-01-01	1	0
5	112707523	A	C	112707523	112707523	+	Haplotype	243004	RCV000234986	SCV000292335	244097	APC	NM_001127511.2:c.-195A>C		NM_001127511.2:c.-195A>C:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 12, 2016	OMIM	OMIM	Familial adenomatous polyposis 1;FAMILIAL ADENOMATOUS POLYPOSIS 1 OF PROXIMAL STOMACH	11598466;15604628;20301519;21368914;21813476;23788249;24310308;25356965;25452455;25645574;27087319;27854360				loss of function	germline	GeneReviews:NBK1345;Genetic Testing Registry (GTR):GTR000172265;Genetic Testing Registry (GTR):GTR000321103;Genetic Testing Registry (GTR):GTR000326160;Genetic Testing Registry (GTR):GTR000330056;Genetic Testing Registry (GTR):GTR000500363;Genetic Testing Registry (GTR):GTR000500599;Genetic Testing Registry (GTR):GTR000500894;Genetic Testing Registry (GTR):GTR000501393;Genetic Testing Registry (GTR):GTR000501394;Genetic Testing Registry (GTR):GTR000501794;Genetic Testing Registry (GTR):GTR000508954;Genetic Testing Registry (GTR):GTR000512300;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000515534;Genetic Testing Registry (GTR):GTR000515885;Genetic Testing Registry (GTR):GTR000515899;Genetic Testing Registry (GTR):GTR000520026;Genetic Testing Registry (GTR):GTR000520047;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520077;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520868;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521915;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000527982;Genetic Testing Registry (GTR):GTR000527984;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000530028;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552290;Genetic Testing Registry (GTR):GTR000552303;Genetic Testing Registry (GTR):GTR000558907;MedGen:C2713442;OMIM:175100;OMIM:611731.0021;OMIM:611731.0028;OMIM:611731.0034;OMIM:611731.0035;OMIM:611731.0036;OMIM:611731.0038;OMIM:611731.0042;OMIM:611731.0043;OMIM:611731.0049	2016-07-12	0	0
5	112707592	GA	G	112707593	112707593	+	Haplotype	243004	RCV000234986	SCV000292335	244084	APC	NM_001127511.2:c.-125delA		NM_001127511.2:c.-125delA:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 12, 2016	OMIM	OMIM	Familial adenomatous polyposis 1;FAMILIAL ADENOMATOUS POLYPOSIS 1 OF PROXIMAL STOMACH	11598466;15604628;20301519;21368914;21813476;23788249;24310308;25356965;25452455;25645574;27087319;27854360				loss of function	germline	GeneReviews:NBK1345;Genetic Testing Registry (GTR):GTR000172265;Genetic Testing Registry (GTR):GTR000321103;Genetic Testing Registry (GTR):GTR000326160;Genetic Testing Registry (GTR):GTR000330056;Genetic Testing Registry (GTR):GTR000500363;Genetic Testing Registry (GTR):GTR000500599;Genetic Testing Registry (GTR):GTR000500894;Genetic Testing Registry (GTR):GTR000501393;Genetic Testing Registry (GTR):GTR000501394;Genetic Testing Registry (GTR):GTR000501794;Genetic Testing Registry (GTR):GTR000508954;Genetic Testing Registry (GTR):GTR000512300;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000515534;Genetic Testing Registry (GTR):GTR000515885;Genetic Testing Registry (GTR):GTR000515899;Genetic Testing Registry (GTR):GTR000520026;Genetic Testing Registry (GTR):GTR000520047;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520077;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520868;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521915;Genetic Testing Registry (GTR):GTR000522559;Genetic Testing Registry (GTR):GTR000527982;Genetic Testing Registry (GTR):GTR000527984;Genetic Testing Registry (GTR):GTR000528912;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000530028;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552290;Genetic Testing Registry (GTR):GTR000552303;Genetic Testing Registry (GTR):GTR000558907;MedGen:C2713442;OMIM:175100;OMIM:611731.0021;OMIM:611731.0028;OMIM:611731.0034;OMIM:611731.0035;OMIM:611731.0036;OMIM:611731.0038;OMIM:611731.0042;OMIM:611731.0043;OMIM:611731.0049	2016-07-12	0	0
5	136056754	C	A	136056754	136056754	+	Haplotype	7874	RCV000008323	SCV000028531	22913	TGFBI	NM_000358.2:c.1637C>A	NP_000349.1:p.Ala546Asp	NM_000358.2:c.1637C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2004	OMIM	OMIM	Lattice corneal dystrophy Type I;CORNEAL DYSTROPHY, LATTICE TYPE I	15111592;15531312					germline	Genetic Alliance:Lattice+corneal+dystrophy+type+1/4117;Genetics Home Reference:lattice-corneal-dystrophy-type-i;MedGen:C1690006;OMIM:122200;Office of Rare Diseases:9678;Orphanet:98964;SNOMED CT:419197009	2004-11-01	0	0
5	136056769	C	A	136056769	136056769	+	Haplotype	7874	RCV000008323	SCV000028531	38388	TGFBI	NM_000358.2:c.1652C>A	NP_000349.1:p.Pro551Gln	NM_000358.2:c.1652C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2004	OMIM	OMIM	Lattice corneal dystrophy Type I;CORNEAL DYSTROPHY, LATTICE TYPE I	15111592;15531312					germline	Genetic Alliance:Lattice+corneal+dystrophy+type+1/4117;Genetics Home Reference:lattice-corneal-dystrophy-type-i;MedGen:C1690006;OMIM:122200;Office of Rare Diseases:9678;Orphanet:98964;SNOMED CT:419197009	2004-11-01	0	0
5	172350405	GC	G	172350406	172350406	-	Distinct chromosomes	488055	RCV000577875	SCV000583573	15228	SH3PXD2B	NM_001017995.2:c.969delG	NP_001017995.1:p.Arg324Glyfs	NM_001017995.2:c.969delG:frameshift variant	Pathogenic	likely pathogenic	0	1	0	0	0	no assertion criteria provided	criteria provided, single submitter	Jun 01, 2017	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Frank Ter Haar syndrome;Opsismodysplasia	1;20137777;29276006					unknown	Genetic Alliance:Frank+Ter+Haar+Syndrome/2915;Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;MedGen:C1855305;OMIM:249420;OMIM:258480;Office of Rare Diseases:4098;Office of Rare Diseases:5138;Orphanet:137834;Orphanet:2746;SNOMED CT:254068007	2017-06-01	0	0
5	177515002	G	T	177515002	177515002	-	Haplotype	403734	RCV000465916	SCV000541081	390711	DDX41	NM_016222.3:c.712C>A	NP_057306.2:p.Pro238Thr	NM_016222.3:c.712C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Acute myeloid leukemia;Myelodysplasia	20963938;22138009;23970018;26944477					germline	GeneReviews:NBK47457;Genetic Testing Registry (GTR):GTR000500636;Human Phenotype Ontology:HP:0002863;Human Phenotype Ontology:HP:0004832;Human Phenotype Ontology:HP:0006730;MeSH:D015470;MedGen:C0023467;MedGen:C1851971;OMIM:601626;Orphanet:519;SNOMED CT:17788007	0000-00-00	0	0
5	177515003	C	A	177515003	177515003	-	Haplotype	403734	RCV000465916	SCV000541081	390712	DDX41	NM_016222.3:c.711G>T	NP_057306.2:p.Leu237Phe	NM_016222.3:c.711G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	Acute myeloid leukemia;Myelodysplasia	20963938;22138009;23970018;26944477					germline	GeneReviews:NBK47457;Genetic Testing Registry (GTR):GTR000500636;Human Phenotype Ontology:HP:0002863;Human Phenotype Ontology:HP:0004832;Human Phenotype Ontology:HP:0006730;MeSH:D015470;MedGen:C0023467;MedGen:C1851971;OMIM:601626;Orphanet:519;SNOMED CT:17788007	0000-00-00	0	0
6	10874380	A	T	10874380	10874380	-	Haplotype	375590	RCV000417072	SCV000494617	362401	GCM2	NM_004752.3:c.1136T>A	NP_004743.1:p.Leu379Gln	NM_004752.3:c.1136T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2017	OMIM	OMIM	Hyperparathyroidism 4;HYPERPARATHYROIDISM 4	27745835					germline	MedGen:CN240514;OMIM:617343	2017-02-10	0	0
6	10874765	G	C	10874765	10874765	-	Haplotype	375590	RCV000417072	SCV000494617	362400	GCM2	NM_004752.3:c.751C>G	NP_004743.1:p.Gln251Glu	NM_004752.3:c.751C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 10, 2017	OMIM	OMIM	Hyperparathyroidism 4;HYPERPARATHYROIDISM 4	27745835					germline	MedGen:CN240514;OMIM:617343	2017-02-10	0	0
6	18130687	T	C	18130687	18130687	-	Haplotype	12722	RCV000013559	SCV000033806	27764	TPMT	NM_000367.4:c.719A>G	NP_000358.1:p.Tyr240Cys	NM_000367.4:c.719A>G:missense variant	drug response, other	drug response	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 21, 2015	OMIM	OMIM	Thiopurine methyltransferase deficiency;THIOPURINES, POOR METABOLISM OF, 1	10208641;12880540;15819814;15967990;8561894;8644731;9177237;9336428;9931345;9931346				loss of function	germline	Genetic Alliance:Thiopurine+S+methyltranferase+deficiency/54;Genetic Testing Registry (GTR):GTR000299976;Genetic Testing Registry (GTR):GTR000502252;Genetic Testing Registry (GTR):GTR000509706;Genetic Testing Registry (GTR):GTR000520079;Genetic Testing Registry (GTR):GTR000522313;Genetic Testing Registry (GTR):GTR000522314;Genetic Testing Registry (GTR):GTR000525921;Genetic Testing Registry (GTR):GTR000553222;Genetic Testing Registry (GTR):GTR000558523;MedGen:C0342801;OMIM:187680.0001;OMIM:187680.0002;OMIM:187680.0003;OMIM:187680.0004;OMIM:187680.0005;OMIM:187680.0006;OMIM:187680.0007;OMIM:610460;Office of Rare Diseases:5173;Office of Rare Diseases:9153;PharmGKB:PA356;SNOMED CT:238012003	2005-06-28	0	0
6	18138997	C	T	18138997	18138997	-	Haplotype	12722	RCV000013559	SCV000033806	27761	TPMT	NM_000367.4:c.460G>A	NP_000358.1:p.Ala154Thr	NM_000367.4:c.460G>A:missense variant	drug response, other	drug response	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2015	OMIM	OMIM	Thiopurine methyltransferase deficiency;THIOPURINES, POOR METABOLISM OF, 1	10208641;12880540;15819814;15967990;8561894;8644731;9177237;9336428;9931345;9931346				loss of function	germline	Genetic Alliance:Thiopurine+S+methyltranferase+deficiency/54;Genetic Testing Registry (GTR):GTR000299976;Genetic Testing Registry (GTR):GTR000502252;Genetic Testing Registry (GTR):GTR000509706;Genetic Testing Registry (GTR):GTR000520079;Genetic Testing Registry (GTR):GTR000522313;Genetic Testing Registry (GTR):GTR000522314;Genetic Testing Registry (GTR):GTR000525921;Genetic Testing Registry (GTR):GTR000553222;Genetic Testing Registry (GTR):GTR000558523;MedGen:C0342801;OMIM:187680.0001;OMIM:187680.0002;OMIM:187680.0003;OMIM:187680.0004;OMIM:187680.0005;OMIM:187680.0006;OMIM:187680.0007;OMIM:610460;Office of Rare Diseases:5173;Office of Rare Diseases:9153;PharmGKB:PA356;SNOMED CT:238012003	2005-06-28	0	0
6	32039807	T	A	32039807	32039807	+	Haplotype	31662	RCV000012947	SCV000033191	33507	CYP21A2	NM_000500.7:c.710T>A	NP_000491.4:p.Ile237Asn	NM_000500.7:c.710T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 2005	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE	15623806;20301350;2249999;2845408					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2005-04-01	0	0
6	32039810	T	A	32039810	32039810	+	Haplotype	31662;65613	RCV000012947;RCV000055823	SCV000033191;SCV000086807	27212	CYP21A2	NM_000500.7:c.713T>A	NP_000491.4:p.Val238Glu	NM_000500.7:c.713T>A:missense variant	-	pathogenic;pathologic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2013	OMIM;GeneReviews	OMIM;GeneReviews	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE;21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia	15623806;20301350;2249999;2845408					germline;not provided	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2005-04-01;2013-08-29	0	0
6	32039816	T	A	32039816	32039816	+	Haplotype	31662;65613	RCV000012947;RCV000055823	SCV000033191;SCV000086807	40032	CYP21A2	NM_000500.7:c.719T>A	NP_000491.4:p.Met240Lys	NM_000500.7:c.719T>A:missense variant	-	pathogenic;pathologic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2013	OMIM;GeneReviews	OMIM;GeneReviews	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY, SALT-WASTING TYPE;21-Hydroxylase-Deficient Congenital Adrenal Hyperplasia	15623806;20301350;2249999;2845408					germline;not provided	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2005-04-01;2013-08-29	0	0
6	32040110	G	T	32040110	32040110	+	Haplotype	12182	RCV000417198	SCV000033208	27190	CYP21A2	NM_000500.7:c.844G>T	NP_000491.4:p.Val282Leu	NM_000500.7:c.844G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2017	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	0	0
6	32040182	G	GT	32040189	32040189	+	Haplotype	12182	RCV000417198	SCV000033208	76519	CYP21A2	NM_000500.7:c.923dupT	NP_000491.4:p.Leu308Phefs	NM_000500.7:c.923dupT:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 29, 2013	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	0	0
6	32040421	C	T	32040421	32040421	+	Haplotype	12182	RCV000417198	SCV000033208	27208	CYP21A2	NM_000500.7:c.955C>T	NP_000491.4:p.Gln319Ter	NM_000500.7:c.955C>T:nonsense	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Sep 03, 2015	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	2	0
6	32040535	C	T	32040535	32040535	+	Haplotype	12182	RCV000417198	SCV000033208	27191	CYP21A2	NM_000500.7:c.1069C>T	NP_000491.4:p.Arg357Trp	NM_000500.7:c.1069C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jan 16, 2015	OMIM	OMIM	21-hydroxylase deficiency;ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	11093272;12915679;20301350;7629224					germline	GeneReviews:NBK1171;Genetic Alliance:21-Hydroxylase+Deficiency/19;Genetics Home Reference:21-hydroxylase-deficiency;MedGen:C0852654;OMIM:201910;Office of Rare Diseases:5757	2003-08-01	1	0
6	39909922	G	A	39909922	39909922	-	Haplotype	208497	RCV000190510	SCV000245396	205013	MOCS1	NM_001075098.3:c.1015C>T	NP_001068566.1:p.Arg339Trp	NM_001075098.3:c.1015C>T:missense variant;NR_033233.1:n.1022C>T:non-coding transcript variant	Uncertain significance	likely benign	0	0	0	1	0	no assertion for the individual variant	no assertion criteria provided	Jul 31, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Molybdenum cofactor deficiency, complementation group A	21031595					germline	Genetics Home Reference:molybdenum-cofactor-deficiency;MedGen:C1854988;OMIM:252150;Orphanet:833	2016-05-13	0	0
6	39912909	C	T	39912909	39912909	-	Haplotype	208497	RCV000190510	SCV000245396	205014	MOCS1	NM_005943.5:c.853G>A	NP_005934.2:p.Glu285Lys	NM_001075098.3:c.853G>A:missense variant;NR_033233.1:n.860G>A:non-coding transcript variant	Uncertain significance	likely benign	0	0	0	1	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 31, 2016	Mendelics Analise Genomica	Mendelics Analise Genomica	Molybdenum cofactor deficiency, complementation group A	21031595					germline	Genetics Home Reference:molybdenum-cofactor-deficiency;MedGen:C1854988;OMIM:252150;Orphanet:833	2016-05-13	2	0
6	49612504	C	T	49612504	49612504	-	Haplotype	13065	RCV000013940	SCV000034187	38460	RHAG	NM_000324.2:c.838G>A	NP_000315.2:p.Gly280Arg	NM_000324.2:c.838G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1999	OMIM	OMIM	Rh-null hemolytic anemia, regulator type;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	9915949					germline	MedGen:C4016364	1999-01-01	0	0
6	49612534	C	T	49612534	49612534	-	Haplotype	13065	RCV000013940	SCV000034187	28104	RHAG	NM_000324.2:c.808G>A	NP_000315.2:p.Val270Ile	NM_000324.2:c.808G>A:missense variant	Benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 18, 2016	OMIM	OMIM	Rh-null hemolytic anemia, regulator type;RH-NULL HEMOLYTIC ANEMIA, REGULATOR TYPE	9915949					germline	MedGen:C4016364	1999-01-01	0	0
6	52424111	C	A	52424111	52424111	+	Haplotype	2067	RCV000002148	SCV000022306	17106	EFHC1	NM_018100.3:c.229C>A	NP_060570.2:p.Pro77Thr	NM_018100.3:c.229C>A:missense variant;NR_033327.1:n.444C>A:non-coding transcript variant	Conflicting interpretations of pathogenicity	risk factor	0	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Myoclonic epilepsy, juvenile 1;MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	12439895;15258581					germline		2004-08-01	1	1
6	52452776	G	A	52452776	52452776	+	Haplotype	2067	RCV000002148	SCV000022306	38421	EFHC1	NM_018100.3:c.662G>A	NP_060570.2:p.Arg221His	NM_018100.3:c.662G>A:missense variant;NR_033327.1:n.877G>A:non-coding transcript variant	Conflicting interpretations of pathogenicity	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 24, 2017	OMIM	OMIM	Myoclonic epilepsy, juvenile 1;MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 1	12439895;15258581					germline		2004-08-01	0	1
6	129280071	A	C	129280071	129280071	+	Haplotype	190218	RCV000170437	SCV000222875	188050	LAMA2	NM_000426.3:c.2461A>C	NP_000417.2:p.Thr821Pro	NM_000426.3:c.2461A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 08, 2015	Mendelics Analise Genomica	Mendelics Analise Genomica	Merosin deficient congenital muscular dystrophy;Merosin deficient congenital muscular dystrophy	20301468;21078917;22420014;22675738					germline	GeneReviews:NBK1291;Genetic Alliance:Muscular+dystrophy+congenital%2C+merosin+negative/4985;MedGen:C1263858;OMIM:607855;Office of Rare Diseases:3843;Orphanet:258;SNOMED CT:111503008	2015-04-08	0	0
6	129502696	T	C	129502696	129502696	+	Haplotype	190218	RCV000170437	SCV000222875	188051	LAMA2	NM_000426.3:c.8282T>C	NP_000417.2:p.Ile2761Thr	NM_000426.3:c.8282T>C:missense variant	Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 14, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Merosin deficient congenital muscular dystrophy;Merosin deficient congenital muscular dystrophy	20301468;21078917;22420014;22675738					germline	GeneReviews:NBK1291;Genetic Alliance:Muscular+dystrophy+congenital%2C+merosin+negative/4985;MedGen:C1263858;OMIM:607855;Office of Rare Diseases:3843;Orphanet:258;SNOMED CT:111503008	2015-04-08	0	0
6	146399690	GGAA	G	146399691	146399693	+	Haplotype	453266	RCV000030784	SCV000053445	45814	GRM1	NM_001278064.1:c.2652_2654delGAA	NP_001264993.1:p.Asn885del		-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 25, 2012	OMIM	OMIM	Spinocerebellar ataxia, autosomal recessive 13;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	22901947					germline	MedGen:C3553816;OMIM:614831;Orphanet:324262	2012-09-07	0	0
6	146399701	T	C	146399701	146399701	+	Haplotype	453266	RCV000030784	SCV000053445	434131	GRM1	NM_001278064.1:c.2660+2T>C		NM_001278064.1:c.2660+2T>C:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 25, 2012	OMIM	OMIM	Spinocerebellar ataxia, autosomal recessive 13;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	22901947					germline	MedGen:C3553816;OMIM:614831;Orphanet:324262	2012-09-07	0	0
6	152376443	C	T	152376443	152376443	-	Haplotype	92124	RCV000077790	SCV000109616	97550	SYNE1	NM_033071.3:c.9283G>A	NP_149062.1:p.Ala3095Thr	NM_182961.3:c.9262G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2013	OMIM	OMIM	Intellectual functioning disability;VARIANT OF UNKNOWN SIGNIFICANCE	21956720;24123876					germline	MedGen:C0025362;SNOMED CT:228156007;SNOMED CT:91138005	2013-12-01	0	0
6	152463486	T	C	152463486	152463486	-	Haplotype	92124	RCV000077790	SCV000109616	97551	SYNE1	NM_033071.3:c.1985A>G	NP_149062.1:p.Gln662Arg	NM_182961.3:c.1964A>G:missense variant	Benign/Likely benign	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 07, 2017	OMIM	OMIM	Intellectual functioning disability;VARIANT OF UNKNOWN SIGNIFICANCE	21956720;24123876					germline	MedGen:C0025362;SNOMED CT:228156007;SNOMED CT:91138005	2013-12-01	0	0
7	87443683	G	C	87443683	87443683	-	Haplotype	217883	RCV000201938	SCV000256879	214536	ABCB4	NM_018849.2:c.1210C>G	NP_061337.1:p.Pro404Ala	NM_018849.2:c.1210C>G:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 25, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Progressive familial intrahepatic cholestasis 3	17726488;9419367					germline	Genetic Alliance:Cholestasis%2C+Progressive+Familial+Intrahepatic+3/1351;Genetics Home Reference:progressive-familial-intrahepatic-cholestasis;MedGen:C1865643;OMIM:602347;Office of Rare Diseases:1289;Orphanet:79305	2014-07-25	0	0
7	87453049	C	T	87453049	87453049	-	Haplotype	217883	RCV000201938	SCV000256879	214537	ABCB4	NM_018849.2:c.431G>A	NP_061337.1:p.Arg144Gln	NM_018849.2:c.431G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 25, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Progressive familial intrahepatic cholestasis 3	17726488;9419367					germline	Genetic Alliance:Cholestasis%2C+Progressive+Familial+Intrahepatic+3/1351;Genetics Home Reference:progressive-familial-intrahepatic-cholestasis;MedGen:C1865643;OMIM:602347;Office of Rare Diseases:1289;Orphanet:79305	2014-07-25	0	0
7	107695963	A	C	107695963	107695963	+	Haplotype	4816	RCV000005085	SCV000025261	38434	SLC26A4	NM_000441.1:c.1468A>C	NP_000432.1:p.Ile490Leu	NM_000441.1:c.1468A>C:missense variant	Likely benign	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 01, 2015	OMIM	OMIM	Enlarged vestibular aqueduct syndrome;DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	18310264;20301607;20301640;9500541					germline	GeneReviews:NBK1467;Genetic Alliance:Enlarged+Vestibular+Aqueduct+Syndrome/2542;Genetic Testing Registry (GTR):GTR000500213;MedGen:C1863752;OMIM:600791;OMIM:601093.0001;OMIM:601093.0002;OMIM:602208.0008;OMIM:602208.0009;OMIM:605646.0004;OMIM:605646.0009;OMIM:605646.0010;OMIM:605646.0011;OMIM:605646.0012;OMIM:605646.0013;OMIM:605646.0014;OMIM:605646.0015;OMIM:605646.0027;OMIM:605646.0028;OMIM:605646.0029;OMIM:605646.0030;OMIM:605646.0031;Office of Rare Diseases:8651;Orphanet:90636	2008-07-01	1	0
7	107695984	G	A	107695984	107695984	+	Haplotype	4816	RCV000005085	SCV000025261	19855	SLC26A4	NM_000441.1:c.1489G>A	NP_000432.1:p.Gly497Ser	NM_000441.1:c.1489G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 30, 2017	OMIM	OMIM	Enlarged vestibular aqueduct syndrome;DEAFNESS, AUTOSOMAL RECESSIVE 4, WITH ENLARGED VESTIBULAR AQUEDUCT	18310264;20301607;20301640;9500541					germline	GeneReviews:NBK1467;Genetic Alliance:Enlarged+Vestibular+Aqueduct+Syndrome/2542;Genetic Testing Registry (GTR):GTR000500213;MedGen:C1863752;OMIM:600791;OMIM:601093.0001;OMIM:601093.0002;OMIM:602208.0008;OMIM:602208.0009;OMIM:605646.0004;OMIM:605646.0009;OMIM:605646.0010;OMIM:605646.0011;OMIM:605646.0012;OMIM:605646.0013;OMIM:605646.0014;OMIM:605646.0015;OMIM:605646.0027;OMIM:605646.0028;OMIM:605646.0029;OMIM:605646.0030;OMIM:605646.0031;Office of Rare Diseases:8651;Orphanet:90636	2008-07-01	2	0
7	117530975	G	A	117530975	117530975	+	Haplotype	209047	RCV000190992	SCV000245925	22148	CFTR	NM_000492.3:c.350G>A	NP_000483.3:p.Arg117His	NM_000492.3:c.350G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	practice guideline	reviewed by expert panel	Oct 31, 2017	CFTR2	CFTR2	Cystic fibrosis;Cystic fibrosis	11280952;12394352;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;23974870;24014130;25431289;25981758				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	0000-00-00	4	0
7	117540305	C	A	117540305	117540305	+	Haplotype	40200	RCV000007589	SCV000027790	22208	CFTR	NM_000492.3:c.1075C>A	NP_000483.3:p.Gln359Lys	NM_000492.3:c.1075C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1993	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;7679367				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	1993-01-01	0	0
7	117540309	C	A	117540309	117540309	+	Haplotype	40200	RCV000007589	SCV000027790	38441	CFTR	NM_000492.3:c.1079C>A	NP_000483.3:p.Thr360Lys	NM_000492.3:c.1079C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1993	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;7679367				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	1993-01-01	0	0
7	117603609	C	T	117603609	117603609	+	Haplotype	7239	RCV000007661	SCV000027862	22244	CFTR	NM_000492.3:c.2735C>T	NP_000483.3:p.Ser912Leu	NM_000492.3:c.2735C>T:missense variant	Benign/Likely benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 03, 2017	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15744523;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;8528204				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	2005-05-01	2	0
7	117642451	G	T	117642451	117642451	+	Haplotype	7239	RCV000007661	SCV000027862	22278	CFTR	NM_000492.3:c.3731G>T	NP_000483.3:p.Gly1244Val	NM_000492.3:c.3731G>T:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion provided	no assertion criteria provided	May 01, 2005	OMIM	OMIM	Cystic fibrosis;CYSTIC FIBROSIS	11280952;12394352;15744523;15789152;17761616;19888064;19914443;19914445;20301428;20605539;20675678;21422883;21938795;22475884;24014130;25431289;25981758;8528204				More than 1,000 CFTR variants have been reported.  Most common pathogenic variant is p.Phe508del.;loss of function	germline	GeneReviews:NBK1250;Genetic Alliance:Cystic+Fibrosis/2071;Genetic Testing Registry (GTR):GTR000004176;Genetic Testing Registry (GTR):GTR000005248;Genetic Testing Registry (GTR):GTR000025280;Genetic Testing Registry (GTR):GTR000028916;Genetic Testing Registry (GTR):GTR000074114;Genetic Testing Registry (GTR):GTR000194834;Genetic Testing Registry (GTR):GTR000209428;Genetic Testing Registry (GTR):GTR000226639;Genetic Testing Registry (GTR):GTR000277984;Genetic Testing Registry (GTR):GTR000288561;Genetic Testing Registry (GTR):GTR000320929;Genetic Testing Registry (GTR):GTR000324499;Genetic Testing Registry (GTR):GTR000328569;Genetic Testing Registry (GTR):GTR000330969;Genetic Testing Registry (GTR):GTR000332363;Genetic Testing Registry (GTR):GTR000501120;Genetic Testing Registry (GTR):GTR000501211;Genetic Testing Registry (GTR):GTR000501918;Genetic Testing Registry (GTR):GTR000501920;Genetic Testing Registry (GTR):GTR000501921;Genetic Testing Registry (GTR):GTR000502992;Genetic Testing Registry (GTR):GTR000505699;Genetic Testing Registry (GTR):GTR000506511;Genetic Testing Registry (GTR):GTR000507003;Genetic Testing Registry (GTR):GTR000507006;Genetic Testing Registry (GTR):GTR000507010;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507950;Genetic Testing Registry (GTR):GTR000508782;Genetic Testing Registry (GTR):GTR000508810;Genetic Testing Registry (GTR):GTR000508811;Genetic Testing Registry (GTR):GTR000508812;Genetic Testing Registry (GTR):GTR000508889;Genetic Testing Registry (GTR):GTR000508890;Genetic Testing Registry (GTR):GTR000508893;Genetic Testing Registry (GTR):GTR000508894;Genetic Testing Registry (GTR):GTR000514611;Genetic Testing Registry (GTR):GTR000515757;Genetic Testing Registry (GTR):GTR000515758;Genetic Testing Registry (GTR):GTR000520059;Genetic Testing Registry (GTR):GTR000521501;Genetic Testing Registry (GTR):GTR000521905;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528606;Genetic Testing Registry (GTR):GTR000529460;Genetic Testing Registry (GTR):GTR000530118;Genetic Testing Registry (GTR):GTR000553017;Genetic Testing Registry (GTR):GTR000556535;Genetic Testing Registry (GTR):GTR000556536;Genetic Testing Registry (GTR):GTR000558875;Genetic Testing Registry (GTR):GTR000558928;MedGen:C0010674;OMIM:219700;Office of Rare Diseases:6233;Orphanet:586;SNOMED CT:190905008	2005-05-01	0	0
8	1771262	C	T	1771262	1771262	+	Haplotype	217887	RCV000201947	SCV000256883	214538	CLN8	NM_018941.3:c.208C>T	NP_061764.2:p.Arg70Cys	NM_018941.3:c.208C>T:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 18, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Ceroid lipofuscinosis neuronal 8	16570191;20301601					germline	GeneReviews:NBK1428;MedGen:C1838570;OMIM:600143;Office of Rare Diseases:4010;Orphanet:168491;Orphanet:228354;Orphanet:79264	2014-08-18	0	0
8	1780498	C	G	1780498	1780498	+	Haplotype	217887	RCV000201947	SCV000256883	106601	CLN8	NM_018941.3:c.792C>G	NP_061764.2:p.Asn264Lys	NM_018941.3:c.792C>G:missense variant	Pathogenic	likely pathogenic	0	1	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 18, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Ceroid lipofuscinosis neuronal 8	16570191;20301601					germline	GeneReviews:NBK1428;MedGen:C1838570;OMIM:600143;Office of Rare Diseases:4010;Orphanet:168491;Orphanet:228354;Orphanet:79264	2014-08-18	0	0
8	31064934	A	T	31064934	31064934	+	Haplotype	5453	RCV000005786	SCV000025968	20492	WRN	NM_000553.5:c.375A>T	NP_000544.2:p.Lys125Asn	NM_000553.5:c.375A>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2006	OMIM	OMIM	Werner syndrome;WERNER SYNDROME	16673358;20301687;22258520					germline	GeneReviews:NBK1514;Genetic Alliance:Werner%27s+syndrome/7471;Genetics Home Reference:werner-syndrome;MedGen:C0043119;OMIM:277700;Office of Rare Diseases:7885;Orphanet:902;SNOMED CT:51626007	2006-06-01	0	0
8	31064962	A	G	31064962	31064962	+	Haplotype	5453	RCV000005786	SCV000025968	38386	WRN	NM_000553.5:c.403A>G	NP_000544.2:p.Lys135Glu	NM_000553.5:c.403A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 2006	OMIM	OMIM	Werner syndrome;WERNER SYNDROME	16673358;20301687;22258520					germline	GeneReviews:NBK1514;Genetic Alliance:Werner%27s+syndrome/7471;Genetics Home Reference:werner-syndrome;MedGen:C0043119;OMIM:277700;Office of Rare Diseases:7885;Orphanet:902;SNOMED CT:51626007	2006-06-01	0	0
8	38414166	G	C	38414166	38414166	-	Haplotype	16292	RCV000030930	SCV000037962	38475	FGFR1	NM_023110.2:c.2172C>G	NP_075598.2:p.Asn724Lys	NM_023110.2:c.2172C>G:missense variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 18, 2006	OMIM	OMIM	Kallmann syndrome 2;HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	16606836;20301509				loss of function	germline	Endocrinology Clinic, Seth G.S. Medical College:FGFR1sn_4;GeneReviews:NBK1334;Genetic Alliance:Kallmann+syndrome+2/3947;Genetic Testing Registry (GTR):GTR000508944;Genetic Testing Registry (GTR):GTR000511562;Genetic Testing Registry (GTR):GTR000511608;Genetic Testing Registry (GTR):GTR000511609;Genetic Testing Registry (GTR):GTR000511610;Genetic Testing Registry (GTR):GTR000511611;Genetic Testing Registry (GTR):GTR000511612;Genetic Testing Registry (GTR):GTR000511613;Genetic Testing Registry (GTR):GTR000512869;Genetic Testing Registry (GTR):GTR000556729;Genetic Testing Registry (GTR):GTR000556731;Genetic Testing Registry (GTR):GTR000558347;MedGen:C1563720;OMIM:136350.0004;OMIM:136350.0013;OMIM:136350.0014;OMIM:136350.0015;OMIM:136350.0016;OMIM:136350.0020;OMIM:136350.0023;OMIM:136350.0024;OMIM:136350.0025;OMIM:147950;Office of Rare Diseases:3070;Orphanet:478	2006-04-18	0	0
8	38414173	G	T	38414173	38414173	-	Haplotype	16292	RCV000030930	SCV000037962	31331	FGFR1	NM_023110.2:c.2165C>A	NP_075598.2:p.Pro722His	NM_023110.2:c.2165C>A:missense variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 18, 2006	OMIM	OMIM	Kallmann syndrome 2;HYPOGONADOTROPIC HYPOGONADISM 2 WITHOUT ANOSMIA, SUSCEPTIBILITY TO	16606836;20301509				loss of function	germline	Endocrinology Clinic, Seth G.S. Medical College:FGFR1sn_4;GeneReviews:NBK1334;Genetic Alliance:Kallmann+syndrome+2/3947;Genetic Testing Registry (GTR):GTR000508944;Genetic Testing Registry (GTR):GTR000511562;Genetic Testing Registry (GTR):GTR000511608;Genetic Testing Registry (GTR):GTR000511609;Genetic Testing Registry (GTR):GTR000511610;Genetic Testing Registry (GTR):GTR000511611;Genetic Testing Registry (GTR):GTR000511612;Genetic Testing Registry (GTR):GTR000511613;Genetic Testing Registry (GTR):GTR000512869;Genetic Testing Registry (GTR):GTR000556729;Genetic Testing Registry (GTR):GTR000556731;Genetic Testing Registry (GTR):GTR000558347;MedGen:C1563720;OMIM:136350.0004;OMIM:136350.0013;OMIM:136350.0014;OMIM:136350.0015;OMIM:136350.0016;OMIM:136350.0020;OMIM:136350.0023;OMIM:136350.0024;OMIM:136350.0025;OMIM:147950;Office of Rare Diseases:3070;Orphanet:478	2006-04-18	0	0
8	142912850	A	G	142912850	142912850	-	Haplotype	16876;16877	RCV000018372;RCV000018373	SCV000038654;SCV000038655	31916	CYP11B2	NM_000498.3:c.1157T>C	NP_000489.3:p.Val386Ala	NM_000498.3:c.1157T>C:missense variant	Benign	pathogenic	2	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Corticosterone methyloxidase type 2 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY;Corticosterone methyloxidase type 1 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	1346492;1594605;3262827;4121586;830445;838841;9814506				loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+2+deficiency/8102;Genetic Testing Registry (GTR):GTR000500407;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:C3463917;OMIM:610600;Orphanet:427;Genetic Alliance:Corticosterone+methyloxidase+type+1+deficiency/8101;Genetic Testing Registry (GTR):GTR000507687;MedGen:CN074214;OMIM:203400;Office of Rare Diseases:5660	1992-06-01;1998-11-01	1	0
8	142915047	T	G	142915047	142915047	-	Haplotype	16877	RCV000018373	SCV000038655	38484	CYP11B2	NM_000498.3:c.594A>C	NP_000489.3:p.Glu198Asp	NM_000498.3:c.594A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 1998	OMIM	OMIM	Corticosterone methyloxidase type 1 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE I DEFICIENCY	9814506				loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+1+deficiency/8101;Genetic Testing Registry (GTR):GTR000500407;Genetic Testing Registry (GTR):GTR000507687;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:CN074214;OMIM:203400;Office of Rare Diseases:5660;Orphanet:427	1998-11-01	0	0
8	142915100	G	A	142915100	142915100	-	Haplotype	16876	RCV000018372	SCV000038654	31915	CYP11B2	NM_000498.3:c.541C>T	NP_000489.3:p.Arg181Trp	NM_000498.3:c.541C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 1992	OMIM	OMIM	Corticosterone methyloxidase type 2 deficiency;CORTICOSTERONE METHYLOXIDASE TYPE II DEFICIENCY	1346492;1594605;3262827;4121586;830445;838841				loss of function	germline	Genetic Alliance:Corticosterone+methyloxidase+type+2+deficiency/8102;Genetic Testing Registry (GTR):GTR000500407;Genetics Home Reference:corticosterone-methyloxidase-deficiency;MedGen:C3463917;OMIM:610600;Orphanet:427	1992-06-01	0	0
9	2115860	G	C	2115860	2115860	+	Haplotype	374221	RCV000415335	SCV000493071	361134	SMARCA2	NM_003070.4:c.3495G>C	NP_003061.3:p.Gln1165His	NM_003070.4:c.3495G>C:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Laboratory of Molecular Genetics,CHU RENNES	Laboratory of Molecular Genetics,CHU RENNES	Nicolaides-Baraitser syndrome;Nicolaides Baraitser syndrome	26468571					de novo	GeneReviews:NBK321516;Genetic Alliance:Nicolaides+Baraitser+syndrome/5221;Genetics Home Reference:nicolaides-baraitser-syndrome;MedGen:C1303073;OMIM:601358;Orphanet:3051;SNOMED CT:401046009	0000-00-00	0	0
9	2123873	G	A	2123873	2123873	+	Haplotype	374221	RCV000415335	SCV000493071	361135	SMARCA2	NM_003070.4:c.3917G>A	NP_003061.3:p.Arg1306Lys	NM_003070.4:c.3917G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Laboratory of Molecular Genetics,CHU RENNES	Laboratory of Molecular Genetics,CHU RENNES	Nicolaides-Baraitser syndrome;Nicolaides Baraitser syndrome	26468571					de novo	GeneReviews:NBK321516;Genetic Alliance:Nicolaides+Baraitser+syndrome/5221;Genetics Home Reference:nicolaides-baraitser-syndrome;MedGen:C1303073;OMIM:601358;Orphanet:3051;SNOMED CT:401046009	0000-00-00	0	0
9	34646575	CCAGT	C	34646586	34646589	+	Haplotype	140570	RCV000128642	SCV000148002	36445	GALT	NM_000155.3:c.-67-52_-67-49delGTCA		NM_000155.3:c.-119_-116del:2KB upstream variant;NM_000155.3:c.-67-52_-67-49delGTCA:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Nov 09, 2017	GeneReviews	GeneReviews	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase;Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase	10408771;10424825;10649501;11216901;11286503;11754113;15633893;15841485;16838075;19224951;2011574;20301691;22475884;25473725					germline	GeneReviews:NBK1518;Genetic Alliance:Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206;MedGen:C0268151;OMIM:230400;Office of Rare Diseases:2424;Orphanet:352;Orphanet:79239;SNOMED CT:124354006	2014-04-03	1	1
9	34648421	C	T	34648421	34648421	+	Haplotype	3620	RCV000003804	SCV000023969	18659	GALT	NM_000155.3:c.652C>T	NP_000146.2:p.Leu218=	NM_000155.3:c.652C>T:synonymous variant	Benign/Likely benign, other	benign	0	0	0	0	1	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 08, 2017	OMIM	OMIM	GALT POLYMORPHISM (LOS ANGELES, D1);GALT POLYMORPHISM (LOS ANGELES, D1)	10408771;10424825;19224951;2011574;4759900;8522334;9012409					germline	OMIM:606999.0012	2009-05-01	2	0
9	34649445	A	G	34649445	34649445	+	Haplotype	140570;3620	RCV000128642;RCV000003804	SCV000148002;SCV000023969	18652	GALT	NM_000155.3:c.940A>G	NP_000146.2:p.Asn314Asp	NM_000155.3:c.940A>G:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic;benign	1	0	0	0	1	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 26, 2017	GeneReviews;OMIM	GeneReviews;OMIM	Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase;GALT POLYMORPHISM (LOS ANGELES, D1)	10408771;10424825;10649501;11216901;11286503;11754113;15633893;15841485;16838075;19224951;2011574;20301691;22475884;25473725;4759900;8522334;9012409					germline	GeneReviews:NBK1518;Genetic Alliance:Deficiency+of+UTP-hexose-1-phosphate+uridylyltransferase/8206;MedGen:C0268151;OMIM:230400;Office of Rare Diseases:2424;Orphanet:352;Orphanet:79239;SNOMED CT:124354006;OMIM:606999.0012	2014-04-03;2009-05-01	1	1
9	37424830	TCC	T	37424832	37424833	+	Haplotype	204246	RCV000186453	SCV000239808	200618	GRHPR	NM_012203.1:c.84-13_84-12delCC		NM_012203.1:c.84-13_84-12delCC:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type II;Primary hyperoxaluria, type II	14635115;20301742				loss of function	germline	GeneReviews:NBK2692;Genetic Alliance:Primary+hyperoxaluria+type+2/5948;Genetic Testing Registry (GTR):GTR000118462;Genetic Testing Registry (GTR):GTR000507682;Genetic Testing Registry (GTR):GTR000522211;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268165;OMIM:260000;Office of Rare Diseases:2836;Orphanet:416;Orphanet:93599;SNOMED CT:40951006	2014-11-27	0	0
9	37424836	TCCCC	T	37424837	37424840	+	Haplotype	204246	RCV000186453	SCV000239808	200619	GRHPR	NM_012203.1:c.84-8_84-5delCCCC		NM_012203.1:c.84-8_84-5delCCCC:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 27, 2014	Clinical Biochemistry Laboratory,Health Services Laboratory	Clinical Biochemistry Laboratory,Health Services Laboratory	Primary hyperoxaluria, type II;Primary hyperoxaluria, type II	14635115;20301742				loss of function	germline	GeneReviews:NBK2692;Genetic Alliance:Primary+hyperoxaluria+type+2/5948;Genetic Testing Registry (GTR):GTR000118462;Genetic Testing Registry (GTR):GTR000507682;Genetic Testing Registry (GTR):GTR000522211;Genetic Testing Registry (GTR):GTR000528276;MedGen:C0268165;OMIM:260000;Office of Rare Diseases:2836;Orphanet:416;Orphanet:93599;SNOMED CT:40951006	2014-11-27	0	0
9	98578034	T	C	98578034	98578034	-	Haplotype	3331	RCV000003495	SCV000023653	18370	GABBR2	NM_005458.7:c.360A>G	NP_005449.5:p.Ala120=	NM_005458.7:c.360A>G:synonymous variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2005	OMIM	OMIM	Tobacco addiction, susceptibility to;NICOTINE DEPENDENCE, SUSCEPTIBILITY TO	15759211					germline	Genetic Alliance:Tobacco+addiction%2C+susceptibility+to/9410;MedGen:C1861063;OMIM:188890;OMIM:607340.0001;OMIM:607340.0002	2005-05-01	0	0
9	124500574	G	A	124500574	124500574	-	Haplotype	12809	RCV000013657;RCV000022775	SCV000033904;SCV000044064	38458	NR5A1	NM_004959.4:c.386C>T	NP_004950.2:p.Pro129Leu	NM_004959.4:c.386C>T:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 08, 2010	OMIM	OMIM	Premature ovarian failure 7;PREMATURE OVARIAN FAILURE 7;Spermatogenic failure 8	19246354;20887963					germline	Genetic Alliance:Premature+ovarian+failure+7/9153;MedGen:C2751825;OMIM:612964;Genetic Alliance:Spermatogenic+failure+8/9327;MedGen:C3151406;OMIM:613957	2010-10-08	0	0
9	124500592	C	G	124500592	124500592	-	Haplotype	12809	RCV000013657;RCV000022775	SCV000033904;SCV000044064	27848	NR5A1	NM_004959.4:c.368G>C	NP_004950.2:p.Gly123Ala	NM_004959.4:c.368G>C:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 08, 2010	OMIM	OMIM	Premature ovarian failure 7;PREMATURE OVARIAN FAILURE 7;Spermatogenic failure 8	19246354;20887963					germline	Genetic Alliance:Premature+ovarian+failure+7/9153;MedGen:C2751825;OMIM:612964;Genetic Alliance:Spermatogenic+failure+8/9327;MedGen:C3151406;OMIM:613957	2010-10-08	0	0
9	132327718	G	A	132327718	132327718	-	Haplotype	441281	RCV000002384	SCV000022542	38425	SETX	NM_015046.5:c.3880C>T	NP_055861.3:p.Arg1294Cys	NM_015046.5:c.3880C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 23, 2006	OMIM	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	16717225;20050888;20301317;20301333					germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753	2006-05-23	0	0
9	132327789	G	A	132327789	132327789	-	Phase unknown	157525	RCV000144869	SCV000172140	167387	SETX	NM_015046.5:c.3809C>T	NP_055861.3:p.Pro1270Leu	NM_015046.5:c.3809C>T:missense variant	Likely benign	uncertain significance	0	0	1	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Nov 09, 2016	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	2	0
9	132328521	C	CTCA	132328522	132328523		Distinct chromosomes	157528	RCV000144873	SCV000172145	167390	REEP1	NM_015046.5:c.3075_3076insTGA	NP_055861.3:p.Arg1026_Lys1360delinsTer	NM_015046.5:c.3075_3076insTGA:inframe_variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2013	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type|spasticity;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	0	0
9	132329641	G	T	132329641	132329641	-	Haplotype	441280	RCV000002383	SCV000022541	38424	SETX	NM_015046.5:c.1957C>A	NP_055861.3:p.Gln653Lys	NM_015046.5:c.1957C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	17096168;20050888;20301317;20301333					germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753	2007-01-01	0	0
9	132329791	T	C	132329791	132329791	-	Haplotype	441280	RCV000002383	SCV000022541	17332	SETX	NM_015046.5:c.1807A>G	NP_055861.3:p.Asn603Asp	NM_015046.5:c.1807A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2007	OMIM	OMIM	Spinocerebellar ataxia autosomal recessive 1;SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1	17096168;20050888;20301317;20301333					germline	GeneReviews:NBK1154;Genetic Alliance:Spinocerebellar+ataxia+autosomal+recessive+1/6771;Genetics Home Reference:ataxia-with-oculomotor-apraxia;MedGen:C1853761;OMIM:606002;Office of Rare Diseases:4949;Orphanet:64753	2007-01-01	0	0
9	132349370	C	T	132349370	132349370	-	Phase unknown	157525	RCV000144869	SCV000172140	167386	SETX	NM_015046.5:c.59G>A	NP_055861.3:p.Arg20His	NM_015046.5:c.59G>A:missense variant	Benign/Likely benign	uncertain significance	0	0	1	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 31, 2017	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	20301532;25025039					tested-inconclusive	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	2	0
9	133255928	C	G	133255928	133255928	-	Haplotype	17738	RCV000019312	SCV000039601	38414	ABO	NM_020469.2:c.803G>C	NP_065202.2:p.Gly268Ala	NM_020469.2:c.803G>C:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	ABO blood group system;ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE	14170898;6775529;8456556					germline	MedGen:C0000778;OMIM:110300.0001;OMIM:110300.0002;OMIM:110300.0003;OMIM:110300.0004;OMIM:110300.0005;OMIM:616093;SNOMED CT:63915006	2015-05-18	0	0
9	133256264	G	A	133256264	133256264	-	Haplotype	17738	RCV000019312	SCV000039601	32777	ABO	NM_020469.2:c.467C>T	NP_065202.2:p.Pro156Leu	NM_020469.2:c.467C>T:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	ABO blood group system;ABO BLOOD GROUP SYSTEM, CIS-AB PHENOTYPE	14170898;6775529;8456556					germline	MedGen:C0000778;OMIM:110300.0001;OMIM:110300.0002;OMIM:110300.0003;OMIM:110300.0004;OMIM:110300.0005;OMIM:616093;SNOMED CT:63915006	2015-05-18	0	0
9	133436862	C	G	133436862	133436862	+	Haplotype	5813	RCV000006169	SCV000026351	20852	ADAMTS13	NM_139025.4:c.1342C>G	NP_620594.1:p.Gln448Glu	NM_139025.4:c.1342C>G:missense variant;NR_024514.2:n.993-2504C>G:intron variant	Benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Upshaw-Schulman syndrome;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	12181489					germline	Genetic Alliance:Thrombotic+thrombocytopenic+purpura%2C+congenital/7089;Genetics Home Reference:thrombotic-thrombocytopenic-purpura;MedGen:C1268935;OMIM:274150;Office of Rare Diseases:9430;SNOMED CT:373420004	2002-09-03	2	0
9	133437836	G	A	133437836	133437836	+	Haplotype	5813	RCV000006169	SCV000026351	38438	ADAMTS13	NM_139025.4:c.1523G>A	NP_620594.1:p.Cys508Tyr	NM_139025.4:c.1523G>A:missense variant;NR_024514.2:n.993-1530G>A:intron variant	not provided	pathogenic	1	0	0	0	0	no assertion provided	no assertion criteria provided	Sep 03, 2002	OMIM	OMIM	Upshaw-Schulman syndrome;THROMBOTIC THROMBOCYTOPENIC PURPURA, CONGENITAL	12181489					germline	Genetic Alliance:Thrombotic+thrombocytopenic+purpura%2C+congenital/7089;Genetics Home Reference:thrombotic-thrombocytopenic-purpura;MedGen:C1268935;OMIM:274150;Office of Rare Diseases:9430;SNOMED CT:373420004	2002-09-03	0	0
9	133636672	G	A	133636672	133636672	+	Haplotype	1752	RCV000001822	SCV000021978	16791	DBH	NM_000787.3:c.301G>A	NP_000778.3:p.Val101Met	NM_000787.3:c.301G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Oct 29, 2015	OMIM	OMIM	Dopamine beta hydroxylase deficiency;DOPAMINE BETA-HYDROXYLASE DEFICIENCY	11857564;20301647					germline	GeneReviews:NBK1474;Genetic Alliance:Dopamine+Beta+Hydroxylase+Deficiency/2316;MedGen:C0342687;OMIM:223360;Office of Rare Diseases:1903;Orphanet:230	2002-03-01	0	0
9	133647854	G	A	133647854	133647854	+	Haplotype	1752	RCV000001822	SCV000021978	38418	DBH	NM_000787.3:c.1033G>A	NP_000778.3:p.Asp345Asn	NM_000787.3:c.1033G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 29, 2015	OMIM	OMIM	Dopamine beta hydroxylase deficiency;DOPAMINE BETA-HYDROXYLASE DEFICIENCY	11857564;20301647					germline	GeneReviews:NBK1474;Genetic Alliance:Dopamine+Beta+Hydroxylase+Deficiency/2316;MedGen:C0342687;OMIM:223360;Office of Rare Diseases:1903;Orphanet:230	2002-03-01	0	0
10	43114496	G	C	43114496	43114496	+	Haplotype	13906	RCV000014920	SCV000035176	28945	RET	NM_020975.4:c.1896G>C	NP_066124.1:p.Glu632Asp	NM_020975.4:c.1896G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1994	OMIM	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416;19469690;20301434;21863057;23788249;24893135;25356965;25394175;27854360;3078962;7907913;8099202;8103403;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009	1994-01-01	0	0
10	43114497	C	G	43114497	43114497	+	Haplotype	13906	RCV000014920	SCV000035176	38399	RET	NM_020975.4:c.1897C>G	NP_066124.1:p.Leu633Val	NM_020975.4:c.1897C>G:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 13, 2016	OMIM	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416;19469690;20301434;21863057;23788249;24893135;25356965;25394175;27854360;3078962;7907913;8099202;8103403;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009	1994-01-01	0	0
10	43114500	T	C	43114500	43114500	+	Haplotype	13906	RCV000014920	SCV000035176	28956	RET	NM_020975.4:c.1900T>C	NP_066124.1:p.Cys634Arg	NM_020975.4:c.1900T>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Sep 28, 2017	OMIM	OMIM	Multiple endocrine neoplasia, type 2a;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA	11739416;19469690;20301434;21863057;23788249;24893135;25356965;25394175;27854360;3078962;7907913;8099202;8103403;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia+type+2A/4956;MeSH:D018813;MedGen:C0025268;OMIM:164761.0001;OMIM:164761.0002;OMIM:164761.0003;OMIM:164761.0004;OMIM:164761.0005;OMIM:164761.0006;OMIM:164761.0007;OMIM:164761.0008;OMIM:164761.0009;OMIM:164761.0010;OMIM:164761.0011;OMIM:164761.0012;OMIM:164761.0024;OMIM:164761.0025;OMIM:164761.0033;OMIM:164761.0040;OMIM:164761.0047;OMIM:164761.0049;OMIM:171400;Orphanet:653;SNOMED CT:61808009	1994-01-01	2	0
10	43119548	G	A	43119548	43119548	+	Haplotype	13945	RCV000014972	SCV000035228	28984	RET	NM_020975.4:c.2410G>A	NP_066124.1:p.Val804Met	NM_020975.4:c.2410G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 27, 2017	OMIM	OMIM	Multiple endocrine neoplasia, type 2b;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	11739416;11788682;19469690;20301434;21863057;23788249;24893135;25356965;27854360;8797874;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia%2C+type+2B/4958;MeSH:D018814;MedGen:C0025269;OMIM:162300;OMIM:164761.0013;OMIM:164761.0043;Orphanet:653;SNOMED CT:6153000;SNOMED CT:61530001	2002-01-01	0	0
10	43120184	C	G	43120184	43120184	+	Haplotype	13945	RCV000014972	SCV000035228	36303	RET	NM_020975.4:c.2711C>G	NP_066124.1:p.Ser904Cys	NM_020975.4:c.2711C>G:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	OMIM	OMIM	Multiple endocrine neoplasia, type 2b;MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB	11739416;11788682;19469690;20301434;21863057;23788249;24893135;25356965;27854360;8797874;8918855					germline	GeneReviews:NBK1257;Genetic Alliance:Multiple+endocrine+neoplasia%2C+type+2B/4958;MeSH:D018814;MedGen:C0025269;OMIM:162300;OMIM:164761.0013;OMIM:164761.0043;Orphanet:653;SNOMED CT:6153000;SNOMED CT:61530001	2002-01-01	0	0
10	62813491	C	A	62813491	62813491	-	Haplotype	16751	RCV000018235	SCV000038514	38481	EGR2	NM_000399.4:c.1147G>T	NP_000390.2:p.Asp383Tyr	NM_000399.4:c.1147G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Oct 18, 2012	OMIM	OMIM	Neuropathy, congenital hypomyelinating, autosomal dominant;NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	9537424					germline	MedGen:CN069993	1998-04-01	0	0
10	62813492	A	C	62813492	62813492	-	Haplotype	16751	RCV000018235	SCV000038514	31790	EGR2	NM_000399.4:c.1146T>G	NP_000390.2:p.Ser382Arg	NM_000399.4:c.1146T>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Oct 18, 2012	OMIM	OMIM	Neuropathy, congenital hypomyelinating, autosomal dominant;NEUROPATHY, CONGENITAL HYPOMYELINATING, AUTOSOMAL DOMINANT	9537424					germline	MedGen:CN069993	1998-04-01	0	0
10	70884002	C	T	70884002	70884002	-	Haplotype	180130	RCV000156929	SCV000206650	178310	PCBD1	NM_000281.3:c.263G>A	NP_000272.1:p.Arg88Gln	NM_000281.3:c.263G>A:missense variant;NM_001323004.1:c.216+1150G>A:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2014	OMIM	OMIM	Hyperphenylalaninemia, BH4-deficient, D;HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	24848070;9760199					germline	Genetic Alliance:Hyperphenylalaninemia+with+primapterinuria/3595;MedGen:C1849700;OMIM:264070;Orphanet:238583	2014-10-01	0	0
10	70885854	C	A	70885854	70885854	-	Haplotype	180130	RCV000156929	SCV000206650	178311	PCBD1	NM_000281.3:c.79G>T	NP_000272.1:p.Glu27Ter	NM_000281.3:c.79G>T:nonsense;NM_001289797.1:c.-69G>T:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2014	OMIM	OMIM	Hyperphenylalaninemia, BH4-deficient, D;HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	24848070;9760199					germline	Genetic Alliance:Hyperphenylalaninemia+with+primapterinuria/3595;MedGen:C1849700;OMIM:264070;Orphanet:238583	2014-10-01	0	0
10	94313343	T	C	94313343	94313343	+	Haplotype	266012	RCV000256386	SCV000323171	260792	PLCE1	NM_016341.3:c.6093T>C	NP_057425.3:p.Thr2031=	NM_016341.3:c.6093T>C:synonymous variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	-	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Nephrotic syndrome, type 3						germline	Genetic Alliance:Nephrotic+syndrome%2C+type+3/8988;MedGen:C1853124;OMIM:610725;Orphanet:656	0000-00-00	0	0
10	94324971	G	A	94324971	94324971	+	Haplotype	266012	RCV000256386	SCV000323171	260793	PLCE1	NM_016341.3:c.6800G>A	NP_057425.3:p.Arg2267Gln	NM_016341.3:c.6800G>A:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	no assertion criteria provided	-	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Bioscientia Institut fuer Medizinische Diagnostik GmbH,Sonic Healthcare	Nephrotic syndrome, type 3						germline	Genetic Alliance:Nephrotic+syndrome%2C+type+3/8988;MedGen:C1853124;OMIM:610725;Orphanet:656	0000-00-00	0	0
10	94942290	C	T	94942290	94942290	+	Haplotype	177709	RCV000154312	SCV000203973	23448	CYP2C9	NM_000771.3:c.430C>T	NP_000762.2:p.Arg144Cys	NM_000771.3:c.430C>T:missense variant	drug response	drug response	0	0	0	0	0	reviewed by expert panel	no assertion criteria provided	Aug 28, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Warfarin response;Warfarin Metabolism	18281915;18281922;24251364;26186657					germline	Genetic Alliance:Warfarin+response/9469;MedGen:CN078029;OMIM:122700;OMIM:122720.0001;OMIM:122720.0005;OMIM:608547.0002;OMIM:608547.0003;OMIM:608547.0004;OMIM:608547.0005;OMIM:608547.0007;PharmGKB:PA451906	2006-11-20	3	0
10	94981296	A	C	94981296	94981296	+	Haplotype	163021	RCV000150378	SCV000197513	23447	CYP2C9	NM_000771.3:c.1075A>C	NP_000762.2:p.Ile359Leu	NM_000771.3:c.1075A>C:missense variant	drug response	drug response	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 10, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Warfarin response;Warfarin Metabolism	18281915;18281922;24251364;26186657					germline	Genetic Alliance:Warfarin+response/9469;MedGen:CN078029;OMIM:122700;OMIM:122720.0001;OMIM:122720.0005;OMIM:608547.0002;OMIM:608547.0003;OMIM:608547.0004;OMIM:608547.0005;OMIM:608547.0007;PharmGKB:PA451906	2006-11-20	0	0
10	119030538	G	A	119030538	119030538	+	Haplotype	65392	RCV000055619	SCV000083844	76326	NANOS1	NM_199461.3:c.737G>A	NP_955631.1:p.Arg246His	NM_199461.3:c.737G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2013	OMIM	OMIM	Spermatogenic failure 12;SPERMATOGENIC FAILURE 12	23315541					germline	MedGen:C3809427;OMIM:615413	2013-03-01	0	0
10	119030627	CG	TA	119030627	119030628	+	Haplotype	65392	RCV000055619	SCV000083844	76327	NANOS1	NM_199461.3:c.826_827delCGinsTA	NP_955631.1:p.Arg276Tyr	NM_199461.3:c.826_827delCGinsTA:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2013	OMIM	OMIM	Spermatogenic failure 12;SPERMATOGENIC FAILURE 12	23315541					germline	MedGen:C3809427;OMIM:615413	2013-03-01	0	0
10	133526101	G	C	133526101	133526101	+	Haplotype	16887	RCV000018383	SCV000038665	136523	CYP2E1	NM_000773.3:c.-1295G>C		NM_000773.3:c.-1295G>C:2KB upstream variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 20, 2016	OMIM	OMIM	CYP2E1*5B ALLELE;CYP2E1*5B ALLELE	10543395;1778977;19444287					germline	OMIM:124040.0001	2016-04-20	0	0
10	133526341	C	T	133526341	133526341	+	Haplotype	16887	RCV000018383	SCV000038665	136524	CYP2E1	NM_000773.3:c.-1055C>T		NM_000773.3:c.-1055C>T:2KB upstream variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 20, 2016	OMIM	OMIM	CYP2E1*5B ALLELE;CYP2E1*5B ALLELE	10543395;1778977;19444287					germline	OMIM:124040.0001	2016-04-20	0	0
11	2572089	G	A	2572089	2572089	+	Haplotype	444879	RCV000003296	SCV000023454	18157	KCNQ1	NM_000218.2:c.760G>A	NP_000209.2:p.Val254Met	NM_000218.2:c.760G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 29, 2017	OMIM	OMIM	Long QT syndrome 1;LONG QT SYNDROME 1	10973849;12820704;14678125;1475667;14756674;20301308;21810866;23788249;25356965;27854360;8528244;9386136					germline	GeneReviews:NBK1129;Genetic Alliance:Long+QT+syndrome+1/4297;MedGen:C0035828;OMIM:192500;Office of Rare Diseases:3284;Orphanet:101016;Orphanet:768;SNOMED CT:20852007	2004-03-01	0	0
11	2587690	G	A	2587690	2587690	+	Haplotype	444879	RCV000003296	SCV000023454	38428	KCNQ1	NM_181798.1:c.868G>A	NP_000209.2:p.Val417Met	NM_000218.2:c.1249G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2004	OMIM	OMIM	Long QT syndrome 1;LONG QT SYNDROME 1	10973849;12820704;14678125;1475667;14756674;20301308;21810866;23788249;25356965;27854360;8528244;9386136					germline	GeneReviews:NBK1129;Genetic Alliance:Long+QT+syndrome+1/4297;MedGen:C0035828;OMIM:192500;Office of Rare Diseases:3284;Orphanet:101016;Orphanet:768;SNOMED CT:20852007	2004-03-01	0	0
11	5225609	T	A	5225609	5225609	-	Haplotype	446749	RCV000016884	SCV000037154	38409	HBB	NM_000518.4:c.433A>T	NP_000509.1:p.Lys145Ter	NM_000518.4:c.433A>T:nonsense	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN KOCHI;HEMOGLOBIN KOCHI	15768550					germline	OMIM:141900.0532	2016-07-20	0	0
11	5225614	G	A	5225614	5225614	-	Haplotype	446738	RCV000016580	SCV000036849	38472	HBB	NM_000518.4:c.428C>T	NP_000509.1:p.Ala143Val	NM_000518.4:c.428C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 1992	OMIM	OMIM	HEMOGLOBIN S (TRAVIS);HEMOGLOBIN S (TRAVIS)	1634360;19257					germline	OMIM:141900.0247	1992-01-01	0	0
11	5225618	G	C	5225618	5225618	-	Haplotype	446749	RCV000016884	SCV000037154	30656	HBB	NM_000518.4:c.424C>G	NP_000509.1:p.Leu142Val	NM_000518.4:c.424C>G:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN KOCHI;HEMOGLOBIN KOCHI	15768550					germline	OMIM:141900.0532	2016-07-20	0	0
11	5225675	A	G	5225675	5225675	-	Haplotype	446744	RCV000016848	SCV000037118	30619	HBB	NM_000518.4:c.367T>C	NP_000509.1:p.Phe123Leu	NM_000518.4:c.367T>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN CASABLANCA;HEMOGLOBIN CASABLANCA	10870883					germline	OMIM:141900.0493	2016-07-20	0	0
11	5225678	C	G	5225678	5225678	-	Haplotype	446739;446740;446745	RCV000016617;RCV000016758;RCV000016858	SCV000036886;SCV000037028;SCV000037128	30191	HBB	NM_000518.4:c.364G>C	NP_000509.1:p.Glu122Gln	NM_000518.4:c.364G>C:missense variant	Conflicting interpretations of pathogenicity, other	other	0	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	HEMOGLOBIN T (CAMBODIA);HEMOGLOBIN CLEVELAND;HEMOGLOBIN D (AGRI)	1177278;1244906;12709369;15108284;16370495;16540414;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136;1787096;11570725					germline	OMIM:141900.0276;OMIM:141900.0407;OMIM:141900.0502	2016-07-20	1	1
11	5225678	C	T	5225678	5225678	-	Haplotype	446736;446746	RCV000016577;RCV000016863	SCV000036846;SCV000037133	30331	HBB	NM_000518.4:c.364G>A	NP_000509.1:p.Glu122Lys	NM_000518.4:c.364G>A:missense variant	Pathogenic, other	pathogenic;other	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	Sickle cell-Hemoglobin O Arab disease;HEMOGLOBIN S (OMAN);HEMOGLOBIN O (TIBESTI)	10203101;1112610;11179419;14282052;15108284;15502081;15543018;15710580;15710581;1732017;18254282;19783722;20704537;20854120;25052315;2930724;3859465;5481775;5915974;6716421;8195007;893136;9049622;9834244;11939508					germline	MedGen:C1264000;OMIM:141900.0245;SNOMED CT:127048005;OMIM:141900.0507	1999-04-01;2016-07-20	0	0
11	5225683	C	T	5225683	5225683	-	Haplotype	446732;446733	RCV000016336;RCV000016486	SCV000036604;SCV000036754	38469	HBB	NM_000518.4:c.359G>A	NP_000509.1:p.Gly120Asp	NM_000518.4:c.359G>A:missense variant	Likely benign	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 26, 2017	OMIM	OMIM	HEMOGLOBIN FANNIN-LUBBOCK;HEMOGLOBIN MASUDA	20942;7852084;2634673					germline	OMIM:141900.0075;OMIM:141900.0172	2017-02-27;2016-07-20	1	0
11	5225699	G	T	5225699	5225699	-	Haplotype	446733	RCV000016486	SCV000036754	30525	HBB	NM_000518.4:c.343C>A	NP_000509.1:p.Leu115Met	NM_000518.4:c.343C>A:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN MASUDA;HEMOGLOBIN MASUDA	2634673					germline	OMIM:141900.0172	2016-07-20	0	0
11	5225708	C	G	5225708	5225708	-	Haplotype	446732	RCV000016336	SCV000036604	30204	HBB	NM_000518.4:c.334G>C	NP_000509.1:p.Val112Leu	NM_000518.4:c.334G>C:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN FANNIN-LUBBOCK;HEMOGLOBIN FANNIN-LUBBOCK	20942;7852084					germline	OMIM:141900.0075	2017-02-27	0	0
11	5226597	C	T	5226597	5226597	-	Haplotype	446743	RCV000016807	SCV000037077	30280	HBB	NM_000518.4:c.295G>A	NP_000509.1:p.Val99Met	NM_000518.4:c.295G>A:missense variant	Pathogenic	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Apr 24, 2017	OMIM	OMIM	HEMOGLOBIN MEDICINE LAKE;HEMOGLOBIN MEDICINE LAKE	7860732					germline	OMIM:141900.0452	2016-07-20	1	0
11	5226606	T	C	5226606	5226606	-	Haplotype	446729	RCV000016251	SCV000036519	30317	HBB	NM_000518.4:c.286A>G	NP_000509.1:p.Lys96Glu	NM_000518.4:c.286A>G:missense variant	Likely benign, other	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 10, 2017	OMIM	OMIM	HEMOGLOBIN ARLINGTON PARK;HEMOGLOBIN ARLINGTON PARK	893139					germline	OMIM:141900.0010	2016-07-20	2	0
11	5226612	A	G	5226612	5226612	-	Haplotype	446740	RCV000016758	SCV000037028	30336	HBB	NM_000518.4:c.280T>C	NP_000509.1:p.Cys94Arg	NM_000518.4:c.280T>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN CLEVELAND;HEMOGLOBIN CLEVELAND	1177278;1244906;12709369;15108284;16370495;16540414;1787096;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136					germline	OMIM:141900.0407	2016-07-20	0	0
11	5226614	T	G	5226614	5226614	-	Haplotype	446742	RCV000016780	SCV000037050	30326	HBB	NM_000518.4:c.278A>C	NP_000509.1:p.His93Pro	NM_000518.4:c.278A>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN DUINO;HEMOGLOBIN DUINO	1511986					germline	OMIM:141900.0427	2016-07-20	0	0
11	5226621	C	T	5226621	5226621	-	Haplotype	446747	RCV000016877	SCV000037147	30130	HBB	NM_000518.4:c.271G>A	NP_000509.1:p.Glu91Lys	NM_000518.4:c.271G>A:missense variant	other	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN S (CAMEROON);HEMOGLOBIN S (CAMEROON)	15182055					germline	OMIM:141900.0521	2004-05-01	0	0
11	5226633	C	G	5226633	5226633	-	Haplotype	446734	RCV000016553	SCV000036821	30650	HBB	NM_000518.4:c.259G>C	NP_000509.1:p.Ala87Pro	NM_000518.4:c.259G>C:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN POISSY;HEMOGLOBIN POISSY	3841063					germline	OMIM:141900.0223	2016-07-20	0	0
11	5226672	C	T	5226672	5226672	-	Haplotype	446730	RCV000016286	SCV000036554	30283	HBB	NM_000518.4:c.220G>A	NP_000509.1:p.Asp74Asn	NM_000518.4:c.220G>A:missense variant	Likely benign, other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 23, 2017	OMIM	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (GEORGETOWN)	13943409;5069596;5490239;5928902					germline	OMIM:141900.0039;OMIM:141900.0040	2017-02-27	0	0
11	5226687	G	A	5226687	5226687	-	Haplotype	446748	RCV000016879	SCV000037149	30652	HBB	NM_000518.4:c.205C>T	NP_000509.1:p.Leu69Phe	NM_000518.4:c.205C>T:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN JAMAICA PLAIN;HEMOGLOBIN JAMAICA PLAIN	15470216;6166632					germline	OMIM:141900.0523	2017-02-27	0	0
11	5226695	T	A	5226695	5226695	-	Haplotype	446744	RCV000016848	SCV000037118	30250	HBB	NM_000518.4:c.197A>T	NP_000509.1:p.Lys66Met	NM_000518.4:c.197A>T:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN CASABLANCA;HEMOGLOBIN CASABLANCA	10870883					germline	OMIM:141900.0493	2016-07-20	0	0
11	5226716	G	C	5226716	5226716	-	Haplotype	446731	RCV000030905	SCV000036556	30437	HBB	NM_000518.4:c.176C>G	NP_000509.1:p.Pro59Arg	NM_000518.4:c.176C>G:missense variant	Pathogenic	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (ZIGUINCHOR)	1225575;893143					germline	OMIM:141900.0039;OMIM:141900.0040	2016-07-20	0	0
11	5226723	C	G	5226723	5226723	-	Haplotype	446734	RCV000016553	SCV000036821	30227	HBB	NM_000518.4:c.169G>C	NP_000509.1:p.Gly57Arg	NM_000518.4:c.169G>C:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 27, 2017	OMIM	OMIM	HEMOGLOBIN POISSY;HEMOGLOBIN POISSY	3841063					germline	OMIM:141900.0223	2016-07-20	0	0
11	5226735	C	T	5226735	5226735	-	Haplotype	446741	RCV000016759	SCV000037029	30341	HBB	NM_000518.4:c.157G>A	NP_000509.1:p.Asp53Asn	NM_000518.4:c.157G>A:missense variant	Conflicting interpretations of pathogenicity	other	0	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jun 27, 2017	OMIM	OMIM	HEMOGLOBIN GRENOBLE;HEMOGLOBIN GRENOBLE	10335988;15008267;16178917;18932067;2079433;5097135;640855					germline	OMIM:141900.0408	2016-07-20	1	1
11	5226738	G	A	5226738	5226738	-	Haplotype	446741	RCV000016759	SCV000037029	30536	HBB	NM_000518.4:c.154C>T	NP_000509.1:p.Pro52Ser	NM_000518.4:c.154C>T:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN GRENOBLE;HEMOGLOBIN GRENOBLE	10335988;15008267;16178917;18932067;2079433;5097135;640855					germline	OMIM:141900.0408	2016-07-20	0	0
11	5226794	A	T	5226794	5226794	-	Haplotype	446743	RCV000016807	SCV000037077	30572	HBB	NM_000518.4:c.98T>A	NP_000509.1:p.Leu33Gln	NM_000518.4:c.98T>A:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN MEDICINE LAKE;HEMOGLOBIN MEDICINE LAKE	7860732					germline	OMIM:141900.0452	2016-07-20	0	0
11	5226943	C	T	5226943	5226943	-	Haplotype	446739	RCV000016617	SCV000036886	30200	HBB	NM_000518.4:c.79G>A	NP_000509.1:p.Glu27Lys	NM_000518.4:c.79G>A:missense variant	Pathogenic, other, protective	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 23, 2017	OMIM	OMIM	HEMOGLOBIN T (CAMBODIA);HEMOGLOBIN T (CAMBODIA)	1177278;1244906;12709369;15108284;16370495;16540414;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136					germline	OMIM:141900.0276	2016-07-20	2	0
11	5226952	C	T	5226952	5226952	-	Haplotype	446735	RCV000016576	SCV000036845	38470	HBB	NM_000518.4:c.70G>A	NP_000509.1:p.Val24Ile	NM_000518.4:c.70G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 01, 1997	OMIM	OMIM	HEMOGLOBIN S (ANTILLES);HEMOGLOBIN S (ANTILLES)	2189492;3467311;9166865					germline	OMIM:141900.0244	1997-06-01	0	0
11	5226988	C	T	5226988	5226988	-	Haplotype	446746	RCV000016863	SCV000037133	30228	HBB	NM_000518.4:c.34G>A	NP_000509.1:p.Val12Ile	NM_000518.4:c.34G>A:missense variant	Uncertain significance, other	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Nov 12, 2016	OMIM	OMIM	HEMOGLOBIN O (TIBESTI);HEMOGLOBIN O (TIBESTI)	1112610;11179419;11939508;14282052;15108284;15502081;15543018;15710580;15710581;1732017;18254282;19783722;20704537;20854120;2930724;3859465;5481775;5915974;6716421;8195007;893136;9049622;9834244					germline	OMIM:141900.0507	2016-07-20	1	0
11	5226993	G	T	5226993	5226993	-	Haplotype	446745	RCV000016858	SCV000037128	30658	HBB	NM_000518.4:c.29C>A	NP_000509.1:p.Ser10Tyr	NM_000518.4:c.29C>A:missense variant	other	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN D (AGRI);HEMOGLOBIN D (AGRI)	11570725;1177278;1244906;12709369;15108284;16370495;16540414;19440680;19460936;20437613;20704537;20838957;21119755;2930724;4613830;640855;893136					germline	OMIM:141900.0502	2016-07-20	0	0
11	5227002	T	A	5227002	5227002	-	Haplotype	446730;446731;446735;446736;446737;446738;446747;446748	RCV000016286;RCV000030905;RCV000016576;RCV000016577;RCV000016579;RCV000016580;RCV000016877;RCV000016879	SCV000036554;SCV000036556;SCV000036845;SCV000036846;SCV000036848;SCV000036849;SCV000037147;SCV000037149	30372	HBB	NM_000518.4:c.20A>T	NP_000509.1:p.Glu7Val	NM_000518.4:c.20A>T:missense variant	Pathogenic, other, protective	other;pathogenic	5	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Dec 11, 2017	OMIM	OMIM	HEMOGLOBIN ZIGUINCHOR;HEMOGLOBIN C (GEORGETOWN);HEMOGLOBIN C (ZIGUINCHOR);HEMOGLOBIN S (ANTILLES);Sickle cell-Hemoglobin O Arab disease;HEMOGLOBIN S (OMAN);HEMOGLOBIN S (PROVIDENCE);HEMOGLOBIN S (TRAVIS);HEMOGLOBIN S (CAMEROON);HEMOGLOBIN JAMAICA PLAIN	13943409;5069596;5490239;5928902;1225575;893143;2189492;3467311;9166865;10203101;1112610;11179419;14282052;15108284;15502081;15543018;15710580;15710581;1732017;18254282;19783722;20704537;20854120;25052315;2930724;3859465;5481775;5915974;6716421;8195007;893136;9049622;9834244;3191036;1634360;19257;15182055;15470216;6166632					germline	OMIM:141900.0039;OMIM:141900.0040;OMIM:141900.0244;MedGen:C1264000;OMIM:141900.0245;SNOMED CT:127048005;OMIM:141900.0246;OMIM:141900.0247;OMIM:141900.0521;OMIM:141900.0523	2017-02-27;2016-07-20;1997-06-01;1999-04-01;1988-10-01;1992-01-01;2004-05-01	2	0
11	5227003	C	T	5227003	5227003	-	Haplotype	446729	RCV000016251	SCV000036519	30165	HBB	NM_000518.4:c.19G>A	NP_000509.1:p.Glu7Lys	NM_000518.4:c.19G>A:missense variant	Pathogenic, protective	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 27, 2017	OMIM	OMIM	HEMOGLOBIN ARLINGTON PARK;HEMOGLOBIN ARLINGTON PARK	893139					germline	OMIM:141900.0010	2016-07-20	2	0
11	5248393	G	C	5248393	5248393	-	Haplotype	446751	RCV000016180	SCV000036448	38468	HBG1	NM_000559.2:c.410C>G	NP_000550.2:p.Ala137Gly	NM_000559.2:c.410C>G:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 15, 2011	OMIM	OMIM	HEMOGLOBIN F (CHARLOTTE);HEMOGLOBIN F (CHARLOTTE)	1714434					germline	OMIM:142200.0032	2011-07-15	0	0
11	5248394	C	A	5248394	5248394	-	Haplotype	446752	RCV000016185	SCV000036453	30080	HBG1	NM_000559.2:c.409G>T	NP_000550.2:p.Ala137Ser	NM_000559.2:c.409G>T:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 18, 2016	OMIM	OMIM	HEMOGLOBIN F (PORTO TORRES);HEMOGLOBIN F (PORTO TORRES)	15666429					germline	OMIM:142200.0037	2016-08-18	0	0
11	5249456	G	A	5249456	5249456	-	Haplotype	446751;446752	RCV000016180;RCV000016185	SCV000036448;SCV000036453	30044	HBG1	NM_000559.2:c.227C>T	NP_000550.2:p.Thr76Ile	NM_000559.2:c.227C>T:missense variant	Benign, other	other	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Aug 18, 2016	OMIM	OMIM	HEMOGLOBIN F (CHARLOTTE);HEMOGLOBIN F (PORTO TORRES)	1714434;15666429					germline	OMIM:142200.0032;OMIM:142200.0037	2011-07-15;2016-08-18	1	0
11	36574823	C	T	36574823	36574823	+	Haplotype	13157	RCV000014043	SCV000034290	28196	RAG1	NM_000448.2:c.1519C>T	NP_000439.1:p.Arg507Trp	NM_000448.2:c.1519C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 08, 2008	OMIM	OMIM	Combined cellular and humoral immune defects with granulomas;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	18463379					germline	Genetic Alliance:Combined+cellular+and+humoral+immune+defects+with+granulomas/8008;MedGen:C2673536;OMIM:233650	2008-05-08	0	0
11	36575514	G	A	36575514	36575514	+	Haplotype	13157	RCV000014043	SCV000034290	28188	RAG1	NM_000448.2:c.2210G>A	NP_000439.1:p.Arg737His	NM_000448.2:c.2210G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 08, 2008	OMIM	OMIM	Combined cellular and humoral immune defects with granulomas;COMBINED CELLULAR AND HUMORAL IMMUNE DEFECTS WITH GRANULOMAS	18463379					germline	Genetic Alliance:Combined+cellular+and+humoral+immune+defects+with+granulomas/8008;MedGen:C2673536;OMIM:233650	2008-05-08	0	0
11	44107972	T	G	44107972	44107972	+	Haplotype	218894	RCV000203245	SCV000258309	137950	EXT2	NM_000401.3:c.359T>G	NP_997005.1:p.Met87Arg	NM_207122.1:c.260T>G:missense variant	Likely benign	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Seizures, scoliosis, and macrocephaly syndrome;SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME (1 family)	26246518					germline	MedGen:C4225248;OMIM:616682	2015-10-01	0	0
11	44107995	C	T	44107995	44107995	+	Haplotype	218894	RCV000203245	SCV000258309	215653	EXT2	NM_000401.3:c.382C>T	NP_997005.1:p.Arg95Cys	NM_207122.1:c.283C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 01, 2015	OMIM	OMIM	Seizures, scoliosis, and macrocephaly syndrome;SEIZURES, SCOLIOSIS, AND MACROCEPHALY SYNDROME (1 family)	26246518					germline	MedGen:C4225248;OMIM:616682	2015-10-01	0	0
11	66346080	G	A	66346080	66346080	-	Haplotype	51008	RCV000043695	SCV000071708	65678	B4GAT1	NM_006876.2:c.1217C>T	NP_006867.1:p.Ala406Val	NM_006876.2:c.1217C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	23359570					germline	MedGen:C3809042;OMIM:615287;Orphanet:899	2013-05-01	0	0
11	66346129	T	C	66346129	66346129	-	Haplotype	51008	RCV000043695	SCV000071708	65679	B4GAT1	NM_006876.2:c.1168A>G	NP_006867.1:p.Asn390Asp	NM_006876.2:c.1168A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a, 13;MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13	23359570					germline	MedGen:C3809042;OMIM:615287;Orphanet:899	2013-05-01	0	0
11	72225013	C	CG	72225019	72225019	+	Haplotype	235823	RCV000224773	SCV000281677	237478	INPPL1	NM_001567.3:c.35dupG	NP_001558.3:p.Ala13Argfs	NM_001567.3:c.35dupG:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					unknown	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0
11	72229558	G	C	72229558	72229558	+	Haplotype	235822	RCV000224420	SCV000281676	237479	INPPL1	NM_001567.3:c.753G>C	NP_001558.3:p.Gln251His	NM_001567.3:c.753G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0
11	72229676	CAG	C	72229677	72229678	+	Haplotype	235825	RCV000224914	SCV000281680	237480	INPPL1	NM_001567.3:c.768_769delAG	NP_001558.3:p.Glu258Alafs	NM_001567.3:c.768_769delAG:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0
11	72232260	G	A	72232260	72232260		Distinct chromosomes	488055	RCV000577875	SCV000583573	481067	SH3PXD2B	NM_001567.3:c.1636G>A	NP_001558.3:p.Val546Ile	NM_001567.3:c.1636G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Lupski Lab, Baylor-Hopkins CMG,Baylor College of Medicine	Frank Ter Haar syndrome;Opsismodysplasia	1;20137777;29276006					unknown	Genetic Alliance:Frank+Ter+Haar+Syndrome/2915;Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;MedGen:C1855305;OMIM:249420;OMIM:258480;Office of Rare Diseases:4098;Office of Rare Diseases:5138;Orphanet:137834;Orphanet:2746;SNOMED CT:254068007	2017-06-01	0	0
11	72232303	GTCACC	G	72232311	72232315	+	Haplotype	235823	RCV000224773	SCV000281677	237481	INPPL1	NM_001567.3:c.1687_1691delACCTC	NP_001558.3:p.Thr563Glyfs	NM_001567.3:c.1687_1691delACCTC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					unknown	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0
11	72234616	G	A	72234616	72234616	+	Haplotype	235825	RCV000224914	SCV000281680	48075	INPPL1	NM_001567.3:c.2415+1G>A		NM_001567.3:c.2415+1G>A:splice donor variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 04, 2013	University of Washington Center for Mendelian Genomics, University of Washington	University of Washington Center for Mendelian Genomics, University of Washington	Opsismodysplasia	23273567					inherited	Genetic Alliance:Opsismodysplasia/5372;MedGen:C0432219;OMIM:258480;Office of Rare Diseases:4098;Orphanet:2746;SNOMED CT:254068007	2013-01-08	0	0
11	121166652	C	T	121166652	121166652	+	Haplotype	7013	RCV000007428	SCV000027628	22052	TECTA	NM_005422.2:c.5458C>T	NP_005413.2:p.Leu1820Phe	NM_005422.2:c.5458C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1998	OMIM	OMIM	Deafness, autosomal dominant 12;DEAFNESS, AUTOSOMAL DOMINANT 12	20301607;9590290					germline	Genetic Alliance:Deafness%2C+autosomal+dominant+12/8133;MedGen:C1832187;OMIM:601543;Orphanet:90635	1998-05-01	0	0
11	121166665	G	A	121166665	121166665	+	Haplotype	7013	RCV000007428	SCV000027628	38440	TECTA	NM_005422.2:c.5471G>A	NP_005413.2:p.Gly1824Asp	NM_005422.2:c.5471G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1998	OMIM	OMIM	Deafness, autosomal dominant 12;DEAFNESS, AUTOSOMAL DOMINANT 12	20301607;9590290					germline	Genetic Alliance:Deafness%2C+autosomal+dominant+12/8133;MedGen:C1832187;OMIM:601543;Orphanet:90635	1998-05-01	0	0
12	57500406	G	A	57500406	57500406	+	Haplotype	189364	RCV000169765;RCV000173000	SCV000196708;SCV000224019	187252	MARS	NM_004990.3:c.1177G>A	NP_004981.2:p.Ala393Thr	NM_004990.3:c.1177G>A:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 07, 2015	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Pulmonary alveolar proteinosis;Interstitial lung and liver disease;INTERSTITIAL LUNG AND LIVER DISEASE	25913036					germline	MedGen:C0034050;SNOMED CT:10501004;MedGen:C4225400;OMIM:615486	2014-12-02;2015-05-07	0	0
12	57512300	C	T	57512300	57512300	+	Haplotype	189364	RCV000169765;RCV000173000	SCV000196708;SCV000224019	187253	MARS	NM_004990.3:c.1700C>T	NP_004981.2:p.Ser567Leu	NM_004990.3:c.1700C>T:missense variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 07, 2015	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Institute of Human Genetics, Klinikum rechts der Isar;OMIM	Pulmonary alveolar proteinosis;Interstitial lung and liver disease;INTERSTITIAL LUNG AND LIVER DISEASE	25913036					germline	MedGen:C0034050;SNOMED CT:10501004;MedGen:C4225400;OMIM:615486	2014-12-02;2015-05-07	0	0
12	80358880	A	G	80358880	80358880	+	Haplotype	229122	RCV000217831	SCV000272283	230419	OTOGL	NM_173591.3:c.6220A>G	NP_775862.3:p.Ile2074Val	NM_173591.3:c.6220A>G:missense variant	Benign	uncertain significance	0	0	1	0	0	criteria provided, single submitter	criteria provided, single submitter	Dec 01, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-01	1	0
12	80358881	T	C	80358881	80358881	+	Haplotype	229122	RCV000217831	SCV000272283	230420	OTOGL	NM_173591.3:c.6221T>C	NP_775862.3:p.Ile2074Thr	NM_173591.3:c.6221T>C:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-12-01	0	0
12	101757254	G	A	101757254	101757254	-	Haplotype	39094	RCV000032361	SCV000056008	47698	GNPTAB	NM_024312.4:c.3392C>T	NP_077288.2:p.Ser1131Phe	NM_024312.4:c.3392C>T:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0
12	101757256	A	AG	101757257	101757258	-	Haplotype	39094	RCV000032361	SCV000056008	47699	GNPTAB	NM_024312.4:c.3388_3389insC	NP_077288.2:p.Val1130Alafs	NM_024312.4:c.3388_3389insC:frameshift variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0
12	101761615	G	A	101761615	101761615	-	Haplotype	39093	RCV000032360	SCV000056007	47696	GNPTAB	NM_024312.4:c.2864C>T	NP_077288.2:p.Ala955Val	NM_024312.4:c.2864C>T:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0
12	101761696	T	C	101761696	101761696	-	Haplotype	39093	RCV000032360	SCV000056007	47697	GNPTAB	NM_024312.4:c.2783A>G	NP_077288.2:p.Lys928Arg	NM_024312.4:c.2783A>G:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0
12	101780579	T	G	101780579	101780579	-	Haplotype	39095	RCV000032362	SCV000056009	47700	GNPTAB	NM_024312.4:c.614A>C	NP_077288.2:p.Gln205Pro	NM_024312.4:c.614A>C:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0
12	101786038	A	T	101786038	101786038	-	Haplotype	39095	RCV000032362	SCV000056009	47701	GNPTAB	NM_024312.4:c.545T>A	NP_077288.2:p.Val182Asp	NM_024312.4:c.545T>A:missense variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 10, 2012	GeneReviews	GeneReviews	I cell disease;Mucolipidosis II	20301728					not provided	GeneReviews:NBK1828;Genetic Alliance:Mucolipidosis+II/3706;Genetics Home Reference:mucolipidosis-ii-alpha-beta;MedGen:C2673377;OMIM:252500;Office of Rare Diseases:6749;Orphanet:576	2012-05-10	0	0
12	102852903	G	A	102852903	102852903	-	Haplotype	217885	RCV000201954	SCV000256881	15623	PAH	NM_000277.2:c.754C>T	NP_000268.1:p.Arg252Trp	NM_000277.2:c.754C>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 07, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Phenylketonuria	20301677;21915151;24385074;24667081;2574153;9429153				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2014-08-07	2	0
12	102852922	C	T	102852922	102852922	-	Haplotype	402236	RCV000454199	SCV000538053	98655	PAH	NM_000277.2:c.735G>A	NP_000268.1:p.Val245=	NM_000277.2:c.735G>A:synonymous variant	Benign	likely pathogenic	0	1	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Jun 14, 2016	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Phenylketonuria	20301677;21915151;24385074;24667081;25741868				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2015-08-13	2	0
12	102852934	GC	G	102852935	102852935	-	Haplotype	402236	RCV000454199	SCV000538053	108542	PAH	NM_000277.2:c.722delG	NP_000268.1:p.Arg241Profs	NM_000277.2:c.722delG:frameshift variant	Likely pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Aug 13, 2015	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Knight Diagnostic Laboratories,Oregon Health and Sciences University	Phenylketonuria	20301677;21915151;24385074;24667081;25741868				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2015-08-13	0	0
12	102878057	C	A	102878057	102878057	-	Haplotype	217885	RCV000201954	SCV000256881	214540	PAH	NM_000277.2:c.353-507G>T		NM_000277.2:c.353-507G>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 07, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Phenylketonuria	20301677;21915151;24385074;24667081;2574153;9429153				loss of function	germline	GeneReviews:NBK1504;Genetic Alliance:Phenylketonuria/5714;Genetic Testing Registry (GTR):GTR000260641;Genetic Testing Registry (GTR):GTR000330994;Genetic Testing Registry (GTR):GTR000505064;Genetic Testing Registry (GTR):GTR000505124;Genetic Testing Registry (GTR):GTR000506557;Genetic Testing Registry (GTR):GTR000507953;Genetic Testing Registry (GTR):GTR000509046;Genetic Testing Registry (GTR):GTR000522527;MedGen:C0031485;OMIM:261600;Office of Rare Diseases:7383;Orphanet:716;SNOMED CT:154735006	2014-08-07	0	0
12	109783751	A	T	109783751	109783751	-	Haplotype	378057	RCV000435546	SCV000513422	472257	TRPV4	NM_021625.4:c.2486T>A	NP_067638.3:p.Val829Glu	NM_021625.4:c.2486T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 03, 2017	OMIM	OMIM	Avascular necrosis of femoral head, primary, 2;AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2 (1 family)	27330106					germline	MedGen:CN240839;OMIM:617383	2017-03-03	0	0
12	109783752	CGCGG	C	109783753	109783756	-	Haplotype	378057	RCV000435546	SCV000513422	380146	TRPV4	NM_021625.4:c.2481_2484delCCGC	NP_067638.3:p.Arg828Trpfs	NM_021625.4:c.2481_2484delCCGC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 03, 2017	OMIM	OMIM	Avascular necrosis of femoral head, primary, 2;AVASCULAR NECROSIS OF FEMORAL HEAD, PRIMARY, 2 (1 family)	27330106					germline	MedGen:CN240839;OMIM:617383	2017-03-03	0	0
13	20189174	G	T	20189174	20189174	-	Haplotype	267367;446728	RCV000258130;RCV000516165	SCV000599732;SCV000328260	186856	GJB2	NM_004004.5:c.408C>A	NP_003995.2:p.Tyr136Ter	NM_004004.5:c.408C>A:nonsense	Likely pathogenic	pathogenic	2	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter;no assertion criteria provided	May 09, 2017	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Deafness, autosomal recessive 1A;DEAFNESS, AUTOSOMAL RECESSIVE 1A	1;20301449;20301607;20497192;12560944;15633193;24785414					germline	GeneReviews:NBK1272;Genetic Alliance:Deafness%2C+autosomal+recessive+1A/8159;MedGen:C2673759;OMIM:220290;Office of Rare Diseases:1697;Orphanet:90636	2017-05-09;2010-11-01	0	0
13	20189241	T	C	20189241	20189241	-	Haplotype	177819	RCV000154452	SCV000204121	53906	GJB2	NM_004004.5:c.341A>G	NP_003995.2:p.Glu114Gly	NM_004004.5:c.341A>G:missense variant	Conflicting interpretations of pathogenicity	likely benign	0	0	0	1	0	criteria provided, conflicting interpretations	criteria provided, single submitter	May 09, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	10607953;10983956;12746422;15070423;17041943;17666888;20083784;20201936;20668687;21298213;23826813;24033266;9529365					germline	MedGen:CN169374	2015-07-28	1	1
13	20189448	C	T	20189448	20189448	-	Haplotype	267367;446728	RCV000258130;RCV000516165	SCV000599732;SCV000328260	32072	GJB2	NM_004004.5:c.134G>A	NP_003995.2:p.Gly45Glu	NM_004004.5:c.134G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	2	0	0	0	0	criteria provided, single submitter	criteria provided, single submitter;no assertion criteria provided	May 09, 2017	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Division of Genomic Diagnostics,The Children's Hospital of Philadelphia;OMIM	Deafness, autosomal recessive 1A;DEAFNESS, AUTOSOMAL RECESSIVE 1A	1;20301449;20301607;20497192;12560944;15633193;24785414					germline	GeneReviews:NBK1272;Genetic Alliance:Deafness%2C+autosomal+recessive+1A/8159;MedGen:C2673759;OMIM:220290;Office of Rare Diseases:1697;Orphanet:90636	2017-05-09;2010-11-01	1	0
13	20189503	C	T	20189503	20189503	-	Haplotype	177819	RCV000154452	SCV000204121	44943	GJB2	NM_004004.5:c.79G>A	NP_003995.2:p.Val27Ile	NM_004004.5:c.79G>A:missense variant	Conflicting interpretations of pathogenicity	likely benign	0	0	0	1	0	no assertion for the individual variant	criteria provided, single submitter	May 09, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	10607953;10983956;12746422;15070423;17041943;17666888;20083784;20201936;20668687;21298213;23826813;24033266;9529365					germline	MedGen:CN169374	2015-07-28	0	1
13	23354972	G	A	23354972	23354972	-	Haplotype	424657	RCV000515975	SCV000574461	327819	SACS	NM_014363.5:c.1640C>T	NP_055178.3:p.Pro547Leu	NM_014363.5:c.1640C>T:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	criteria provided, single submitter	Mar 07, 2017	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Hereditary spastic paraplegia	20301682;28832565				loss of function	inherited	GeneReviews:NBK1509;Genetic Alliance:Hereditary+spastic+paraplegia/3383;Genetic Testing Registry (GTR):GTR000500041;Genetic Testing Registry (GTR):GTR000500218;Genetic Testing Registry (GTR):GTR000500428;Genetic Testing Registry (GTR):GTR000508756;Genetic Testing Registry (GTR):GTR000525862;Genetic Testing Registry (GTR):GTR000525863;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000529007;MedGen:C0037773;OMIM:PS303350;Office of Rare Diseases:6637;Orphanet:ORPHA685;SNOMED CT:39912006	2017-03-07	1	0
13	23354978	C	A	23354978	23354978	-	Haplotype	424657	RCV000515975	SCV000574461	411584	SACS	NM_014363.5:c.1634G>T	NP_055178.3:p.Trp545Leu	NM_014363.5:c.1634G>T:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 07, 2017	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Unit for Genetic & Epidemiological Research on Neurological Disorders,Instituto de Investigação e Inovação em Saúde	Hereditary spastic paraplegia	20301682;28832565				loss of function	inherited	GeneReviews:NBK1509;Genetic Alliance:Hereditary+spastic+paraplegia/3383;Genetic Testing Registry (GTR):GTR000500041;Genetic Testing Registry (GTR):GTR000500218;Genetic Testing Registry (GTR):GTR000500428;Genetic Testing Registry (GTR):GTR000508756;Genetic Testing Registry (GTR):GTR000525862;Genetic Testing Registry (GTR):GTR000525863;Genetic Testing Registry (GTR):GTR000528277;Genetic Testing Registry (GTR):GTR000529007;MedGen:C0037773;OMIM:PS303350;Office of Rare Diseases:6637;Orphanet:ORPHA685;SNOMED CT:39912006	2017-03-07	0	0
13	51941111	C	T	51941111	51941111	-	Haplotype	3863	RCV000004067	SCV000024233	38430	ATP7B	NM_000053.3:c.3526G>A	NP_000044.2:p.Gly1176Arg	NM_000053.3:c.3526G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2005	OMIM	OMIM	Wilson disease;WILSON DISEASE	15845031;18506894;20301685;20482602;27854360				loss of function	germline	GeneReviews:NBK1512;Genetic Alliance:Wilson+disease/7506;Genetic Testing Registry (GTR):GTR000260623;Genetic Testing Registry (GTR):GTR000501125;Genetic Testing Registry (GTR):GTR000503091;Genetic Testing Registry (GTR):GTR000507952;Genetic Testing Registry (GTR):GTR000508735;Genetic Testing Registry (GTR):GTR000509712;Genetic Testing Registry (GTR):GTR000515523;Genetic Testing Registry (GTR):GTR000520457;Genetic Testing Registry (GTR):GTR000521900;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528632;Genetic Testing Registry (GTR):GTR000528928;Genetic Testing Registry (GTR):GTR000530035;Genetic Testing Registry (GTR):GTR000530097;Genetic Testing Registry (GTR):GTR000552345;Genetic Testing Registry (GTR):GTR000553937;Genetics Home Reference:wilson-disease;MedGen:C0019202;OMIM:277900;Office of Rare Diseases:7893;Orphanet:905;SNOMED CT:88518009	2005-05-01	0	0
13	51941194	A	G	51941194	51941194	-	Haplotype	3863	RCV000004067	SCV000024233	18902	ATP7B	NM_000053.3:c.3443T>C	NP_000044.2:p.Ile1148Thr	NM_000053.3:c.3443T>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Sep 10, 2014	OMIM	OMIM	Wilson disease;WILSON DISEASE	15845031;18506894;20301685;20482602;27854360				loss of function	germline	GeneReviews:NBK1512;Genetic Alliance:Wilson+disease/7506;Genetic Testing Registry (GTR):GTR000260623;Genetic Testing Registry (GTR):GTR000501125;Genetic Testing Registry (GTR):GTR000503091;Genetic Testing Registry (GTR):GTR000507952;Genetic Testing Registry (GTR):GTR000508735;Genetic Testing Registry (GTR):GTR000509712;Genetic Testing Registry (GTR):GTR000515523;Genetic Testing Registry (GTR):GTR000520457;Genetic Testing Registry (GTR):GTR000521900;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528632;Genetic Testing Registry (GTR):GTR000528928;Genetic Testing Registry (GTR):GTR000530035;Genetic Testing Registry (GTR):GTR000530097;Genetic Testing Registry (GTR):GTR000552345;Genetic Testing Registry (GTR):GTR000553937;Genetics Home Reference:wilson-disease;MedGen:C0019202;OMIM:277900;Office of Rare Diseases:7893;Orphanet:905;SNOMED CT:88518009	2005-05-01	1	0
13	103049423	G	A	103049423	103049423	-	Haplotype	8241	RCV000008724	SCV000028933	38442	SLC10A2	NM_000452.2:c.785C>T	NP_000443.1:p.Thr262Met	NM_000452.2:c.785C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 15, 1997	OMIM	OMIM	Bile acid malabsorption, primary;BILE ACID MALABSORPTION, PRIMARY	9109432					germline	Genetic Alliance:Bile+acid+malabsorption%2C+primary/7818;MedGen:C2750087;OMIM:613291	1997-04-15	0	0
13	103051290	A	G	103051290	103051290	-	Haplotype	8241	RCV000008724	SCV000028933	23280	SLC10A2	NM_000452.2:c.728T>C	NP_000443.1:p.Leu243Pro	NM_000452.2:c.728T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 15, 1997	OMIM	OMIM	Bile acid malabsorption, primary;BILE ACID MALABSORPTION, PRIMARY	9109432					germline	Genetic Alliance:Bile+acid+malabsorption%2C+primary/7818;MedGen:C2750087;OMIM:613291	1997-04-15	0	0
14	23425798	G	A	23425798	23425798	-	Haplotype	487487	RCV000015167	SCV000035424	29150	MYH7	NM_000257.3:c.2183C>T	NP_000248.2:p.Ala728Val	NM_000257.3:c.2183C>T:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 27, 2017	OMIM	OMIM	Familial hypertrophic cardiomyopathy 1;CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	11424919;20301559;20301725;21267010;23788249;25173338;25356965;27854360					germline	GeneReviews:NBK1768;Genetic Alliance:Familial+hypertrophic+cardiomyopathy+1/8382;MedGen:C3495498;OMIM:192600	2001-06-01	2	0
14	23427657	C	T	23427657	23427657	-	Haplotype	487487	RCV000015167	SCV000035424	29130	MYH7	NM_000257.3:c.1816G>A	NP_000248.2:p.Val606Met	NM_000257.3:c.1816G>A:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 13, 2017	OMIM	OMIM	Familial hypertrophic cardiomyopathy 1;CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 1	11424919;20301559;20301725;21267010;23788249;25173338;25356965;27854360					germline	GeneReviews:NBK1768;Genetic Alliance:Familial+hypertrophic+cardiomyopathy+1/8382;MedGen:C3495498;OMIM:192600	2001-06-01	2	0
14	28767842	C	G	28767842	28767842	+	Phase unknown	189607	RCV000170068	SCV000222377	169055	FOXG1	NM_005249.4:c.563C>G	NP_005240.3:p.Ala188Gly	NM_005249.4:c.563C>G:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 08, 2013	RettBASE	RettBASE	not provided;Not provided						de novo	MedGen:CN517202	2011-02-15	1	0
14	28767923	TC	CT	28767923	28767924	+	Phase unknown	189607	RCV000170068	SCV000222377	187407	FOXG1	NM_005249.4:c.644_645delTCinsCT	NP_005240.3:p.Phe215Ser	NM_005249.4:c.644_645delTCinsCT:missense variant	Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 08, 2013	RettBASE	RettBASE	not provided;Not provided						de novo	MedGen:CN517202	2011-02-15	0	0
14	31562125	G	A	31562125	31562125	+	Haplotype	7	RCV000000017	SCV000020160;SCV000245520	15046	NUBPL	NM_025152.2:c.166G>A	NP_079428.2:p.Gly56Arg	NM_025152.2:c.166G>A:missense variant;NR_120408.1:n.221G>A:non-coding transcript variant	Uncertain significance	pathogenic;pathogenic	2	0	0	0	0	criteria provided, single submitter	no assertion criteria provided;criteria provided, single submitter	Feb 22, 2017	OMIM;Baylor Miraca Genetics Laboratories	OMIM;Baylor Miraca Genetics Laboratories	Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY;Mitochondrial complex I deficiency	20818383;22072591;23553477;24088041;26633545					germline;maternal;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	2013-04-23;2014-04-09	1	0
14	31850092	T	C	31850092	31850092	+	Haplotype	7	RCV000000017	SCV000020160;SCV000245520	59458	NUBPL	NM_025152.2:c.815-27T>C		NM_025152.2:c.815-27T>C:intron variant	Conflicting interpretations of pathogenicity	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Aug 14, 2017	OMIM;Baylor Miraca Genetics Laboratories	OMIM;Baylor Miraca Genetics Laboratories	Mitochondrial complex I deficiency;MITOCHONDRIAL COMPLEX I DEFICIENCY;Mitochondrial complex I deficiency	20818383;22072591;23553477;24088041;26633545					germline;maternal;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	2013-04-23;2014-04-09	0	1
14	50911725	AGTAC	A	50911726	50911729	-	Haplotype	38368	RCV000020505	SCV000040956	46929	PYGL	NM_002863.4:c.1969+1_1969+4delGTAC		NM_002863.4:c.1969+1_1969+4delGTAC:intron variant	-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 17, 2011	GeneReviews	GeneReviews	Glycogen storage disease, type VI;Glycogen Storage Disease Type VI	17705025;20301760					not provided	GeneReviews:NBK5941;Genetic Alliance:Glycogen+Storage+Disease+Type+6/3126;MedGen:C0017925;OMIM:232700;Office of Rare Diseases:6529;Orphanet:369;SNOMED CT:237971004;SNOMED CT:29291001	2011-05-17	0	0
14	50911730	CTTTTT	AAAAAG	50911730	50911735	-	Haplotype	38368	RCV000020505	SCV000040956	46930	PYGL	NM_002863.4:c.1964_1969invAAAAAG	NP_002854.3:p.Glu655_Lys656del		-	pathologic	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 17, 2011	GeneReviews	GeneReviews	Glycogen storage disease, type VI;Glycogen Storage Disease Type VI	17705025;20301760					not provided	GeneReviews:NBK5941;Genetic Alliance:Glycogen+Storage+Disease+Type+6/3126;MedGen:C0017925;OMIM:232700;Office of Rare Diseases:6529;Orphanet:369;SNOMED CT:237971004;SNOMED CT:29291001	2011-05-17	0	0
14	75103841	C	A	75103841	75103841	-	Haplotype	242987	RCV000234965	SCV000292296	248590	NEK9	NM_033116.5:c.1731+1G>T		NM_033116.5:c.1731+1G>T:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2016	OMIM	OMIM	Nevus comedonicus;NEVUS COMEDONICUS, SOMATIC	27153399					somatic	MedGen:C0265987;OMIM:617025	2016-07-11	0	0
14	75103858	C	A	75103858	75103858	-	Haplotype	242987	RCV000234965	SCV000292296	244069	NEK9	NM_033116.5:c.1715G>T	NP_149107.4:p.Gly572Val	NM_033116.5:c.1715G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2016	OMIM	OMIM	Nevus comedonicus;NEVUS COMEDONICUS, SOMATIC	27153399					somatic	MedGen:C0265987;OMIM:617025	2016-07-11	0	0
14	94380925	T	A	94380925	94380925	-	Haplotype	440500;440501	RCV000508742;RCV000508836	SCV000605935;SCV000605936	33008	SERPINA1	NM_001127701.1:c.863A>T	NP_001121173.1:p.Glu288Val	NM_001127701.1:c.863A>T:missense variant	Pathogenic, other	pathogenic	2	0	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Oct 23, 2017	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency;Alpha-1 Antitrypsin Deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2016-07-12;2015-11-13	2	0
14	94381049	G	A	94381049	94381049	-	Haplotype	219354	RCV000205893	SCV000259189	33000	SERPINA1	NM_001127707.1:c.739C>T	NP_001121179.1:p.Arg247Cys	NM_001127701.1:c.739C>T:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Jul 15, 2016	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2015-07-23	1	1
14	94382636	T	C	94382636	94382636	-	Haplotype	440500	RCV000508742	SCV000605935	434125	SERPINA1	NM_001127701.1:c.602A>G	NP_001121173.1:p.Asp201Gly	NM_001127701.1:c.602A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jul 12, 2016	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency;Alpha-1 Antitrypsin Deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2016-07-12	0	0
14	94382724	C	T	94382724	94382724	-	Haplotype	17972	RCV000019572	SCV000039869	33011	SERPINA1	NM_001127701.1:c.514G>A	NP_001121173.1:p.Gly172Arg	NM_001127701.1:c.514G>A:missense variant	Uncertain significance	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 15, 2016	OMIM	OMIM	PI M(NICHINAN);PI M(NICHINAN)	2309708;6162902					germline	OMIM:107400.0017	2016-07-15	0	0
14	94383008	GAGA	G	94383009	94383011	-	Haplotype	17972	RCV000019572	SCV000039869	321860	SERPINA1	NM_001127701.1:c.227_229delTCT	NP_001121173.1:p.Phe76del	NM_001127701.1:c.227_229delTCT:inframe_variant	Pathogenic, other	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jul 15, 2016	OMIM	OMIM	PI M(NICHINAN);PI M(NICHINAN)	2309708;6162902					germline	OMIM:107400.0017	2016-07-15	2	0
14	94383048	G	T	94383048	94383048	-	Haplotype	440501	RCV000508836	SCV000605936	434128	SERPINA1	NM_001127701.1:c.190C>A	NP_001121173.1:p.Gln64Lys	NM_001127701.1:c.190C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Nov 13, 2015	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency;Alpha-1 Antitrypsin Deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2015-11-13	0	0
14	94383051	G	A	94383051	94383051	-	Haplotype	219354	RCV000205893	SCV000259189	33013	SERPINA1	NM_001127701.1:c.187C>T	NP_001121173.1:p.Arg63Cys	NM_001127701.1:c.187C>T:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Oct 11, 2016	HerediLab, Inc.	HerediLab, Inc.	Alpha-1-antitrypsin deficiency	15685488;20301692;24121147					germline	GeneReviews:NBK1519;Genetic Alliance:Alpha+1-Antitrypsin+Deficiency/325;MedGen:C0221757;OMIM:613490;Office of Rare Diseases:5784;Orphanet:60;SNOMED CT:30188007	2015-07-23	1	1
15	40471616	C	G	40471616	40471616	+	Haplotype	446172	RCV000002428	SCV000022586	439519	CHST14	NM_130468.3:c.403C>G	NP_569735.1:p.Arg135Gly	NM_130468.3:c.403C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2009	OMIM	OMIM	Ehlers-Danlos syndrome, musculocontractural type;EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	11666007;20004762					germline	Genetic Alliance:Adducted+Thumb+and+Clubfoot+Syndrome/216;Genetics Home Reference:ehlers-danlos-syndrome;MedGen:C1866294;OMIM:601776;Orphanet:2953	2009-12-01	0	0
15	40471623	T	A	40471623	40471623	+	Haplotype	446172	RCV000002428	SCV000022586	439520	CHST14	NM_130468.3:c.410T>A	NP_569735.1:p.Leu137Gln	NM_130468.3:c.410T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 2009	OMIM	OMIM	Ehlers-Danlos syndrome, musculocontractural type;EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1	11666007;20004762					germline	Genetic Alliance:Adducted+Thumb+and+Clubfoot+Syndrome/216;Genetics Home Reference:ehlers-danlos-syndrome;MedGen:C1866294;OMIM:601776;Orphanet:2953	2009-12-01	0	0
15	48744948	CGTT	C	48744949	48744951	-	Haplotype	446758	RCV000077752	SCV000109558	97524	CEP152				-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Primary autosomal recessive microcephaly 9;MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	20301772;22775483					germline	GeneReviews:NBK9587;GeneTests:279904;MedGen:C3553886;OMIM:614852;Orphanet:2512	2013-05-01	0	0
15	48756099	A	G	48756099	48756099	-	Haplotype	446758	RCV000077752	SCV000109558	97321	CEP152	NM_001194998.1:c.3149T>C	NP_001181927.1:p.Leu1050Pro	NM_001194998.1:c.3149T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 2013	OMIM	OMIM	Primary autosomal recessive microcephaly 9;MICROCEPHALY 9, PRIMARY, AUTOSOMAL RECESSIVE	20301772;22775483					germline	GeneReviews:NBK9587;GeneTests:279904;MedGen:C3553886;OMIM:614852;Orphanet:2512	2013-05-01	0	0
15	50490429	T	G	50490429	50490429	+	Haplotype	161994	RCV000149419	SCV000192010	171716	USP8	NM_005154.4:c.2138T>G	NP_005145.3:p.Leu713Arg	NM_001128610.2:c.2138T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 18, 2014	Institute of Human Genetics, Klinikum rechts der Isar	Institute of Human Genetics, Klinikum rechts der Isar	Pituitary dependent hypercortisolism;Pituitary dependent hypercortisolism	22720333					somatic	GeneReviews:NBK97965;Genetic Alliance:Pituitary+dependent+hypercortisolism/9118;MedGen:C0221406;OMIM:219090;Orphanet:96253;SNOMED CT:190502001	2014-11-18	0	0
15	50490441	A	G	50490441	50490441	+	Haplotype	161994	RCV000149419	SCV000192010	171717	USP8	NM_005154.4:c.2150A>G	NP_005145.3:p.Tyr717Cys	NM_001128610.2:c.2150A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 18, 2014	Institute of Human Genetics, Klinikum rechts der Isar	Institute of Human Genetics, Klinikum rechts der Isar	Pituitary dependent hypercortisolism;Pituitary dependent hypercortisolism	22720333					somatic	GeneReviews:NBK97965;Genetic Alliance:Pituitary+dependent+hypercortisolism/9118;MedGen:C0221406;OMIM:219090;Orphanet:96253;SNOMED CT:190502001	2014-11-18	0	0
15	50958492	G	A	50958492	50958492	+	Haplotype	224506	RCV000210065	SCV000265991	226246	AP4E1	NM_007347.4:c.1549G>A	NP_031373.2:p.Val517Ile	NM_007347.4:c.1549G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 16, 2016	OMIM	OMIM	Stuttering, familial persistent 1;STUTTERING, FAMILIAL PERSISTENT, 1	23239121;26544806					germline	Gene:100049541;MedGen:C3489627;OMIM:184450	2016-03-16	0	0
15	50997380	G	A	50997380	50997380	+	Haplotype	224506	RCV000210065	SCV000265991	226245	AP4E1	NM_007347.4:c.2401G>A	NP_031373.2:p.Glu801Lys	NM_007347.4:c.2401G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 16, 2016	OMIM	OMIM	Stuttering, familial persistent 1;STUTTERING, FAMILIAL PERSISTENT, 1	23239121;26544806					germline	Gene:100049541;MedGen:C3489627;OMIM:184450	2016-03-16	0	0
15	72351207	C	T	72351207	72351207	-	Haplotype	446267	RCV000004129	SCV000024295	38431	HEXA	NM_000520.5:c.598G>A	NP_000511.2:p.Val200Met	NM_000520.5:c.598G>A:missense variant;NR_134869.1:n.1099G>A:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1996	OMIM	OMIM	Tay-Sachs disease, B1 variant;TAY-SACHS DISEASE, B1 VARIANT	1415222;2976595;8198136;8659543					germline	MedGen:C1848916	1996-07-01	0	0
15	72351231	C	G	72351231	72351231	-	Haplotype	446267	RCV000004129	SCV000024295	18962	HEXA	NM_000520.5:c.574G>C	NP_000511.2:p.Val192Leu	NM_000520.5:c.574G>C:missense variant;NR_134869.1:n.1075G>C:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1996	OMIM	OMIM	Tay-Sachs disease, B1 variant;TAY-SACHS DISEASE, B1 VARIANT	1415222;2976595;8198136;8659543					germline	MedGen:C1848916	1996-07-01	0	0
15	89323426	C	G	89323426	89323426	-	Phase unknown	157526	RCV000144870	SCV000172142	28546	POLG	NM_002693.2:c.2243G>C	NP_002684.1:p.Trp748Ser	NM_002693.2:c.2243G>C:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 14, 2017	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	15477547;15824347;20301532;22189570;25025039;28812649					not applicable	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	1	1
15	89327006	C	G	89327006	89327006	-	Phase unknown	157526	RCV000144870	SCV000172142	28549	POLG	NM_002693.2:c.1491G>C	NP_002684.1:p.Gln497His	NM_002693.2:c.1491G>C:missense variant	Conflicting interpretations of pathogenicity	uncertain significance	0	0	1	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Jul 21, 2017	Section of Medical Genetics, Telemark Hospital	Section of Medical Genetics, Telemark Hospital	Charcot-Marie-Tooth disease;axonal type;Charcot-Marie-Tooth disease	15477547;15824347;20301532;22189570;25025039;28812649					not applicable	GeneReviews:NBK1358;Genetic Alliance:Charcot-Marie-Tooth+Disease/1276;Genetics Home Reference:charcot-marie-tooth-disease;MedGen:C0007959;OMIM:PS118220;Office of Rare Diseases:6034;SNOMED CT:50548001	2013-11-01	1	1
16	173510	C	G	173510	173510	+	Haplotype	375745	RCV000417222	SCV000503054	362631	HBA2	NM_000517.4:c.339C>G	NP_000508.1:p.His113Gln	NM_000517.4:c.339C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 29, 2016	GeneReviews	GeneReviews	alpha Thalassemia	20301608;25052315;8735302					germline	GeneReviews:NBK1435;Genetic Alliance:Alpha-Thalassemia/333;MedGen:C0002312;OMIM:604131;Orphanet:846;SNOMED CT:68913001	2016-12-29	0	0
16	173510	CCTCCCCGCCGAG	C	173511	173522	+	Haplotype	375745	RCV000417222	SCV000503054	362632	HBA2	NM_000517.4:c.340_351delCTCCCCGCCGAG	NP_000508.1:p.Leu114_Glu117del		-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 29, 2016	GeneReviews	GeneReviews	alpha Thalassemia	20301608;25052315;8735302					germline	GeneReviews:NBK1435;Genetic Alliance:Alpha-Thalassemia/333;MedGen:C0002312;OMIM:604131;Orphanet:846;SNOMED CT:68913001	2016-12-29	0	0
16	177068	A	G	177068	177068	+	Haplotype	15762	RCV000017073	SCV000037345	30800	HBA1	NM_000558.4:c.235A>G	NP_000549.1:p.Asn79Asp	NM_000558.4:c.235A>G:missense variant	other	other	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN J (SINGAPORE);HEMOGLOBIN J (SINGAPORE)	5085670					germline	OMIM:141800.0075	2016-07-20	0	0
16	177072	C	G	177072	177072	+	Haplotype	15762	RCV000017073	SCV000037345	38474	HBA1	NM_000558.4:c.239C>G	NP_000549.1:p.Ala80Gly	NM_000558.4:c.239C>G:missense variant	-	other	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 20, 2016	OMIM	OMIM	HEMOGLOBIN J (SINGAPORE);HEMOGLOBIN J (SINGAPORE)	5085670					germline	OMIM:141800.0075	2016-07-20	0	0
16	1204325	G	A	1204325	1204325	+	Haplotype	2704	RCV000002823	SCV000022981	17743	CACNA1H	NM_021098.2:c.2318G>A	NP_066921.2:p.Gly773Asp	NM_021098.2:c.2318G>A:missense variant	-	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 11, 2005	OMIM	OMIM	Epilepsy, childhood absence 6;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	12891677;15888660					germline	Genetic Alliance:Epilepsy%2C+childhood+absence+6/8325;MedGen:C2749872;OMIM:611942;Orphanet:64280	2005-05-11	0	0
16	1204369	C	T	1204369	1204369	+	Haplotype	2704	RCV000002823	SCV000022981	38427	CACNA1H	NM_021098.2:c.2362C>T	NP_066921.2:p.Arg788Cys	NM_021098.2:c.2362C>T:missense variant	Benign	risk factor	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 03, 2013	OMIM	OMIM	Epilepsy, childhood absence 6;EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 6	12891677;15888660					germline	Genetic Alliance:Epilepsy%2C+childhood+absence+6/8325;MedGen:C2749872;OMIM:611942;Orphanet:64280	2005-05-11	1	0
16	1495524	C	T	1495524	1495524	+	Haplotype	236230	RCV000225207	SCV000282071;SCV000298029	237798	TELO2	NM_016111.3:c.514C>T	NP_057195.2:p.Gln172Ter	NM_016111.3:c.514C>T:nonsense	-	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Jun 17, 2016	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	You-Hoover-Fong syndrome;YOU-HOOVER-FONG SYNDROME	27132593					germline	MedGen:C4310778;OMIM:616954	2016-06-17;0000-00-00	0	0
16	1505602	G	A	1505602	1505602	+	Haplotype	236230	RCV000225207	SCV000282071;SCV000298029	237812	TELO2	NM_016111.3:c.2034+1G>A		NM_016111.3:c.2034+1G>A:splice donor variant	-	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Jun 17, 2016	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	OMIM;Baylor-Hopkins Center for Mendelian Genomics,Johns Hopkins University	You-Hoover-Fong syndrome;YOU-HOOVER-FONG SYNDROME	27132593					germline	MedGen:C4310778;OMIM:616954	2016-06-17;0000-00-00	0	0
16	2060650	T	A	2060650	2060650	+	Haplotype	65347	RCV000055571	SCV000083795	76281	TSC2	NM_000548.4:c.976-20T>A		NM_000548.4:c.976-20T>A:intron variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0
16	2081728	C	CCTGTACAAGTCA	2081729	2081740	+	Haplotype	64881	RCV000055081	SCV000083299	75810	TSC2	NM_000548.4:c.3745_3756dupCTGTACAAGTCA	NP_000539.2:p.Leu1253_Ser1254insTyrLysSerLeu	NM_000548.4:c.3745_3756dupCTGTACAAGTCA:inframe_variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	15798777;20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0
16	2084578	GCC	G	2084580	2084581	+	Haplotype	65324	RCV000055548	SCV000083772	76256	TSC2	NM_000548.4:c.4358_4359delCC	NP_000539.2:p.Pro1453Glnfs	NM_000548.4:c.4358_4359delCC:frameshift variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	11468687;20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0
16	2084582	AGTGGCCTCCGGC	A	2084583	2084594	+	Haplotype	65324	RCV000055548	SCV000083772	76257	TSC2	NM_000548.4:c.4361_4372delGTGGCCTCCGGC	NP_000539.2:p.Ser1454_Pro1458delinsThr	NM_000548.4:c.4361_4372delGTGGCCTCCGGC:inframe_variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	11468687;20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0
16	2085278	TACGACACCC	T	2085281	2085289		Haplotype	65183	RCV000055400	SCV000083621	76115		NM_000548.4:c.4621_4629delGACACCCAC	NP_000539.2:p.Asp1541_His1543del	NM_000548.4:c.4621_4629delGACACCCAC:inframe_variant	-	not provided	0	0	0	0	0	no assertion for the individual variant	no assertion provided	-	Tuberous sclerosis database (TSC2)	Tuberous sclerosis database (TSC2)	Tuberous sclerosis syndrome;TSC	20301399;23519317;23788249;27854360					germline	GeneReviews:NBK1220;MedGen:C0041341;OMIM:191100;OMIM:PS191100;SNOMED CT:7199000	0000-00-00	0	0
16	3243405	C	T	3243405	3243405	-	Haplotype	2555	RCV000002664	SCV000022822	17578	MEFV	NM_000243.2:c.2082G>A	NP_000234.1:p.Met694Ile	NM_000243.2:c.2082G>A:missense variant;NM_001198536.1:c.*286G>A:3 prime UTR variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Jun 06, 2017	OMIM	OMIM	Familial mediterranean fever, autosomal dominant;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	10024914;10090880;10364520;10612841;10787449;10980540;11484206;11938447;12401847;12929299;12955725;15942916;16255051;17331080;18097735;19967574;20041150;20301405;20534143;9668175					germline	GeneReviews:NBK1227;Genetic Alliance:Familial+mediterranean+fever%2C+autosomal+dominant/8401;MedGen:C1851347;OMIM:134610;Orphanet:342	2000-04-01	2	0
16	3254626	C	G	3254626	3254626	-	Haplotype	2555	RCV000002664	SCV000022822	17581	MEFV	NM_000243.2:c.442G>C	NP_000234.1:p.Glu148Gln	NM_000243.2:c.442G>C:missense variant;NM_001198536.1:c.277+1685G>C:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 29, 2017	OMIM	OMIM	Familial mediterranean fever, autosomal dominant;FAMILIAL MEDITERRANEAN FEVER, AUTOSOMAL DOMINANT	10024914;10090880;10364520;10612841;10787449;10980540;11484206;11938447;12401847;12929299;12955725;15942916;16255051;17331080;18097735;19967574;20041150;20301405;20534143;9668175					germline	GeneReviews:NBK1227;Genetic Alliance:Familial+mediterranean+fever%2C+autosomal+dominant/8401;MedGen:C1851347;OMIM:134610;Orphanet:342	2000-04-01	0	1
16	14593355	A	AT	14593356	14593356	-	Phase unknown	180663	RCV000162315	SCV000206799	178829	PARN	NM_002582.3:c.863dupA	NP_002573.1:p.Asn288Lysfs	NM_002582.3:c.863dupA:frameshift variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 13, 2015	Bone Marrow Failure laboratory,Queen Mary University London	Bone Marrow Failure laboratory,Queen Mary University London	Dyskeratosis congenita;Dyskeratosis congenita	20301779					germline	GeneReviews:NBK22301;Genetic Alliance:Dyskeratosis+congenita/9566;MedGen:C0265965;OMIM:PS127550;SNOMED CT:74911008	2015-02-04	0	0
16	14608273	ATACT	A	14608274	14608277	-	Phase unknown	180663	RCV000162315	SCV000206799	178830	PARN	NM_002582.3:c.659+4_659+7delAGTA		NM_002582.3:c.659+4_659+7delAGTA:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 12, 2015	Bone Marrow Failure laboratory,Queen Mary University London	Bone Marrow Failure laboratory,Queen Mary University London	Dyskeratosis congenita;Dyskeratosis congenita	20301779					germline	GeneReviews:NBK22301;Genetic Alliance:Dyskeratosis+congenita/9566;MedGen:C0265965;OMIM:PS127550;SNOMED CT:74911008	2015-02-04	0	0
16	15718337	C	T	15718337	15718337	-	Haplotype	14131	RCV000015192	SCV000035449	29170	MYH11	NM_001040113.1:c.5294G>A	NP_001035202.1:p.Arg1765Gln	NM_001040113.1:c.5294G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 03, 2016	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	14722581;16444274;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2006-03-01	0	1
16	15721421	C	A	15721421	15721421	-	Haplotype	14131	RCV000015192	SCV000035449	75290	MYH11	NM_001040113.1:c.4599+1G>T		NM_001040113.1:c.4599+1G>T:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2006	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	14722581;16444274;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2006-03-01	0	0
16	15726882	C	A	15726882	15726882	-	Haplotype	440783	RCV000015194	SCV000035451	29173	MYH11	NM_001040114.1:c.3845G>T	NP_001035203.1:p.Arg1282Leu	NM_001040113.1:c.3845G>T:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Oct 29, 2013	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	17666408;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2007-10-15	1	0
16	15726915	A	G	15726915	15726915	-	Haplotype	440783	RCV000015194	SCV000035451	94510	MYH11	NM_001040113.1:c.3812T>C	NP_001035202.1:p.Leu1271Pro	NM_001040113.1:c.3812T>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 28, 2015	OMIM	OMIM	Aortic aneurysm, familial thoracic 4;AORTIC ANEURYSM, FAMILIAL THORACIC 4	17666408;20301299;23788249;24882528;25173340;25356965;27854360					germline	Genetic Alliance:Aortic+Aneurysm%2C+Familial+Thoracic+4/532;Genetic Testing Registry (GTR):GTR000330980;Genetics Home Reference:familial-thoracic-aortic-aneurysm-and-dissection;MedGen:C1851504;OMIM:132900;Office of Rare Diseases:9876	2007-10-15	0	0
16	30086309	C	T	30086309	30086309	-	Haplotype	188053	RCV000167863	SCV000218510	255673	TBX6	NM_004608.3:c.1227G>A	NP_004599.2:p.Pro409=	NM_004608.3:c.1227G>A:synonymous variant	Benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 28, 2016	OMIM	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	20301771;25564734					germline	GeneReviews:NBK8828;Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600	2015-01-22	2	0
16	30091481	T	C	30091481	30091481	-	Haplotype	188053	RCV000167863	SCV000218510	418555	TBX6	NM_004608.3:c.-48-240A>G		NM_004608.3:c.-48-240A>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 22, 2015	OMIM	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	20301771;25564734					germline	GeneReviews:NBK8828;Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600	2015-01-22	0	0
16	30091839	C	A	30091839	30091839	-	Haplotype	188053	RCV000167863	SCV000218510	185945	TBX6	NM_004608.3:c.-49+34G>T		NM_004608.3:c.-49+34G>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 22, 2015	OMIM	OMIM	Spondylocostal dysostosis 5;SPONDYLOCOSTAL DYSOSTOSIS 5	20301771;25564734					germline	GeneReviews:NBK8828;Genetics Home Reference:spondylocostal-dysostosis;MedGen:C1852521;OMIM:122600	2015-01-22	0	0
16	47696408	T	C	47696408	47696408	+	Haplotype	13621	RCV000014591	SCV000034845	28660	PHKB	NM_000293.2:c.2923T>C	NP_000284.1:p.Tyr975His	NM_000293.2:c.2923T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1997	OMIM	OMIM	Glycogen storage disease IXb;GLYCOGEN STORAGE DISEASE IXb	21634085;9215682					germline	GeneReviews:NBK55061;Genetic Alliance:Glycogen+storage+disease+IXb/8483;MedGen:C0543514;OMIM:261750;Orphanet:79240	1997-07-01	0	0
16	47696411	G	T	47696411	47696411	+	Haplotype	13621	RCV000014591	SCV000034845	38463	PHKB	NM_000293.2:c.2926G>T	NP_000284.1:p.Glu976Ter	NM_000293.2:c.2926G>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 1997	OMIM	OMIM	Glycogen storage disease IXb;GLYCOGEN STORAGE DISEASE IXb	21634085;9215682					germline	GeneReviews:NBK55061;Genetic Alliance:Glycogen+storage+disease+IXb/8483;MedGen:C0543514;OMIM:261750;Orphanet:79240	1997-07-01	0	0
16	56868355	C	T	56868355	56868355	+	Haplotype	8596	RCV000009127	SCV000029344	23635	SLC12A3	NM_000339.2:c.488C>T	NP_000330.2:p.Thr163Met	NM_000339.2:c.488C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 26, 2006	OMIM	OMIM	Familial hypokalemia-hypomagnesemia;GITELMAN SYNDROME	17000984;21343949					germline	Genetic Alliance:Familial+hypokalemia-hypomagnesemia/8399;MedGen:C0268450;OMIM:263800;Orphanet:358;SNOMED CT:3188003	2006-09-26	0	0
16	56894594	G	A	56894594	56894594	+	Haplotype	8596	RCV000009127	SCV000029344	38443	SLC12A3	NM_000339.2:c.2612G>A	NP_000330.2:p.Arg871His	NM_000339.2:c.2612G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 26, 2006	OMIM	OMIM	Familial hypokalemia-hypomagnesemia;GITELMAN SYNDROME	17000984;21343949					germline	Genetic Alliance:Familial+hypokalemia-hypomagnesemia/8399;MedGen:C0268450;OMIM:263800;Orphanet:358;SNOMED CT:3188003	2006-09-26	0	0
16	67942567	G	A	67942567	67942567	-	Haplotype	3667	RCV000003852	SCV000024017	38429	LCAT	NM_000229.1:c.544C>T	NP_000220.1:p.Arg182Cys	NM_000229.1:c.544C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 1993	OMIM	OMIM	Norum disease;LCAT DEFICIENCY	8432868					germline	Genetic Alliance:Norum+disease/5271;MedGen:C0023195;OMIM:245900;Office of Rare Diseases:4011;Orphanet:650;Orphanet:79293	1993-02-01	0	0
16	67942939	C	T	67942939	67942939	-	Haplotype	3667	RCV000003852	SCV000024017	18706	LCAT	NM_000229.1:c.349G>A	NP_000220.1:p.Ala117Thr	NM_000229.1:c.349G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 1993	OMIM	OMIM	Norum disease;LCAT DEFICIENCY	8432868					germline	Genetic Alliance:Norum+disease/5271;MedGen:C0023195;OMIM:245900;Office of Rare Diseases:4011;Orphanet:650;Orphanet:79293	1993-02-01	0	0
16	88720174	G	A	88720174	88720174	-	Haplotype	55809	RCV000049235	SCV000077488	70465	PIEZO1	NM_001142864.3:c.6059C>T	NP_001136336.2:p.Ala2020Val	NM_001142864.3:c.6059C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS	23479567;9718354					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0
16	88727144	G	A	88727144	88727144	-	Haplotype	55809	RCV000049235	SCV000077488	70466	PIEZO1	NM_001142864.3:c.3350C>T	NP_001136336.2:p.Ser1117Leu	NM_001142864.3:c.3350C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS	23479567;9718354					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0
16	88733652	C	T	88733652	88733652	-	Haplotype	55813	RCV000049238	SCV000077491	70476	PIEZO1	NM_001142864.3:c.2423G>A	NP_001136336.2:p.Arg808Gln	NM_001142864.3:c.2423G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917;23479567;9827909					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0
16	88733731	C	T	88733731	88733731	-	Haplotype	55813	RCV000049238	SCV000077491	70475	PIEZO1	NM_001142864.3:c.2344G>A	NP_001136336.2:p.Gly782Ser	NM_001142864.3:c.2344G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917;23479567;9827909					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0
16	88734844	G	C	88734844	88734844	-	Haplotype	55813	RCV000049238	SCV000077491	70469	PIEZO1	NM_001142864.3:c.1848+31C>G		NM_001142864.3:c.1848+31C>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 09, 2013	OMIM	OMIM	Xerocytosis;DEHYDRATED HEREDITARY STOMATOCYTOSIS WITH PSEUDOHYPERKALEMIA AND PERINATAL EDEMA	11001917;23479567;9827909					germline	Gene:10774;Genetic Alliance:Dehydrated+Hereditary+Stomatocytosis+Pseudohyperkalemia+and+Peri;Genetic Alliance:Stomatocytosis+II/6894;MedGen:C0272051;OMIM:177720;OMIM:194380;OMIM:611184.0003;OMIM:611184.0005;OMIM:611184.0008;Orphanet:3202;SNOMED CT:87994004	2013-05-09	0	0
17	7220519	C	T	7220519	7220519	+	Haplotype	441528	RCV000001698	SCV000021854	16670	ACADVL	NM_000018.3:c.194C>T	NP_000009.1:p.Pro65Leu	NM_000018.3:c.194C>T:missense variant;NM_001033859.2:c.139-85C>T:intron variant;NM_001270448.1:c.-35C>T:5 prime UTR variant	Benign/Likely benign	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	Very long chain acyl-CoA dehydrogenase deficiency;VLCAD DEFICIENCY	10790204;20301763					germline	GeneReviews:NBK6816;Genetic Alliance:VLCAD+deficiency/7410;MedGen:C3887523;OMIM:201475;Office of Rare Diseases:5508;Orphanet:26793;SNOMED CT:237996001;SNOMED CT:237997005	2000-01-01	2	0
17	7222068	A	C	7222068	7222068	+	Haplotype	441528	RCV000001698	SCV000021854	38417	ACADVL	NM_000018.3:c.739A>C	NP_000009.1:p.Lys247Gln	NM_000018.3:c.739A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2000	OMIM	OMIM	Very long chain acyl-CoA dehydrogenase deficiency;VLCAD DEFICIENCY	10790204;20301763					germline	GeneReviews:NBK6816;Genetic Alliance:VLCAD+deficiency/7410;MedGen:C3887523;OMIM:201475;Office of Rare Diseases:5508;Orphanet:26793;SNOMED CT:237996001;SNOMED CT:237997005	2000-01-01	0	0
17	8014699	G	C	8014699	8014699	+	Haplotype	453243;453244	RCV000009948;RCV000009950	SCV000030169;SCV000030171	24393	GUCY2D	NM_000180.3:c.2511G>C	NP_000171.1:p.Glu837Asp	NM_000180.3:c.2511G>C:missense variant	not provided	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 15, 2017	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10647719;11565546;9097965;9618177;10951519					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2000-01-01;2017-12-15	0	0
17	8014700	C	A	8014700	8014700	+	Haplotype	453243	RCV000009948	SCV000030169	38445	GUCY2D	NM_000180.3:c.2512C>A	NP_000171.1:p.Arg838Ser	NM_000180.3:c.2512C>A:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2000	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10647719;11565546;9097965;9618177					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2000-01-01	0	0
17	8014700	C	T	8014700	8014700	+	Haplotype	453244	RCV000009950	SCV000030171	24394	GUCY2D	NM_000180.3:c.2512C>T	NP_000171.1:p.Arg838Cys	NM_000180.3:c.2512C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 15, 2017	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10951519					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2017-12-15	0	0
17	8014704	C	T	8014704	8014704	+	Haplotype	453244	RCV000009950	SCV000030171	38391	GUCY2D	NM_000180.3:c.2516C>T	NP_000171.1:p.Thr839Met	NM_000180.3:c.2516C>T:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 15, 2017	OMIM	OMIM	Cone-rod dystrophy 6;CONE-ROD DYSTROPHY 6	10951519					germline	Genetic Alliance:Cone-Rod+Dystrophy+6/1771;Genetics Home Reference:cone-rod-dystrophy;MedGen:C1866293;OMIM:601777;Office of Rare Diseases:10117;Office of Rare Diseases:10656;Orphanet:1872	2017-12-15	0	0
17	17215294	G	TC	17215294	17215294	-	Haplotype	3377	RCV000003544	SCV000023702	243924	FLCN	NM_144997.5:c.1323delCinsGA	NP_659434.2:p.His442Thrfs	NM_144997.5:c.1323delCinsGA:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2009	OMIM	OMIM	Multiple fibrofolliculomas;BIRT-HOGG-DUBE SYNDROME	19320655;19562744;20301695;24319509;25394175					germline	GeneReviews:NBK1522;Genetic Alliance:Multiple+fibrofolliculomas/8920;Genetics Home Reference:birt-hogg-dube-syndrome;MedGen:C0346010;OMIM:135150;Office of Rare Diseases:2322;Orphanet:122;SNOMED CT:110985001	2009-09-01	0	0
17	17215312	AAACTCTGTAAC	A	17215313	17215323	-	Haplotype	3377	RCV000003544	SCV000023702	18416	FLCN	NM_144997.5:c.1301-7_1304delGTTACAGAGTT		NM_144997.5:c.1301-7_1304delGTTACAGAGTT:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2009	OMIM	OMIM	Multiple fibrofolliculomas;BIRT-HOGG-DUBE SYNDROME	19320655;19562744;20301695;24319509;25394175					germline	GeneReviews:NBK1522;Genetic Alliance:Multiple+fibrofolliculomas/8920;Genetics Home Reference:birt-hogg-dube-syndrome;MedGen:C0346010;OMIM:135150;Office of Rare Diseases:2322;Orphanet:122;SNOMED CT:110985001	2009-09-01	0	0
17	19657797	G	A	19657797	19657797	+	Haplotype	438264	RCV000504796	SCV000598618	260161	ALDH3A2	NM_000382.2:c.733G>A	NP_000373.1:p.Asp245Asn	NM_000382.2:c.733G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0
17	19661229	G	C	19661229	19661229	+	Haplotype	438264	RCV000504796	SCV000598618	431886	ALDH3A2	NM_000382.2:c.901G>C	NP_000373.1:p.Ala301Pro	NM_000382.2:c.901G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0
17	19661230	CT	C	19661234	19661234	+	Haplotype	438264	RCV000504796	SCV000598618	431887	ALDH3A2	NM_000382.2:c.906delT	NP_000373.1:p.Phe302Leufs	NM_000382.2:c.906delT:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0
17	19661237	T	G	19661237	19661237	+	Haplotype	438264	RCV000504796	SCV000598618	431888	ALDH3A2	NM_000382.2:c.909T>G	NP_000373.1:p.Gly303=	NM_000382.2:c.909T>G:synonymous variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Jun 01, 2017	Rizzo Lab,University of Nebraska Medical Center	Rizzo Lab,University of Nebraska Medical Center	Sjögren-Larsson syndrome;Ichthyosis;Spasticity;Intellectual disability;Sjogren-Larsson syndrome	10577908					germline	Genetic Alliance:Sjogren-Larsson+syndrome/6627;Genetics Home Reference:sjogren-larsson-syndrome;MedGen:C0037231;OMIM:270200;Office of Rare Diseases:7654;Orphanet:816;SNOMED CT:111303009	2017-06-01	0	0
17	31250916	TA	T	31250917	31250917	+	Haplotype	217112	RCV000200907	SCV000255592	213715	NF1	NM_001042492.2:c.4110+1798del		NM_000267.3:c.4110+1798del:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Medical Genomics Laboratory,Department of Genetics UAB	Medical Genomics Laboratory,Department of Genetics UAB	Neurofibromatosis, type 1;Neurofibromatosis, type 1	15604628;17636453;20065170;20301288;20301471;24893135;26189818				loss of function	unknown	GeneReviews:NBK1109;Genetic Alliance:Neurofibromatosis+type+1/5174;Genetic Testing Registry (GTR):GTR000260605;Genetic Testing Registry (GTR):GTR000335545;Genetic Testing Registry (GTR):GTR000500115;Genetic Testing Registry (GTR):GTR000500672;Genetic Testing Registry (GTR):GTR000500881;Genetic Testing Registry (GTR):GTR000500970;Genetic Testing Registry (GTR):GTR000500971;Genetic Testing Registry (GTR):GTR000500972;Genetic Testing Registry (GTR):GTR000501087;Genetic Testing Registry (GTR):GTR000501088;Genetic Testing Registry (GTR):GTR000509686;Genetic Testing Registry (GTR):GTR000510677;Genetic Testing Registry (GTR):GTR000510679;Genetic Testing Registry (GTR):GTR000511186;Genetic Testing Registry (GTR):GTR000511188;Genetic Testing Registry (GTR):GTR000514608;Genetic Testing Registry (GTR):GTR000514913;Genetic Testing Registry (GTR):GTR000514981;Genetic Testing Registry (GTR):GTR000515566;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520393;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000521399;Genetic Testing Registry (GTR):GTR000521505;Genetic Testing Registry (GTR):GTR000521546;Genetic Testing Registry (GTR):GTR000522322;Genetic Testing Registry (GTR):GTR000528459;Genetic Testing Registry (GTR):GTR000528529;Genetic Testing Registry (GTR):GTR000528533;Genetic Testing Registry (GTR):GTR000528913;Genetic Testing Registry (GTR):GTR000528930;Genetic Testing Registry (GTR):GTR000529017;Genetic Testing Registry (GTR):GTR000529068;Genetic Testing Registry (GTR):GTR000551630;Genetic Testing Registry (GTR):GTR000552183;Genetic Testing Registry (GTR):GTR000552305;Genetic Testing Registry (GTR):GTR000556576;MedGen:C0027831;OMIM:162200;OMIM:613113.0001;OMIM:613113.0002;OMIM:613113.0003;OMIM:613113.0004;OMIM:613113.0005;OMIM:613113.0006;OMIM:613113.0007;OMIM:613113.0008;OMIM:613113.0009;OMIM:613113.0012;OMIM:613113.0013;OMIM:613113.0014;OMIM:613113.0015;OMIM:613113.0016;OMIM:613113.0021;OMIM:613113.0022;OMIM:613113.0023;OMIM:613113.0024;OMIM:613113.0025;OMIM:613113.0026;OMIM:613113.0027;OMIM:613113.0029;OMIM:613113.0030;OMIM:613113.0031;OMIM:613113.0032;OMIM:613113.0037;OMIM:613113.0038;OMIM:613113.0040;OMIM:613113.0041;OMIM:613113.0042;OMIM:613113.0043;OMIM:613113.0044;OMIM:613113.0046;Office of Rare Diseases:7866;Orphanet:636;Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia,Universidade Católica de Brasília:R34;SNOMED CT:92824003	0000-00-00	0	0
17	43095875	T	C	43095875	43095875	-	Haplotype	236265	RCV000225499	SCV000282252	46245	BRCA1	NM_007294.3:c.641A>G	NP_009225.1:p.Asp214Gly	NM_007294.3:c.641A>G:missense variant;NR_027676.1:n.777A>G:non-coding transcript variant	Benign	benign	0	0	0	0	1	reviewed by expert panel	reviewed by expert panel	Jul 19, 2017	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Breast-ovarian cancer, familial 1	1;10;15604628;17392385;17508274;17924331;19305347;20;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27008870;27854360;3;548;70				loss of function	germline	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2016-04-15	3	0
17	43095924	T	G	43095924	43095924	-	Haplotype	236265	RCV000225499	SCV000282252	46242	BRCA1	NM_007294.3:c.594-2A>C		NM_007294.3:c.594-2A>C:splice acceptor variant	Benign	benign	0	0	0	0	1	no assertion for the individual variant	reviewed by expert panel	Jul 19, 2017	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA)	Breast-ovarian cancer, familial 1	1;10;15604628;17392385;17508274;17924331;19305347;20;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27008870;27854360;3;548;70				loss of function	germline	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2016-04-15	0	0
17	43124094	C	T	43124094	43124094	-	Haplotype	487432	RCV000576499	SCV000677891	424868	BRCA1	NM_007294.3:c.3G>A	NP_009225.1:p.Met1Ile	NM_007294.3:c.3G>A:missense variant	Uncertain significance	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Apr 05, 2017	Counsyl	Counsyl	Breast-ovarian cancer, familial 1	15604628;16267036;16941470;17392385;17508274;19305347;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27854360				loss of function	unknown	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2017-04-05	0	0
17	43124097	T	C	43124097	43124097	-	Haplotype	487432	RCV000576499	SCV000677891	480485	BRCA1	NM_007294.3:c.-1A>G			-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Apr 05, 2017	Counsyl	Counsyl	Breast-ovarian cancer, familial 1	15604628;16267036;16941470;17392385;17508274;19305347;20065170;20301425;23188549;23788249;23918944;24366376;24366402;24432435;24493721;25356965;25394175;27854360				loss of function	unknown	GeneReviews:NBK1247;Genetic Alliance:Breast-ovarian+cancer%2C+familial+1/7865;Genetic Testing Registry (GTR):GTR000017876;Genetic Testing Registry (GTR):GTR000021517;Genetic Testing Registry (GTR):GTR000320777;Genetic Testing Registry (GTR):GTR000325409;Genetic Testing Registry (GTR):GTR000330054;Genetic Testing Registry (GTR):GTR000501196;Genetic Testing Registry (GTR):GTR000501743;Genetic Testing Registry (GTR):GTR000501746;Genetic Testing Registry (GTR):GTR000501817;Genetic Testing Registry (GTR):GTR000505644;Genetic Testing Registry (GTR):GTR000507653;Genetic Testing Registry (GTR):GTR000507764;Genetic Testing Registry (GTR):GTR000507864;Genetic Testing Registry (GTR):GTR000507913;Genetic Testing Registry (GTR):GTR000507930;Genetic Testing Registry (GTR):GTR000509001;Genetic Testing Registry (GTR):GTR000509002;Genetic Testing Registry (GTR):GTR000509348;Genetic Testing Registry (GTR):GTR000509349;Genetic Testing Registry (GTR):GTR000509363;Genetic Testing Registry (GTR):GTR000509450;Genetic Testing Registry (GTR):GTR000509451;Genetic Testing Registry (GTR):GTR000509692;Genetic Testing Registry (GTR):GTR000509980;Genetic Testing Registry (GTR):GTR000509982;Genetic Testing Registry (GTR):GTR000509983;Genetic Testing Registry (GTR):GTR000512320;Genetic Testing Registry (GTR):GTR000512644;Genetic Testing Registry (GTR):GTR000512645;Genetic Testing Registry (GTR):GTR000512816;Genetic Testing Registry (GTR):GTR000514601;Genetic Testing Registry (GTR):GTR000519030;Genetic Testing Registry (GTR):GTR000520069;Genetic Testing Registry (GTR):GTR000520071;Genetic Testing Registry (GTR):GTR000520072;Genetic Testing Registry (GTR):GTR000520394;Genetic Testing Registry (GTR):GTR000520410;Genetic Testing Registry (GTR):GTR000520865;Genetic Testing Registry (GTR):GTR000520866;Genetic Testing Registry (GTR):GTR000520867;Genetic Testing Registry (GTR):GTR000520869;Genetic Testing Registry (GTR):GTR000520870;Genetic Testing Registry (GTR):GTR000520871;Genetic Testing Registry (GTR):GTR000520872;Genetic Testing Registry (GTR):GTR000521908;Genetic Testing Registry (GTR):GTR000522159;Genetic Testing Registry (GTR):GTR000522160;Genetic Testing Registry (GTR):GTR000522161;Genetic Testing Registry (GTR):GTR000522162;Genetic Testing Registry (GTR):GTR000522243;Genetic Testing Registry (GTR):GTR000527942;Genetic Testing Registry (GTR):GTR000528915;Genetic Testing Registry (GTR):GTR000528916;Genetic Testing Registry (GTR):GTR000530120;Genetic Testing Registry (GTR):GTR000530202;Genetic Testing Registry (GTR):GTR000531275;Genetic Testing Registry (GTR):GTR000551440;Genetic Testing Registry (GTR):GTR000552245;Genetic Testing Registry (GTR):GTR000552304;MedGen:C2676676;OMIM:113705.0001;OMIM:113705.0002;OMIM:113705.0003;OMIM:113705.0004;OMIM:113705.0005;OMIM:113705.0006;OMIM:113705.0007;OMIM:113705.0008;OMIM:113705.0009;OMIM:113705.0010;OMIM:113705.0012;OMIM:113705.0013;OMIM:113705.0014;OMIM:113705.0015;OMIM:113705.0016;OMIM:113705.0017;OMIM:113705.0018;OMIM:113705.0019;OMIM:113705.0020;OMIM:113705.0021;OMIM:113705.0023;OMIM:113705.0024;OMIM:113705.0025;OMIM:113705.0026;OMIM:113705.0027;OMIM:113705.0028;OMIM:113705.0029;OMIM:113705.0030;OMIM:113705.0031;OMIM:113705.0032;OMIM:113705.0033;OMIM:113705.0034;OMIM:113705.0035;OMIM:113705.0036;OMIM:113705.0037;OMIM:602667.0001;OMIM:604370;Orphanet:145	2017-04-05	0	0
17	44911369	C	T	44911369	44911369	-	Haplotype	190352	RCV000192152	SCV000223016	77412	GFAP	NM_002055.4:c.994G>A	NP_002046.1:p.Glu332Lys	NM_002055.4:c.994G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2015	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	18004641;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	0	0
17	44911375	G	C	44911375	44911375	-	Haplotype	190352	RCV000192152	SCV000223016	77410	GFAP	NM_002055.4:c.988C>G	NP_002046.1:p.Arg330Gly	NM_002055.4:c.988C>G:missense variant	not provided	pathogenic	1	0	0	0	0	no assertion provided	no assertion criteria provided	Jan 08, 2015	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	18004641;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	0	0
17	44913382	C	G	44913382	44913382	-	Haplotype	190336	RCV000192110	SCV000222969	77391	GFAP	NM_002055.4:c.667G>C	NP_002046.1:p.Glu223Gln	NM_002055.4:c.667G>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 08, 2015	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	14707518;15060693;19444543;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	0	0
17	44915251	C	T	44915251	44915251	-	Haplotype	190336	RCV000192110	SCV000222969	31209	GFAP	NM_002055.4:c.236G>A	NP_002046.1:p.Arg79His	NM_002055.4:c.236G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Nov 08, 2016	GeneReviews	GeneReviews	Alexander's disease;Alexander's disease	14707518;15060693;19444543;20301351;21533827					germline	GeneReviews:NBK1172;Genetic Alliance:Alexander+Disease/302;MedGen:C0270726;OMIM:203450;Orphanet:58;SNOMED CT:81854007	2015-01-08	1	0
17	63941803	C	T	63941803	63941803	-	Haplotype	21158	RCV000020275	SCV000040630	34011	SCN4A	NM_000334.4:c.4479G>A	NP_000325.4:p.Met1493Ile	NM_000334.4:c.4479G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 28, 2016	GeneReviews	GeneReviews	Hyperkalemic Periodic Paralysis Type 1	10930446;20298421;20301669					germline	GeneReviews:NBK1496;GeneTests:2133;Genetic Alliance:Hyperkalemic+Periodic+Paralysis+Type+1/8591;MedGen:CN074266;OMIM:170500;Orphanet:682	2016-01-28	0	0
17	63941814	A	G	63941814	63941814	-	Haplotype	21158	RCV000020275	SCV000040630	34010	SCN4A	NM_000334.4:c.4468T>C	NP_000325.4:p.Phe1490Leu	NM_000334.4:c.4468T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 28, 2016	GeneReviews	GeneReviews	Hyperkalemic Periodic Paralysis Type 1	10930446;20298421;20301669					germline	GeneReviews:NBK1496;GeneTests:2133;Genetic Alliance:Hyperkalemic+Periodic+Paralysis+Type+1/8591;MedGen:CN074266;OMIM:170500;Orphanet:682	2016-01-28	0	0
17	75517064	T	C	75517064	75517064	+	Haplotype	2121	RCV000002203	SCV000022361	38422	TSEN54	NM_207346.2:c.277T>C	NP_997229.2:p.Ser93Pro	NM_207346.2:c.277T>C:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Sep 08, 2009	OMIM	OMIM	Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA, TYPE 4	18711368;20301773					germline	GeneReviews:NBK9673;Genetic Alliance:Pontocerebellar+hypoplasia+type+4/5866;MedGen:C1856974;OMIM:225753;Office of Rare Diseases:343;Orphanet:166063	2008-09-01	0	0
17	75522000	G	T	75522000	75522000	+	Haplotype	2121	RCV000002203	SCV000022361	17159	TSEN54	NM_207346.2:c.919G>T	NP_997229.2:p.Ala307Ser	NM_207346.2:c.919G>T:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Nov 01, 2017	OMIM	OMIM	Pontocerebellar hypoplasia type 4;PONTOCEREBELLAR HYPOPLASIA, TYPE 4	18711368;20301773					germline	GeneReviews:NBK9673;Genetic Alliance:Pontocerebellar+hypoplasia+type+4/5866;MedGen:C1856974;OMIM:225753;Office of Rare Diseases:343;Orphanet:166063	2008-09-01	2	0
17	81717813	C	T	81717813	81717813	+	Haplotype	446176	RCV000516170	SCV000611120	439524	SLC25A10	NM_001270888.1:c.684C>T	NP_001257817.1:p.Pro228=	NM_001270888.1:c.684C>T:synonymous variant;NM_001270953.1:c.574C>T:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Computational Biology Unit,University of Bari	Computational Biology Unit,University of Bari	Mitochondrial complex I deficiency;Epileptic encephalopathy;Decreased activity of mitochondrial complex I;Infantile muscular hypotonia	29211846					not applicable;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;HP:HP:0008947;HP:HP:0011923;HP:HP:0200134;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	0000-00-00	0	0
17	81719939	G	A	81719939	81719939	+	Haplotype	446176	RCV000516170	SCV000611120	439525	SLC25A10	NM_001270888.1:c.790-37G>A		NM_001270888.1:c.790-37G>A:intron variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	-	Computational Biology Unit,University of Bari	Computational Biology Unit,University of Bari	Mitochondrial complex I deficiency;Epileptic encephalopathy;Decreased activity of mitochondrial complex I;Infantile muscular hypotonia	29211846					not applicable;paternal	Genetic Alliance:Mitochondrial+complex+I+deficiency/4823;HP:HP:0008947;HP:HP:0011923;HP:HP:0200134;MedGen:C1838979;OMIM:252010;Office of Rare Diseases:3908;Orphanet:2609	0000-00-00	0	0
18	3215158	CAC	GAG	3215158	3215160	-	Haplotype	229030	RCV000221703	SCV000272178	230906	MYOM1	NM_003803.3:c.64_66delGTGinsCTC	NP_003794.3:p.Val22Leu	NM_003803.3:c.64_66delGTGinsCTC:missense variant	-	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Jul 08, 2015	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-07-08	0	0
18	3215159	A	C	3215159	3215159	-	Haplotype	229030	RCV000221703	SCV000272178	230904	MYOM1	NM_003803.3:c.65T>G	NP_003794.3:p.Val22Gly	NM_003803.3:c.65T>G:missense variant	Uncertain significance	uncertain significance	0	0	1	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 26, 2017	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	Laboratory for Molecular Medicine,Partners HealthCare Personalized Medicine	not specified;Not specified	24033266					germline	MedGen:CN169374	2015-07-08	0	0
18	45865614	C	G	45865614	45865614	-	Haplotype	267449	RCV000496979	SCV000328418	262702	EPG5	NM_020964.2:c.6766+1G>C		NM_020964.2:c.6766+1G>C:splice donor variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45879089	CA	C	45879090	45879090	-	Haplotype	267444	RCV000496982	SCV000328413	262703	EPG5	NM_020964.2:c.5792delT	NP_066015.2:p.Leu1931Trpfs	NM_020964.2:c.5792delT:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45908057	C	T	45908057	45908057	-	Haplotype	267445	RCV000496976	SCV000328414	262704	EPG5	NM_020964.2:c.4230G>A	NP_066015.2:p.Trp1410Ter	NM_020964.2:c.4230G>A:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45910617	AG	A	45910618	45910618	-	Haplotype	267447	RCV000496985	SCV000328416	262705	EPG5	NM_020964.2:c.4108delC	NP_066015.2:p.Leu1370Serfs	NM_020964.2:c.4108delC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45916009	C	T	45916009	45916009	-	Haplotype	267446	RCV000496981	SCV000328415	262712	EPG5	NM_020964.2:c.3582G>A	NP_066015.2:p.Lys1194=	NM_020964.2:c.3582G>A:synonymous variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45917766	G	C	45917766	45917766	-	Haplotype	267445	RCV000496976	SCV000328414	262706	EPG5	NM_020964.2:c.3152C>G	NP_066015.2:p.Ser1051Ter	NM_020964.2:c.3152C>G:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45922395	G	A	45922395	45922395	-	Haplotype	267449	RCV000496979	SCV000328418	262707	EPG5	NM_020964.2:c.3044C>T	NP_066015.2:p.Ala1015Val	NM_020964.2:c.3044C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45925858	T	C	45925858	45925858	-	Haplotype	267448	RCV000496977	SCV000328417	262708	EPG5	NM_020964.2:c.2598A>G	NP_066015.2:p.Gln866=	NM_020964.2:c.2598A>G:synonymous variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45928961	G	A	45928961	45928961	-	Haplotype	267446	RCV000496981	SCV000328415	262711	EPG5	NM_020964.2:c.2461C>T	NP_066015.2:p.Arg821Ter	NM_020964.2:c.2461C>T:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45952463	TG	T	45952464	45952464	-	Haplotype	267448	RCV000496977	SCV000328417	262709	EPG5	NM_020964.2:c.1188delC	NP_066015.2:p.Tyr396Terfs	NM_020964.2:c.1188delC:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45967238	A	G	45967238	45967238	-	Haplotype	267444	RCV000496982	SCV000328413	262710	EPG5	NM_020964.2:c.2T>C	NP_066015.2:p.Met1Thr	NM_020964.2:c.2T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	45967239	T	C	45967239	45967239	-	Haplotype	267447	RCV000496985	SCV000328416	262713	EPG5	NM_020964.2:c.1A>G	NP_066015.2:p.Met1Val	NM_020964.2:c.1A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 11, 2016	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Department of Pediatrics and Neonatology,Nagoya City University Graduate School of Medical Sciences	Absent corpus callosum cataract immunodeficiency;Vici syndrome	21965116;28615637;3344762					germline	Genetic Alliance:Absent+Corpus+Callosum+Cataract+Immunodeficiency/81;MedGen:C1855772;OMIM:242840;Office of Rare Diseases:448;Orphanet:1493	2016-08-11	0	0
18	53467923	A	G	53467923	53467923	+	Haplotype	375288	RCV000416369	SCV000485060	362059	DCC	NM_005215.3:c.3649A>G	NP_005206.2:p.Met1217Val	NM_005215.3:c.3649A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2016	Neurogenetics Research, Murdoch Childrens Research Institute	Neurogenetics Research, Murdoch Childrens Research Institute	Corpus callosum agenesis						germline	Genetic Alliance:Agenesis+of+the+Corpus+Callosum/263;MedGen:C0175754;OMIM:217990;Office of Rare Diseases:1535;Orphanet:200	2016-01-01	0	0
18	53486808	G	A	53486808	53486808	+	Haplotype	375288	RCV000416369	SCV000485060	362060	DCC	NM_005215.3:c.3748G>A	NP_005206.2:p.Ala1250Thr	NM_005215.3:c.3748G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 01, 2016	Neurogenetics Research, Murdoch Childrens Research Institute	Neurogenetics Research, Murdoch Childrens Research Institute	Corpus callosum agenesis						germline	Genetic Alliance:Agenesis+of+the+Corpus+Callosum/263;MedGen:C0175754;OMIM:217990;Office of Rare Diseases:1535;Orphanet:200	2016-01-01	0	0
18	57550753	A	C	57550753	57550753	-	Haplotype	561	RCV000000591	SCV000020740	38381	FECH	NM_001012515.2:c.1249T>G	NP_001012533.1:p.Cys417Gly	NM_000140.3:c.1231T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 15, 2000	OMIM	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404;23016163					germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005	2000-08-15	0	0
18	57550759	G	A	57550759	57550759	-	Haplotype	561	RCV000000591	SCV000020740	38382	FECH	NM_001012515.2:c.1243C>T	NP_001012533.1:p.Pro415Ser	NM_000140.3:c.1225C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 15, 2000	OMIM	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404;23016163					germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005	2000-08-15	0	0
18	57550760	A	T	57550760	57550760	-	Haplotype	561	RCV000000591	SCV000020740	15600	FECH	NM_001012515.2:c.1242T>A	NP_001012533.1:p.Asn414Lys	NM_000140.3:c.1224T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 15, 2000	OMIM	OMIM	Erythropoietic protoporphyria;PROTOPORPHYRIA, ERYTHROPOIETIC	10942404;23016163					germline	GeneReviews:NBK100826;Genetic Alliance:Erythropoietic+Protoporphyria/2648;MedGen:C0162568;OMIM:177000;Office of Rare Diseases:4527;Orphanet:79278;SNOMED CT:51022005	2000-08-15	0	0
19	853329	G	T	853329	853329	+	Haplotype	16747	RCV000018231	SCV000038510	31786	ELANE	NM_001972.3:c.292G>T	NP_001963.1:p.Val98Leu	NM_001972.3:c.292G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2007	OMIM	OMIM	Severe congenital neutropenia autosomal dominant;NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	17436313;20301705					germline	GeneReviews:NBK1533;Genetic Alliance:Severe+congenital+neutropenia+autosomal+dominant/6527;MedGen:C1859966;OMIM:130130.0006;OMIM:130130.0007;OMIM:130130.0008;OMIM:130130.0009;OMIM:130130.0010;OMIM:130130.0011;OMIM:202700;Office of Rare Diseases:9558;Orphanet:486	2007-09-01	0	0
19	853338	G	T	853338	853338	+	Haplotype	16747	RCV000018231	SCV000038510	38480	ELANE	NM_001972.3:c.301G>T	NP_001963.1:p.Val101Leu	NM_001972.3:c.301G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 01, 2007	OMIM	OMIM	Severe congenital neutropenia autosomal dominant;NEUTROPENIA, SEVERE CONGENITAL, 1, AUTOSOMAL DOMINANT	17436313;20301705					germline	GeneReviews:NBK1533;Genetic Alliance:Severe+congenital+neutropenia+autosomal+dominant/6527;MedGen:C1859966;OMIM:130130.0006;OMIM:130130.0007;OMIM:130130.0008;OMIM:130130.0009;OMIM:130130.0010;OMIM:130130.0011;OMIM:202700;Office of Rare Diseases:9558;Orphanet:486	2007-09-01	0	0
19	863114	T	G	863114	863114	+	Haplotype	16565	RCV000018033	SCV000038312	31604	CFD	NM_001928.3:c.638T>G	NP_001919.2:p.Val213Gly	NM_001928.3:c.638T>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 15, 2006	OMIM	OMIM	Complement factor d deficiency;COMPLEMENT FACTOR D DEFICIENCY	16527897					germline	Genetic Alliance:Complement+factor+d+deficiency/8033;MedGen:C1851396;OMIM:613912	2006-06-15	0	0
19	863116	T	C	863116	863116	+	Haplotype	16565	RCV000018033	SCV000038312	38479	CFD	NM_001928.3:c.640T>C	NP_001919.2:p.Cys214Arg	NM_001928.3:c.640T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 15, 2006	OMIM	OMIM	Complement factor d deficiency;COMPLEMENT FACTOR D DEFICIENCY	16527897					germline	Genetic Alliance:Complement+factor+d+deficiency/8033;MedGen:C1851396;OMIM:613912	2006-06-15	0	0
19	5844332	C	T	5844332	5844332	-	Haplotype	17716	RCV000019289	SCV000039578	38486	FUT3	NM_000149.3:c.508G>A	NP_000140.1:p.Gly170Ser	NM_000149.3:c.508G>A:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Le(-) PHENOTYPE;Le(-) PHENOTYPE	8219240					germline	OMIM:111100.0001	2015-05-18	0	0
19	5844781	A	C	5844781	5844781	-	Haplotype	17716	RCV000019289	SCV000039578	32755	FUT3	NM_000149.3:c.59T>G	NP_000140.1:p.Leu20Arg	NM_000149.3:c.59T>G:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Le(-) PHENOTYPE;Le(-) PHENOTYPE	8219240					germline	OMIM:111100.0001	2015-05-18	0	0
19	7125381	C	T	7125381	7125381	-	Haplotype	377384	RCV000496626	SCV000503037	364259	INSR	NM_000208.3:c.3160G>A	NP_000199.2:p.Val1054Met	NM_000208.3:c.3160G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Insulin-resistant diabetes mellitus AND acanthosis nigricans	28765322					germline	Genetic Alliance:Insulin-resistant+diabetes+mellitus+AND+acanthosis+nigricans/8675;Genetics Home Reference:type-a-insulin-resistance-syndrome;MedGen:C0271690;OMIM:610549;Orphanet:2297;SNOMED CT:9859006	2014-06-02	0	0
19	7126600	A	C	7126600	7126600	-	Haplotype	377383	RCV000496343	SCV000503036	364260	INSR	NM_000208.3:c.2997T>G	NP_000199.2:p.Tyr999Ter	NM_000208.3:c.2997T>G:nonsense	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0
19	7142833	G	A	7142833	7142833	-	Haplotype	377382	RCV000496805	SCV000503035	364261	INSR	NM_000208.3:c.2525C>T	NP_000199.2:p.Ala842Val	NM_000208.3:c.2525C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0
19	7142854	C	A	7142854	7142854	-	Haplotype	377382	RCV000496805	SCV000503035	364262	INSR	NM_000208.3:c.2504G>T	NP_000199.2:p.Ser835Ile	NM_000208.3:c.2504G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0
19	7163092	C	A	7163092	7163092	-	Haplotype	377381	RCV000496605	SCV000503034	364263	INSR	NM_000208.3:c.1969G>T	NP_000199.2:p.Val657Phe	NM_000208.3:c.1969G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Leprechaunism syndrome	28765322					germline	Genetic Alliance:Leprechaunism+syndrome/8731;Genetics Home Reference:donohue-syndrome;MedGen:C0265344;OMIM:246200;Orphanet:508;SNOMED CT:111307005	2014-06-02	0	0
19	7170555	T	C	7170555	7170555	-	Haplotype	377384	RCV000496626	SCV000503037	364264	INSR	NM_000208.3:c.1465A>G	NP_000199.2:p.Asn489Asp	NM_000208.3:c.1465A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Insulin-resistant diabetes mellitus AND acanthosis nigricans	28765322					germline	Genetic Alliance:Insulin-resistant+diabetes+mellitus+AND+acanthosis+nigricans/8675;Genetics Home Reference:type-a-insulin-resistance-syndrome;MedGen:C0271690;OMIM:610549;Orphanet:2297;SNOMED CT:9859006	2014-06-02	0	0
19	7184524	G	A	7184524	7184524	-	Haplotype	377383	RCV000496343	SCV000503036	364265	INSR	NM_000208.3:c.766C>T	NP_000199.2:p.Arg256Cys	NM_000208.3:c.766C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 02, 2014	Medical Research Institute,Tokyo Medical and Dental University	Medical Research Institute,Tokyo Medical and Dental University	Pineal hyperplasia AND diabetes mellitus syndrome	28765322					germline	Genetic Alliance:Pineal+hyperplasia+AND+diabetes+mellitus+syndrome/9115;Genetics Home Reference:rabson-mendenhall-syndrome;MedGen:C0271695;OMIM:262190;Orphanet:769;SNOMED CT:33559001	2014-06-02	0	0
19	10380510	C	T	10380510	10380510	-	Haplotype	440728	RCV000508928	SCV000606721	434354	TYK2	NM_003331.4:c.-316G>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0
19	10380511	C	T	10380511	10380511	-	Haplotype	440728	RCV000508928	SCV000606721	434355	TYK2	NM_003331.4:c.-317G>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion criteria provided	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0
19	10380572	T	C	10380572	10380572	-	Haplotype	440728	RCV000508928	SCV000606721	342540	TYK2	NM_003331.4:c.-378A>G		NM_003331.4:c.-378A>G:5 prime UTR variant	Uncertain significance	risk factor	0	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jun 14, 2016	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	1	0
19	10380676	T	G	10380676	10380676	-	Haplotype	440728	RCV000508928	SCV000606721	434356	TYK2	NM_003331.4:c.-482A>C			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0
19	10381501	A	T	10381501	10381501	-	Haplotype	440728	RCV000508928	SCV000606721	434357	TYK2	NM_003331.4:c.-1307T>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0
19	10381502	C	T	10381502	10381502	-	Haplotype	440728	RCV000508928	SCV000606721	434358	TYK2	NM_003331.4:c.-1308G>A			Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	-	Division of Host Defense,Kyushu University	Division of Host Defense,Kyushu University	Virus-induced diabetes;Virus-induced diabetes	26288847					inherited		0000-00-00	0	0
19	11105552	T	TGTGATG	11105555	11105560	+	Haplotype	250923	RCV000238362	SCV000294356	245688	LDLR	NM_000527.4:c.649_654dupGATGGT	NP_000518.1:p.Gly218_Gly219insAspGly	NM_000527.4:c.649_654dupGATGGT:inframe_variant;NM_001195800.1:c.314-1837_314-1832dup:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 25, 2016	LDLR-LOVD, British Heart Foundation	LDLR-LOVD, British Heart Foundation	Familial hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;27854360;7649546					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2016-03-25	0	0
19	11105561	GGCCCC	G	11105563	11105567	+	Haplotype	250923	RCV000238362	SCV000294356	245692	LDLR	NM_000527.4:c.657_661delCCCCG	NP_000518.1:p.Pro220Leufs	NM_000527.4:c.657_661delCCCCG:frameshift variant;NM_001195800.1:c.314-1829_314-1825delCCCCG:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 25, 2016	LDLR-LOVD, British Heart Foundation	LDLR-LOVD, British Heart Foundation	Familial hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;27854360;7649546					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2016-03-25	0	0
19	11107403	G	A	11107403	11107403	+	Haplotype	430765	RCV000495914	SCV000583747	181238	LDLR	NM_000527.4:c.829G>A	NP_000518.1:p.Glu277Lys	NM_000527.4:c.829G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Apr 24, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;28145427					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	1	1
19	11107506	A	G	11107506	11107506	+	Haplotype	430769	RCV000495938	SCV000583762	245864	LDLR	NM_000527.4:c.932A>G	NP_000518.1:p.Lys311Arg	NM_000527.4:c.932A>G:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	1	1
19	11107513	C	G	11107513	11107513	+	Haplotype	430769	RCV000495938	SCV000583762	245873	LDLR	NM_000527.4:c.939C>G	NP_000518.1:p.Cys313Trp	NM_000527.4:c.939C>G:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0
19	11113359	T	C	11113359	11113359	+	Haplotype	430765	RCV000495914	SCV000583747	246074	LDLR	NM_000527.4:c.1268T>C	NP_000518.1:p.Ile423Thr	NM_000527.4:c.1268T>C:missense variant	Pathogenic/Likely pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;28145427					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	2	0
19	11116197	A	C	11116197	11116197	+	Haplotype	3737	RCV000003935	SCV000024100;SCV000583862	18776	LDLR	NM_000527.4:c.1690A>C	NP_000518.1:p.Asn564His	NM_000527.4:c.1690A>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Mar 30, 2017	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;FH AARHUS;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	1439789;15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;8528204;9143924					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	1997-01-01;2017-03-30	0	1
19	11120225	A	C	11120225	11120225	+	Haplotype	430800	RCV000495898	SCV000583944	424334	LDLR	NM_000527.4:c.1979A>C	NP_000518.1:p.Gln660Pro	NM_000527.4:c.1979A>C:missense variant	Likely pathogenic	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0
19	11128055	G	A	11128055	11128055	+	Haplotype	430800	RCV000495898	SCV000583944	424344	LDLR	NM_000527.4:c.2359G>A	NP_000518.1:p.Val787Met	NM_000527.4:c.2359G>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Mar 30, 2017	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	2017-03-30	0	0
19	11129515	CTCCTCGTCT	C	11129520	11129528	+	Haplotype	3737	RCV000003935	SCV000024100;SCV000583862	71434	LDLR	NM_000527.4:c.2397_2405delCGTCTTCCT	NP_000518.1:p.Val800_Leu802del	NM_000527.4:c.2397_2405delCGTCTTCCT:inframe_variant	Pathogenic/Likely pathogenic	pathogenic;pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided;criteria provided, single submitter	Mar 30, 2017	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	OMIM;U4M - Lille University & CHRU Lille,Université Lille 2 - CHRU de Lille	Familial hypercholesterolemia;FH AARHUS;Hyperbetalipoproteinemia;Hypercholesterolemia;Familial Hypercholesterolemia	1439789;15177124;21600525;22364837;23725921;23788249;24404629;24418289;24636176;25053660;25356965;25404096;25741868;27854360;8528204;9143924					germline	GeneReviews:NBK174884;Genetic Alliance:Familial+Hypercholesterolemia/2746;HP:HP:0003124;HP:HP:0003141;MedGen:C0020445;OMIM:143890;OMIM:144400;OMIM:600946.0028;Orphanet:391665;SNOMED CT:397915002;SNOMED CT:398036000	1997-01-01;2017-03-30	0	0
19	18594338	A	C	18594338	18594338	-	Haplotype	5706	RCV000006060	SCV000026242	34280	CRLF1	NM_004750.4:c.1121T>G	NP_004741.1:p.Leu374Arg	NM_004750.4:c.1121T>G:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Mar 03, 2011	OMIM	OMIM	Cold-induced sweating syndrome 1;COLD-INDUCED SWEATING SYNDROME 1	12509788;21370513					germline	GeneReviews:NBK52917;Genetic Alliance:Cold-induced+sweating+syndrome+1/8000;Genetic Alliance:Crisponi+Syndrome/2012;MedGen:C1848947;OMIM:272430;Orphanet:157820	2003-02-01	0	0
19	18599720	C	T	18599720	18599720	-	Haplotype	5706	RCV000006060	SCV000026242	20745	CRLF1	NM_004750.4:c.242G>A	NP_004741.1:p.Arg81His	NM_004750.4:c.242G>A:missense variant	Benign	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Mar 03, 2011	OMIM	OMIM	Cold-induced sweating syndrome 1;COLD-INDUCED SWEATING SYNDROME 1	12509788;21370513					germline	GeneReviews:NBK52917;Genetic Alliance:Cold-induced+sweating+syndrome+1/8000;Genetic Alliance:Crisponi+Syndrome/2012;MedGen:C1848947;OMIM:272430;Orphanet:157820	2003-02-01	0	0
19	35842429	T	A	35842429	35842429	-	Haplotype	6872	RCV000007275	SCV000027471	38439	NPHS1	NM_004646.3:c.2456A>T	NP_004637.1:p.Asp819Val	NM_004646.3:c.2456A>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 01, 2000	OMIM	OMIM	Finnish congenital nephrotic syndrome;NEPHROTIC SYNDROME, TYPE 1	10652016					germline	Genetic Alliance:Congenital+Nephrotic+Syndrome+Finnish+Type/1861;MedGen:C0403399;OMIM:256300;OMIM:602716.0001;OMIM:602716.0002;OMIM:602716.0003;OMIM:602716.0004;OMIM:602716.0005;OMIM:602716.0006;OMIM:602716.0007;OMIM:602716.0008;OMIM:602716.0009;OMIM:602716.0010;Office of Rare Diseases:1500;Orphanet:839;SNOMED CT:197601003	2000-02-01	0	0
19	35848142	C	T	35848142	35848142	-	Haplotype	6872	RCV000007275	SCV000027471	21911	NPHS1	NM_004646.3:c.1339G>A	NP_004637.1:p.Glu447Lys	NM_004646.3:c.1339G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 18, 2016	OMIM	OMIM	Finnish congenital nephrotic syndrome;NEPHROTIC SYNDROME, TYPE 1	10652016					germline	Genetic Alliance:Congenital+Nephrotic+Syndrome+Finnish+Type/1861;MedGen:C0403399;OMIM:256300;OMIM:602716.0001;OMIM:602716.0002;OMIM:602716.0003;OMIM:602716.0004;OMIM:602716.0005;OMIM:602716.0006;OMIM:602716.0007;OMIM:602716.0008;OMIM:602716.0009;OMIM:602716.0010;Office of Rare Diseases:1500;Orphanet:839;SNOMED CT:197601003	2000-02-01	0	1
19	38489352	AAG	A	38489355	38489356	+	Haplotype	29876	RCV000022757	SCV000044046	38831	RYR1	NM_000540.2:c.5726_5727delAG	NP_000531.2:p.Glu1909Glyfs	NM_000540.2:c.5726_5727delAG:frameshift variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 2010	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	20301467;20839240;22009146;23788249;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	0	0
19	38504319	C	T	38504319	38504319	+	Haplotype	12985	RCV000013857	SCV000034104	28024	RYR1	NM_000540.2:c.8026C>T	NP_000531.2:p.Arg2676Trp	NM_000540.2:c.8026C>T:missense variant	Uncertain significance	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 02, 2013	OMIM	OMIM	Malignant hyperthermia, susceptibility to, 1;MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	14732627;14870754;16163667;16917943;20301325;23788249;25356965;27854360					germline	GeneReviews:NBK1146;MedGen:CN031421;OMIM:145600;Office of Rare Diseases:3363;Orphanet:423	2004-01-01	0	0
19	38505358	C	G	38505358	38505358	+	Haplotype	12985	RCV000013857	SCV000034104	38459	RYR1	NM_000540.2:c.8360C>G	NP_000531.2:p.Thr2787Ser	NM_000540.2:c.8360C>G:missense variant	Benign/Likely benign	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 10, 2017	OMIM	OMIM	Malignant hyperthermia, susceptibility to, 1;MALIGNANT HYPERTHERMIA, SUSCEPTIBILITY TO, 1	14732627;14870754;16163667;16917943;20301325;23788249;25356965;27854360					germline	GeneReviews:NBK1146;MedGen:CN031421;OMIM:145600;Office of Rare Diseases:3363;Orphanet:423	2004-01-01	0	0
19	38512253	T	C	38512253	38512253	+	Haplotype	29876	RCV000022757	SCV000044046	51078	RYR1	NM_000540.2:c.9242T>C	NP_000531.2:p.Met3081Thr	NM_000540.2:c.9242T>C:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 08, 2017	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	20301467;20839240;22009146;23788249;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	1	1
19	38523211	C	G	38523211	38523211	+	Haplotype	65396	RCV000022758	SCV000044047	70540	RYR1	NM_000540.2:c.10348-6C>G		NM_000540.2:c.10348-6C>G:intron variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 11, 2017	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	18253926;20301467;20839240;22009146;23788249;27854218;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	0	0
19	38580382	G	A	38580382	38580382	+	Haplotype	65396	RCV000022758	SCV000044047	38832	RYR1	NM_000540.2:c.14524G>A	NP_000531.2:p.Val4842Met	NM_000540.2:c.14524G>A:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 11, 2017	OMIM	OMIM	Minicore myopathy with external ophthalmoplegia;MINICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	18253926;20301467;20839240;22009146;23788249;27854218;27854360					germline	GeneReviews:NBK1290;Genetic Alliance:Minicore+myopathy+with+external+ophthalmoplegia/4818;MedGen:C1850674;OMIM:255320;Office of Rare Diseases:10316;Orphanet:598	2010-11-01	1	0
19	41860817	G	T	41860817	41860817	+	Haplotype	6319	RCV000033188	SCV000057024	21358	RPS19	NM_001022.3:c.43G>T	NP_001013.1:p.Val15Phe	NM_001022.3:c.43G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 03, 2015	OMIM	OMIM	Diamond-Blackfan anemia 1;DIAMOND-BLACKFAN ANEMIA 1	12586610;20301769					germline	GeneReviews:NBK7047;Genetic Alliance:Diamond-Blackfan+anemia+1/8226;MedGen:C2676137;OMIM:105650;Orphanet:124	2003-06-15	0	0
19	41861204	C	T	41861204	41861204	+	Haplotype	6319	RCV000033188	SCV000057024	38387	RPS19	NM_001022.3:c.164C>T	NP_001013.1:p.Thr55Met	NM_001022.3:c.164C>T:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 13, 2017	OMIM	OMIM	Diamond-Blackfan anemia 1;DIAMOND-BLACKFAN ANEMIA 1	12586610;20301769					germline	GeneReviews:NBK7047;Genetic Alliance:Diamond-Blackfan+anemia+1/8226;MedGen:C2676137;OMIM:105650;Orphanet:124	2003-06-15	1	0
19	44907807	G	A	44907807	44907807	+	Haplotype	441264	RCV000019443	SCV000039733	32899	APOE	NM_000041.3:c.91G>A	NP_000032.1:p.Glu31Lys	NM_000041.3:c.91G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Nov 01, 1992	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	1361196;1674745;22962670					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1992-11-01	0	0
19	44907853	T	C	44907853	44907853	+	Haplotype	441268	RCV000019456	SCV000039746	32909	APOE	NM_000041.3:c.137T>C	NP_000032.1:p.Leu46Pro	NM_000041.3:c.137T>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	criteria provided, single submitter	no assertion criteria provided	Feb 15, 2017	OMIM	OMIM	APOE4(-)-FREIBURG;APOE4(-)-FREIBURG	21500874					germline	OMIM:107741.0023	2017-02-15	1	0
19	44908601	C	G	44908601	44908601	+	Haplotype	441269	RCV000019458	SCV000039748	32911	APOE	NM_000041.3:c.305C>G	NP_000032.1:p.Pro102Arg	NM_000041.3:c.305C>G:missense variant	-	association	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 10, 2018	OMIM	OMIM	APOE4 VARIANT;APOE4 VARIANT	18583979;21500874;2341812;3585172					germline	OMIM:107741.0025;OMIM:107741.0028	2018-01-10	0	0
19	44908645	G	A	44908645	44908645	+	Haplotype	441270	RCV000019459	SCV000039749	32912	APOE	NM_000041.3:c.349G>A	NP_000032.1:p.Ala117Thr	NM_000041.3:c.349G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2008	OMIM	OMIM	APOE3 VARIANT;APOE3 VARIANT	18583979;6327682					germline	OMIM:107741.0026	2008-07-01	0	0
19	44908684	T	C	44908684	44908684	+	Haplotype	440870;441267;441268;441269	RCV000019438;RCV000019455;RCV000019456;RCV000019458	SCV000039727;SCV000039745;SCV000039746;SCV000039748	32903	APOE	NM_000041.3:c.388T>C	NP_000032.1:p.Cys130Arg	NM_000041.3:c.388T>C:missense variant	Pathogenic, other	pathogenic;association	3	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 10, 2018	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4;APOE4(-)-FREIBURG;APOE4 VARIANT	1730728;21500874;22962670;25333069;2539388;6860421;8488843;18583979;2341812;3585172					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005;OMIM:107741.0023;OMIM:107741.0025;OMIM:107741.0028	2017-02-14;1993-05-01;2017-02-15;2018-01-10	0	0
19	44908730	G	A	44908730	44908730	+	Haplotype	441262	RCV000019439	SCV000039729	32895	APOE	NM_000041.3:c.434G>A	NP_000032.1:p.Gly145Asp	NM_000041.3:c.434G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1984	OMIM	OMIM	Apolipoproteinemia E1;APOLIPOPROTEINEMIA E1	6323533					germline		1984-04-01	0	0
19	44908774	C	T	44908774	44908774	+	Haplotype	440870	RCV000019438	SCV000039727	38488	APOE	NM_000041.3:c.478C>T	NP_000032.1:p.Arg160Cys	NM_000041.3:c.478C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 14, 2017	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, AUTOSOMAL DOMINANT	1730728;21500874;22962670;25333069;2539388;6860421					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	2017-02-14	0	0
19	44908783	C	T	44908783	44908783	+	Haplotype	441264	RCV000019443	SCV000039733	32890	APOE	NM_000041.3:c.487C>T	NP_000032.1:p.Arg163Cys	NM_000041.3:c.487C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Nov 01, 1992	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, DUE TO APOE4-PHILADELPHIA	1361196;1674745;22962670					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1992-11-01	0	0
19	44908804	G	C	44908804	44908804	+	Haplotype	441270	RCV000019459	SCV000039749	38495	APOE	NM_000041.3:c.508G>C	NP_000032.1:p.Ala170Pro	NM_000041.3:c.508G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2008	OMIM	OMIM	APOE3 VARIANT;APOE3 VARIANT	18583979;6327682					germline	OMIM:107741.0026	2008-07-01	0	0
19	44908822	C	T	44908822	44908822	+	Haplotype	441262;441265;441266	RCV000019439;RCV000019452;RCV000019454	SCV000039729;SCV000039741;SCV000039744	32887	APOE	NM_000041.3:c.526C>T	NP_000032.1:p.Arg176Cys	NM_000041.3:c.526C>T:missense variant	drug response	pathogenic	3	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 21, 2017	OMIM	OMIM	Apolipoproteinemia E1;APOLIPOPROTEINEMIA E1;Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	6323533;22962670;8664327;8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1984-04-01;2017-02-21;1993-05-01	0	0
19	44909021	G	A	44909021	44909021	+	Haplotype	441265	RCV000019452	SCV000039741	38490	APOE	NM_000041.3:c.725G>A	NP_000032.1:p.Arg242Gln	NM_000041.3:c.725G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 21, 2017	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III	22962670;8664327					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	2017-02-21	0	0
19	44909057	T	A	44909057	44909057	+	Haplotype	441266	RCV000019454	SCV000039744	38491	APOE	NM_000041.3:c.761T>A	NP_000032.1:p.Val254Glu	NM_000041.3:c.761T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1993	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE2	22962670;8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1993-05-01	0	0
19	44909080	G	A	44909080	44909080	+	Haplotype	441263	RCV000019435	SCV000039725	32893	APOE	NM_000041.3:c.784G>A	NP_000032.1:p.Glu262Lys	NM_000041.3:c.784G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1995	OMIM	OMIM	HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7;HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7	2470732;2738044;6480826;7586659					germline	OMIM:107741.0007	1995-08-01	0	0
19	44909083	G	A	44909083	44909083	+	Haplotype	441263	RCV000019435	SCV000039725	38487	APOE	NM_000041.3:c.787G>A	NP_000032.1:p.Glu263Lys	NM_000041.3:c.787G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1995	OMIM	OMIM	HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7;HYPERLIPOPROTEINEMIA, TYPE III, AND ATHEROSCLEROSIS ASSOCIATED WITH APOE7	2470732;2738044;6480826;7586659					germline	OMIM:107741.0007	1995-08-01	0	0
19	44909101	C	G	44909101	44909101	+	Haplotype	441267	RCV000019455	SCV000039745	38492	APOE	NM_000041.3:c.805C>G	NP_000032.1:p.Arg269Gly	NM_000041.3:c.805C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 01, 1993	OMIM	OMIM	Familial type 3 hyperlipoproteinemia;HYPERLIPOPROTEINEMIA, TYPE III, ASSOCIATED WITH APOE4	21500874;22962670;8488843					germline	MedGen:C0020479;OMIM:617347;SNOMED CT:398796005	1993-05-01	0	0
19	46755524	C	A	46755524	46755524	+	Phase unknown	224674	RCV000226653	SCV000265787	226485	FKRP	NM_024301.4:c.74C>A	NP_077277.1:p.Ser25Ter	NM_024301.4:c.74C>A:nonsense	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Center for Genetic Medicine Research,Children's National Medical Center	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218					unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515	2015-12-01	0	0
19	46755524	CGT	C	46755526	46755527	+	Phase unknown	224674	RCV000226653	SCV000265787	226486	FKRP	NM_024301.4:c.76_77delTG	NP_077277.1:p.Trp26Alafs	NM_024301.4:c.76_77delTG:frameshift variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	criteria provided, single submitter	Dec 01, 2015	Center for Genetic Medicine Research,Children's National Medical Center	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218					unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515	2015-12-01	0	0
19	46756276	C	A	46756276	46756276	+	Phase unknown	224674	RCV000226653	SCV000265787	19260	FKRP	NM_024301.4:c.826C>A	NP_077277.1:p.Leu276Ile	NM_024301.4:c.826C>A:missense variant	Pathogenic	likely pathogenic	0	1	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Aug 07, 2017	Center for Genetic Medicine Research,Children's National Medical Center	Center for Genetic Medicine Research,Children's National Medical Center	Limb-girdle muscular dystrophy-dystroglycanopathy, type C5	27854218					unknown	Genetic Alliance:Limb-girdle+muscular+dystrophy-dystroglycanopathy%2C+type+C5/8754;MedGen:C1846672;OMIM:606596.0004;OMIM:606596.0005;OMIM:606596.0006;OMIM:606596.0011;OMIM:606596.0012;OMIM:606596.0013;OMIM:606596.0014;OMIM:606596.0015;OMIM:606596.0016;OMIM:607155;Orphanet:34515	2015-12-01	2	0
19	48965326	C	T	48965326	48965326	+	Haplotype	441527	RCV000017941	SCV000038220	31516	FTL	NM_000146.3:c.-182C>T		NM_000146.3:c.-182C>T:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 19, 2013	OMIM	OMIM	Hyperferritinemia cataract syndrome;HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	23421845;9226182					germline	Genetic Alliance:Hyperferritinemia+cataract+syndrome/3553;Genetics Home Reference:hyperferritinemia-cataract-syndrome;MedGen:C1833213;OMIM:134790.0001;OMIM:134790.0002;OMIM:134790.0003;OMIM:134790.0004;OMIM:134790.0005;OMIM:134790.0006;OMIM:134790.0007;OMIM:134790.0008;OMIM:134790.0009;OMIM:134790.0011;OMIM:134790.0012;OMIM:134790.0017;OMIM:134790.0020;OMIM:600886;Office of Rare Diseases:2806;Orphanet:163	2013-02-19	0	0
19	48965330	T	G	48965330	48965330	+	Haplotype	441527	RCV000017941	SCV000038220	260732	FTL	NM_000146.3:c.-178T>G		NM_000146.3:c.-178T>G:5 prime UTR variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 19, 2013	OMIM	OMIM	Hyperferritinemia cataract syndrome;HYPERFERRITINEMIA WITH OR WITHOUT CATARACT	23421845;9226182					germline	Genetic Alliance:Hyperferritinemia+cataract+syndrome/3553;Genetics Home Reference:hyperferritinemia-cataract-syndrome;MedGen:C1833213;OMIM:134790.0001;OMIM:134790.0002;OMIM:134790.0003;OMIM:134790.0004;OMIM:134790.0005;OMIM:134790.0006;OMIM:134790.0007;OMIM:134790.0008;OMIM:134790.0009;OMIM:134790.0011;OMIM:134790.0012;OMIM:134790.0017;OMIM:134790.0020;OMIM:600886;Office of Rare Diseases:2806;Orphanet:163	2013-02-19	0	0
19	49016626	A	G	49016626	49016626	-	Haplotype	441529	RCV000015495	SCV000035760	38465	LHB	NM_000894.2:c.104T>C	NP_000885.1:p.Ile35Thr	NM_000894.2:c.104T>C:missense variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2003	OMIM	OMIM	LUTEINIZING HORMONE POLYMORPHISM;LUTEINIZING HORMONE POLYMORPHISM	10199775;10323405;10468997;12620433;1727817;7714098;7904610;8784083					germline	OMIM:152780.0002	2003-03-01	0	0
19	49016648	A	G	49016648	49016648	-	Haplotype	441529	RCV000015495	SCV000035760	29453	LHB	NM_000894.2:c.82T>C	NP_000885.1:p.Trp28Arg	NM_000894.2:c.82T>C:missense variant	-	benign	0	0	0	0	1	no assertion for the individual variant	no assertion criteria provided	Mar 01, 2003	OMIM	OMIM	LUTEINIZING HORMONE POLYMORPHISM;LUTEINIZING HORMONE POLYMORPHISM	10199775;10323405;10468997;12620433;1727817;7714098;7904610;8784083					germline	OMIM:152780.0002	2003-03-01	0	0
20	4699605	A	G	4699605	4699605	+	Haplotype	13399;453225;453226	RCV000014337;RCV000032588;RCV000014336	SCV000034586;SCV000034587;SCV000034585	28436	PRNP	NM_000311.4:c.385A>G	NP_000302.1:p.Met129Val	NM_000311.4:c.385A>G:missense variant;NM_001271561.1:c.*74A>G:3 prime UTR variant	Benign/Likely benign, risk factor	pathogenic	3	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jun 14, 2016	OMIM	OMIM	Fatal familial insomnia;FATAL FAMILIAL INSOMNIA;Jakob-Creutzfeldt disease;CREUTZFELDT-JAKOB DISEASE	10581230;12205650;1353341;1353342;1469441;16227536;1671440;1671983;1684756;19038218;20301407;7709737;9751723;1347910;1357594;14732629;15623717;15806397;20038778;7630420;7783865;8105681;20298421					germline	GeneReviews:NBK1229;Genetic Alliance:Fatal+Familial+Insomnia/2793;MedGen:C0206042;OMIM:600072;Orphanet:466;SNOMED CT:83157008;Genetic Alliance:Creutzfeldt-Jakob+Disease/2006;MedGen:C0022336;OMIM:123400;Office of Rare Diseases:6956;Orphanet:204;Orphanet:282166;Orphanet:454700;SNOMED CT:792004	2008-11-26;2010-01-05	0	0
20	4699752	G	A	4699752	4699752	+	Haplotype	13399;453225;453226	RCV000014337;RCV000032588;RCV000014336	SCV000034586;SCV000034587;SCV000034585	28438	PRNP	NM_000311.4:c.532G>A	NP_000302.1:p.Asp178Asn	NM_000311.4:c.532G>A:missense variant;NM_001271561.1:c.*221G>A:3 prime UTR variant	Pathogenic	pathogenic	3	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Jan 05, 2010	OMIM	OMIM	Fatal familial insomnia;FATAL FAMILIAL INSOMNIA;Jakob-Creutzfeldt disease;CREUTZFELDT-JAKOB DISEASE	10581230;12205650;1353341;1353342;1469441;16227536;1671440;1671983;1684756;19038218;20301407;7709737;9751723;1347910;1357594;14732629;15623717;15806397;20038778;7630420;7783865;8105681;20298421					germline	GeneReviews:NBK1229;Genetic Alliance:Fatal+Familial+Insomnia/2793;MedGen:C0206042;OMIM:600072;Orphanet:466;SNOMED CT:83157008;Genetic Alliance:Creutzfeldt-Jakob+Disease/2006;MedGen:C0022336;OMIM:123400;Office of Rare Diseases:6956;Orphanet:204;Orphanet:282166;Orphanet:454700;SNOMED CT:792004	2008-11-26;2010-01-05	0	0
20	10412791	C	A	10412791	10412791	-	Haplotype	448914	RCV000005632	SCV000025814	38435	MKKS	NM_170784.2:c.724G>T	NP_740754.1:p.Ala242Ser	NM_170784.2:c.724G>T:missense variant;NR_072977.1:n.364-3988G>T:intron variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	criteria provided, conflicting interpretations	no assertion criteria provided	Aug 15, 2017	OMIM	OMIM	McKusick Kaufman syndrome;MCKUSICK-KAUFMAN SYNDROME	10802661;16104012;20301675					germline	GeneReviews:NBK1502;Genetic Alliance:McKusick+Kaufman+syndrome/4529;MedGen:C0948368;OMIM:236700;Office of Rare Diseases:3427;Orphanet:2473	2005-09-15	1	1
20	10413265	G	A	10413265	10413265	-	Haplotype	448914	RCV000005632	SCV000025814	20347	MKKS	NM_170784.2:c.250C>T	NP_740754.1:p.His84Tyr	NM_170784.2:c.250C>T:missense variant;NR_072977.1:n.364-4462C>T:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 15, 2005	OMIM	OMIM	McKusick Kaufman syndrome;MCKUSICK-KAUFMAN SYNDROME	10802661;16104012;20301675					germline	GeneReviews:NBK1502;Genetic Alliance:McKusick+Kaufman+syndrome/4529;MedGen:C0948368;OMIM:236700;Office of Rare Diseases:3427;Orphanet:2473	2005-09-15	0	0
20	41114115	A	G	41114115	41114115	+	Haplotype	16773	RCV000018261	SCV000038540	31812	TOP1	NM_003286.3:c.1598A>G	NP_003277.1:p.Asp533Gly	NM_003286.3:c.1598A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 11, 1991	OMIM	OMIM	DNA topoisomerase I, camptothecin-resistant;DNA TOPOISOMERASE I, CAMPTOTHECIN-RESISTANT	1849260					germline	MedGen:C4016020	1991-01-11	0	0
20	44626502	G	C	44626502	44626502	-	Haplotype	1981	RCV000002058	SCV000022216	38420	ADA	NM_000022.3:c.316C>G	NP_001308979.1:p.Thr9=	NM_000022.3:c.316C>G:missense variant;NM_001322050.1:c.27C>G:synonymous variant;NR_136160.1:n.467C>G:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 1997	OMIM	OMIM	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	3304460;9361033					germline	MedGen:C0392607	1997-12-01	0	0
20	44626528	T	C	44626528	44626528	-	Haplotype	1981	RCV000002058	SCV000022216	17020	ADA	NM_000022.3:c.290A>G	NP_000013.2:p.Tyr97Cys	NM_000022.3:c.290A>G:missense variant;NR_136160.1:n.441A>G:non-coding transcript variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 01, 1997	OMIM	OMIM	Severe combined immunodeficiency, autosomal recessive, T cell-negative, B cell-negative, NK cell-negative, due to adenosine deaminase deficiency;SEVERE COMBINED IMMUNODEFICIENCY, AUTOSOMAL RECESSIVE, T CELL-NEGATIVE, B CELL-NEGATIVE, NK CELL-NEGATIVE, DUE TO ADENOSINE DEAMINASE DEFICIENCY	3304460;9361033					germline	MedGen:C0392607	1997-12-01	0	0
20	63413478	G	T	63413478	63413478	-	Haplotype	369808	RCV000408720	SCV000484644	390693	KCNQ2	NM_172107.3:c.1735C>A	NP_742105.1:p.Leu579Met	NM_172107.3:c.1735C>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 31, 2016	GeneReviews	GeneReviews	Early infantile epileptic encephalopathy 7	20437616;25818041					germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218	2016-03-31	0	0
20	63413478	GC	TT	63413478	63413479	-	Haplotype	369808	RCV000408720	SCV000484644	203721	KCNQ2	NM_172107.3:c.1734_1735delGCinsAA	NP_742105.1:p.Met578_Leu579delinsIleMet	NM_172107.3:c.1734_1735delGCinsAA:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 31, 2016	GeneReviews	GeneReviews	Early infantile epileptic encephalopathy 7	20437616;25818041					germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218	2016-03-31	0	0
20	63413479	C	T	63413479	63413479	-	Haplotype	369808	RCV000408720	SCV000484644	390692	KCNQ2	NM_172107.3:c.1734G>A	NP_742105.1:p.Met578Ile	NM_172107.3:c.1734G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Mar 31, 2016	GeneReviews	GeneReviews	Early infantile epileptic encephalopathy 7	20437616;25818041					germline	GeneReviews:NBK32534;Genetic Alliance:Epileptic+encephalopathy%2C+early+infantile%2C+7/8345;MedGen:C3150986;OMIM:613720;Orphanet:439218	2016-03-31	0	0
21	33579447	T	G	33579447	33579447	-	Haplotype	431417	RCV000496974	SCV000588191	424961	DONSON	NM_017613.3:c.1466A>C	NP_060083.1:p.Lys489Thr	NM_017613.3:c.1466A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES;MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	28191891					germline	MedGen:CN373593;OMIM:611428.0001;OMIM:611428.0002;OMIM:611428.0003;OMIM:611428.0004;OMIM:611428.0005;OMIM:611428.0006;OMIM:611428.0007;OMIM:617604	2017-08-04	0	0
21	33583699	T	C	33583699	33583699	-	Haplotype	431417	RCV000496974	SCV000588191	424940	DONSON	NM_017613.3:c.786-33A>G		NM_017613.3:c.786-33A>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES;MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	28191891					germline	MedGen:CN373593;OMIM:611428.0001;OMIM:611428.0002;OMIM:611428.0003;OMIM:611428.0004;OMIM:611428.0005;OMIM:611428.0006;OMIM:611428.0007;OMIM:617604	2017-08-04	0	0
21	33588560	T	G	33588560	33588560	-	Haplotype	431417	RCV000496974	SCV000588191	424962	DONSON	NM_017613.3:c.82A>C	NP_060083.1:p.Ser28Arg	NM_017613.3:c.82A>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 04, 2017	OMIM	OMIM	MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES;MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES	28191891					germline	MedGen:CN373593;OMIM:611428.0001;OMIM:611428.0002;OMIM:611428.0003;OMIM:611428.0004;OMIM:611428.0005;OMIM:611428.0006;OMIM:611428.0007;OMIM:617604	2017-08-04	0	0
21	36461442	A	T	36461442	36461442	-	Haplotype	375673	RCV000417144	SCV000494729	19890	CLDN14	NM_012130.3:c.254T>A	NP_036262.1:p.Val85Asp	NM_001146077.1:c.254T>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Aug 30, 2016	Laboratory of Molecular Genetics,National Institutes of Health	Laboratory of Molecular Genetics,National Institutes of Health	Perrault Syndrome;Deafness;Primary ovarian insufficiency;Perrault Syndrome						germline	Illumina Clinical Services Laboratory,Illumina:37522;MedGen:CN239459	2016-08-30	0	0
21	46131981	G	A	46131981	46131981	+	Haplotype	29642	RCV000022490	SCV000043779	38596	COL6A2	NM_001849.3:c.2489G>A	NP_001840.3:p.Arg830Gln	NM_001849.3:c.2489G>A:missense variant	Conflicting interpretations of pathogenicity	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 08, 2015	OMIM	OMIM	BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE;BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE	18852439;19949035					germline	OMIM:120240.0011;OMIM:120240.0017;OMIM:120240.0018;OMIM:120240.0019	2009-12-01	0	1
21	46132019	C	T	46132019	46132019	+	Haplotype	29642	RCV000022490	SCV000043779	38597	COL6A2	NM_001849.3:c.2527C>T	NP_001840.3:p.Arg843Trp	NM_001849.3:c.2527C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Sep 13, 2016	OMIM	OMIM	BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE;BETHLEM MYOPATHY 1, AUTOSOMAL RECESSIVE	18852439;19949035					germline	OMIM:120240.0011;OMIM:120240.0017;OMIM:120240.0018;OMIM:120240.0019	2009-12-01	0	0
22	23767463	C	G	23767463	23767463	-	Haplotype	180222;204293	RCV000157071;RCV000192234	SCV000206796;SCV000239873	178410	CHCHD10	NM_213720.2:c.172G>C	NP_998885.1:p.Gly58Arg	NM_213720.2:c.172G>C:missense variant;NR_125755.1:n.217G>C:non-coding transcript variant;NR_125756.1:n.139+371G>C:intron variant	-	pathogenic	2	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 14, 2015	OMIM;GeneReviews	OMIM;GeneReviews	Myopathy, isolated mitochondrial, autosomal dominant;MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT (1 family)	25193783;26131548;9324076;2519378					germline	GeneReviews:NBK304142;MedGen:C4015513;OMIM:616209;Orphanet:457050	2015-01-01;2015-04-14	0	0
22	23767592	G	C	23767592	23767592	-	Haplotype	204293	RCV000192234	SCV000239873	200690	CHCHD10	NM_213720.2:c.43C>G	NP_998885.1:p.Arg15Gly	NM_213720.2:c.43C>G:missense variant;NR_125755.1:n.140-52C>G:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 14, 2015	GeneReviews	GeneReviews	Myopathy, isolated mitochondrial, autosomal dominant;Myopathy, isolated mitochondrial, autosomal dominant	2519378;26131548					germline	GeneReviews:NBK304142;MedGen:C4015513;OMIM:616209;Orphanet:457050	2015-04-14	0	0
22	23767592	G	T	23767592	23767592	-	Haplotype	180222	RCV000157071	SCV000206796	178409	CHCHD10	NM_213720.2:c.43C>A	NP_998885.1:p.Arg15Ser	NM_213720.2:c.43C>A:missense variant;NR_125755.1:n.140-52C>A:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 02, 2015	OMIM	OMIM	Myopathy, isolated mitochondrial, autosomal dominant;MYOPATHY, ISOLATED MITOCHONDRIAL, AUTOSOMAL DOMINANT (1 family)	25193783;26131548;9324076					germline	GeneReviews:NBK304142;MedGen:C4015513;OMIM:616209;Orphanet:457050	2015-01-01	0	0
22	25229472	C	A	25229472	25229472	+	Haplotype	217348	RCV000203383	SCV000256031	214001	CRYBB2	NM_000496.2:c.343C>A	NP_000487.1:p.Pro115Thr	NM_000496.2:c.343C>A:missense variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 09, 2015	Eye Genetics Research Group,Children's Medical Research Institute	Eye Genetics Research Group,Children's Medical Research Institute	Congenital cataract	26694549					de novo	Human Phenotype Ontology:HP:0000519;Human Phenotype Ontology:HP:0001108;Human Phenotype Ontology:HP:0007679;Human Phenotype Ontology:HP:0007726;Human Phenotype Ontology:HP:0007788;MedGen:C1842324	2015-01-09	0	0
22	25229484	G	A	25229484	25229484	+	Haplotype	217348	RCV000203383	SCV000256031	214002	CRYBB2	NM_000496.2:c.355G>A	NP_000487.1:p.Gly119Arg	NM_000496.2:c.355G>A:missense variant	Pathogenic	likely pathogenic	0	1	0	0	0	criteria provided, single submitter	no assertion criteria provided	Jul 10, 2017	Eye Genetics Research Group,Children's Medical Research Institute	Eye Genetics Research Group,Children's Medical Research Institute	Congenital cataract	26694549					de novo	Human Phenotype Ontology:HP:0000519;Human Phenotype Ontology:HP:0001108;Human Phenotype Ontology:HP:0007679;Human Phenotype Ontology:HP:0007726;Human Phenotype Ontology:HP:0007788;MedGen:C1842324	2015-01-09	1	0
22	36265860	A	G	36265860	36265860	+	Haplotype	6080	RCV000006453	SCV000026636	21119	APOL1	NM_145343.2:c.1072A>G	NP_663318.1:p.Ser358Gly	NM_145343.2:c.1072A>G:missense variant	not provided	risk factor	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Dec 09, 2014	OMIM	OMIM	Focal segmental glomerulosclerosis 4, susceptibility to;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	20647424;24206458					germline	Genetic Alliance:Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438;MedGen:C2675525;OMIM:612551;Orphanet:84271	2010-08-13	0	0
22	36265988	T	G	36265988	36265988	+	Haplotype	6080	RCV000006453	SCV000026636	76004	APOL1	NM_145343.2:c.1200T>G	NP_663318.1:p.Ile400Met	NM_145343.2:c.1200T>G:missense variant	not provided	risk factor	0	0	0	0	0	no assertion provided	no assertion criteria provided	Dec 09, 2014	OMIM	OMIM	Focal segmental glomerulosclerosis 4, susceptibility to;FOCAL SEGMENTAL GLOMERULOSCLEROSIS 4, SUSCEPTIBILITY TO	20647424;24206458					germline	Genetic Alliance:Focal+segmental+glomerulosclerosis+4%2C+susceptibility+to/8438;MedGen:C2675525;OMIM:612551;Orphanet:84271	2010-08-13	0	0
22	40361619	G	C	40361619	40361619	+	Haplotype	208488	RCV000190501	SCV000245387	205025	ADSL	NM_000026.3:c.994G>C	NP_000017.1:p.Asp332His	NM_000026.3:c.994G>C:missense variant;NR_134256.1:n.1053G>C:non-coding transcript variant	-	likely pathogenic	0	1	0	0	0	no assertion for the individual variant	no assertion criteria provided	Feb 17, 2014	Mendelics Analise Genomica	Mendelics Analise Genomica	Adenylosuccinate lyase deficiency;Adenylosuccinate lyase deficiency	10090474;23519317					germline	Genetic Alliance:Adenylosuccinase+Deficiency/230;MedGen:C0268126;OMIM:103050;Office of Rare Diseases:550;Orphanet:46;SNOMED CT:15285008	2014-02-17	0	0
22	40364965	G	A	40364965	40364965	+	Haplotype	208488	RCV000190501	SCV000245387	17501	ADSL	NM_000026.3:c.1277G>A	NP_000017.1:p.Arg426His	NM_000026.3:c.1277G>A:missense variant;NM_001123378.1:c.1191+600G>A:intron variant;NR_134256.1:n.1367G>A:non-coding transcript variant	Pathogenic	likely pathogenic	0	1	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Sep 12, 2017	Mendelics Analise Genomica	Mendelics Analise Genomica	Adenylosuccinate lyase deficiency;Adenylosuccinate lyase deficiency	10090474;23519317					germline	Genetic Alliance:Adenylosuccinase+Deficiency/230;MedGen:C0268126;OMIM:103050;Office of Rare Diseases:550;Orphanet:46;SNOMED CT:15285008	2014-02-17	2	0
22	42126611	C	G	42126611	42126611	-	Haplotype	16895	RCV000018391	SCV000038673	38485	CYP2D6	NM_000106.5:c.1457G>C	NP_000097.3:p.Ser486Thr	NM_000106.5:c.1457G>C:missense variant	-	drug response	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Debrisoquine, ultrarapid metabolism of;DEBRISOQUINE, ULTRARAPID METABOLISM OF	7903454;7927337					germline	MedGen:C1837157	2015-05-18	0	0
22	42127941	G	A	42127941	42127941	-	Haplotype	16895	RCV000018391	SCV000038673	31934	CYP2D6	NM_000106.5:c.886C>T	NP_000097.3:p.Arg296Cys	NM_000106.5:c.886C>T:missense variant	-	drug response	0	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	May 18, 2015	OMIM	OMIM	Debrisoquine, ultrarapid metabolism of;DEBRISOQUINE, ULTRARAPID METABOLISM OF	7903454;7927337					germline	MedGen:C1837157	2015-05-18	0	0
X	13750693	TCTCAAACACTTGGG	T	13750699	13750712		Haplotype	11542	RCV000012298	SCV000032532	76962		NM_003611.2:c.936-550_936-537delACACTTGGGCTCAA		NM_003611.2:c.936-550_936-537delACACTTGGGCTCAA:intron variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2004	OMIM	OMIM	Oral-facial-digital syndrome;OROFACIODIGITAL SYNDROME I	15221448;20301367					germline	GeneReviews:NBK1188;Genetic Alliance:Orofaciodigital+syndromes/5428;MedGen:C1510460;OMIM:311200;Office of Rare Diseases:4121;Orphanet:2750;SNOMED CT:52868006	2004-07-01	0	0
X	22094005	T	C	22094005	22094005	+	Haplotype	10818	RCV000011565	SCV000031797	25857	PHEX	NM_000444.5:c.755T>C	NP_000435.3:p.Phe252Ser	NM_000444.5:c.755T>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1997	OMIM	OMIM	Familial X-linked hypophosphatemic vitamin D refractory rickets;HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	22319799;7550339;9106524					germline	GeneReviews:NBK83985;Genetic Alliance:Familial+Hypophosphatemic+Rickets/2752;MedGen:C0733682;OMIM:307800;Office of Rare Diseases:6735;Orphanet:89936;SNOMED CT:82236004	1997-04-01	0	0
X	22094009	G	A	22094009	22094009	+	Haplotype	10818	RCV000011565	SCV000031797	38453	PHEX	NM_000444.5:c.759G>A	NP_000435.3:p.Met253Ile	NM_000444.5:c.759G>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1997	OMIM	OMIM	Familial X-linked hypophosphatemic vitamin D refractory rickets;HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT	22319799;7550339;9106524					germline	GeneReviews:NBK83985;Genetic Alliance:Familial+Hypophosphatemic+Rickets/2752;MedGen:C0733682;OMIM:307800;Office of Rare Diseases:6735;Orphanet:89936;SNOMED CT:82236004	1997-04-01	0	0
X	101403846	G	A	101403846	101403846	-	Haplotype	10723	RCV000011470	SCV000031702	38452	GLA	NM_000169.2:c.334C>T	NP_000160.1:p.Arg112Cys	NM_000169.2:c.334C>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	Mar 09, 2017	OMIM	OMIM	Fabry disease;FABRY DISEASE	12735292;1315715;16980809;20301469;20505683;20610207;21934708;23788249;23860966;25173338;25355838;25356965;27854360				Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function	germline	GeneReviews:NBK1292;Genetic Alliance:Fabry+Disease/2690;Genetic Testing Registry (GTR):GTR000246735;Genetic Testing Registry (GTR):GTR000260631;Genetic Testing Registry (GTR):GTR000325415;Genetic Testing Registry (GTR):GTR000327665;Genetic Testing Registry (GTR):GTR000337467;Genetic Testing Registry (GTR):GTR000500007;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000505068;Genetic Testing Registry (GTR):GTR000507480;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000512526;Genetic Testing Registry (GTR):GTR000514924;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520414;Genetic Testing Registry (GTR):GTR000520447;Genetic Testing Registry (GTR):GTR000522329;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000528516;Genetic Testing Registry (GTR):GTR000528528;Genetic Testing Registry (GTR):GTR000528536;Genetic Testing Registry (GTR):GTR000551442;Genetic Testing Registry (GTR):GTR000552214;Genetic Testing Registry (GTR):GTR000556501;Genetic Testing Registry (GTR):GTR000556520;Genetic Testing Registry (GTR):GTR000556725;Genetic Testing Registry (GTR):GTR000558532;Genetics Home Reference:fabry-disease;MedGen:C0002986;OMIM:301500;Office of Rare Diseases:6400;Orphanet:324;SNOMED CT:16652001	2010-08-01	2	0
X	101403984	C	G	101403984	101403984	-	Haplotype	10723	RCV000011470	SCV000031702	25762	GLA	NM_000169.2:c.196G>C	NP_000160.1:p.Glu66Gln	NM_000169.2:c.196G>C:missense variant	Uncertain significance	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 24, 2013	OMIM	OMIM	Fabry disease;FABRY DISEASE	12735292;1315715;16980809;20301469;20505683;20610207;21934708;23788249;23860966;25173338;25355838;25356965;27854360				Fabry disease is due to inactivating mutations in the X-linked GLA gene resulting in deficiency of the enzyme Alpha Galactosidase-A.;loss of function	germline	GeneReviews:NBK1292;Genetic Alliance:Fabry+Disease/2690;Genetic Testing Registry (GTR):GTR000246735;Genetic Testing Registry (GTR):GTR000260631;Genetic Testing Registry (GTR):GTR000325415;Genetic Testing Registry (GTR):GTR000327665;Genetic Testing Registry (GTR):GTR000337467;Genetic Testing Registry (GTR):GTR000500007;Genetic Testing Registry (GTR):GTR000503671;Genetic Testing Registry (GTR):GTR000505068;Genetic Testing Registry (GTR):GTR000507480;Genetic Testing Registry (GTR):GTR000507942;Genetic Testing Registry (GTR):GTR000512526;Genetic Testing Registry (GTR):GTR000514924;Genetic Testing Registry (GTR):GTR000519366;Genetic Testing Registry (GTR):GTR000519384;Genetic Testing Registry (GTR):GTR000520061;Genetic Testing Registry (GTR):GTR000520062;Genetic Testing Registry (GTR):GTR000520063;Genetic Testing Registry (GTR):GTR000520414;Genetic Testing Registry (GTR):GTR000520447;Genetic Testing Registry (GTR):GTR000522329;Genetic Testing Registry (GTR):GTR000522527;Genetic Testing Registry (GTR):GTR000528276;Genetic Testing Registry (GTR):GTR000528288;Genetic Testing Registry (GTR):GTR000528500;Genetic Testing Registry (GTR):GTR000528516;Genetic Testing Registry (GTR):GTR000528528;Genetic Testing Registry (GTR):GTR000528536;Genetic Testing Registry (GTR):GTR000551442;Genetic Testing Registry (GTR):GTR000552214;Genetic Testing Registry (GTR):GTR000556501;Genetic Testing Registry (GTR):GTR000556520;Genetic Testing Registry (GTR):GTR000556725;Genetic Testing Registry (GTR):GTR000558532;Genetics Home Reference:fabry-disease;MedGen:C0002986;OMIM:301500;Office of Rare Diseases:6400;Orphanet:324;SNOMED CT:16652001	2010-08-01	0	0
X	108580713	G	T	108580713	108580713	+	Haplotype	10464	RCV000011210	SCV000031437	35671	COL4A5	NM_033380.2:c.866G>T	NP_203699.1:p.Gly289Val	NM_000495.4:c.866G>T:missense variant	Pathogenic	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	Dec 04, 2012	OMIM	OMIM	Alport syndrome, X-linked recessive;ALPORT SYNDROME, X-LINKED	20301386;22166944;7706490;9195222					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome/335;MedGen:C1567742;OMIM:301050;Orphanet:63;Orphanet:88917	1995-04-01	0	0
X	108686096	C	T	108686096	108686096	+	Haplotype	10464	RCV000011210	SCV000031437	38451	COL4A5	NM_033380.2:c.4282C>T	NP_203699.1:p.Arg1428Cys	NM_000495.4:c.4264C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Apr 01, 1995	OMIM	OMIM	Alport syndrome, X-linked recessive;ALPORT SYNDROME, X-LINKED	20301386;22166944;7706490;9195222					germline	GeneReviews:NBK1207;Genetic Alliance:Alport+Syndrome/335;MedGen:C1567742;OMIM:301050;Orphanet:63;Orphanet:88917	1995-04-01	0	0
X	136656393	T	A	136656393	136656393	+	Haplotype	11158	RCV000011908	SCV000032141	26197	CD40LG	NM_000074.2:c.384T>A	NP_000065.1:p.Ser128Arg	NM_000074.2:c.384T>A:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 29, 1993	OMIM	OMIM	Immunodeficiency with hyper IgM type 1;IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	20301576;7678782					germline	GeneReviews:NBK1402;Genetic Alliance:Immunodeficiency+with+hyper+IgM+type+1/3776;MedGen:C0398689;OMIM:308230;Office of Rare Diseases:73	1993-01-29	0	0
X	136656395	A	G	136656395	136656395	+	Haplotype	11158	RCV000011908	SCV000032141	38454	CD40LG	NM_000074.2:c.386A>G	NP_000065.1:p.Glu129Gly	NM_000074.2:c.386A>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jan 29, 1993	OMIM	OMIM	Immunodeficiency with hyper IgM type 1;IMMUNODEFICIENCY WITH HYPER-IgM, TYPE 1	20301576;7678782					germline	GeneReviews:NBK1402;Genetic Alliance:Immunodeficiency+with+hyper+IgM+type+1/3776;MedGen:C0398689;OMIM:308230;Office of Rare Diseases:73	1993-01-29	0	0
X	149482933	C	G	149482933	149482933	-	Haplotype	10502	RCV000011248	SCV000031475	25541	IDS	NM_000202.7:c.1466G>C	NP_000193.1:p.Gly489Ala	NM_000202.7:c.1466G>C:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2003	OMIM	OMIM	Mucopolysaccharidosis, MPS-II;MUCOPOLYSACCHARIDOSIS, TYPE II	12794697;20301451;21863056;25071396					germline	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2003-07-01	0	0
X	149482935	C	A	149482935	149482935	-	Haplotype	10502	RCV000011248	SCV000031475	38394	IDS	NM_000202.7:c.1464G>T	NP_000193.1:p.Met488Ile	NM_000202.7:c.1464G>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Jul 01, 2003	OMIM	OMIM	Mucopolysaccharidosis, MPS-II;MUCOPOLYSACCHARIDOSIS, TYPE II	12794697;20301451;21863056;25071396					germline	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2003-07-01	0	0
X	149482996	C	T	149482996	149482996	-	Haplotype	221203	RCV000204179	SCV000262516	25537	IDS	NM_000202.7:c.1403G>A	NP_000193.1:p.Arg468Gln	NM_000202.7:c.1403G>A:missense variant	Pathogenic	pathogenic	1	0	0	0	0	criteria provided, multiple submitters, no conflicts	criteria provided, single submitter	Sep 25, 2013	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	Mucopolysaccharidosis, MPS-II	18414213;20301451;21863056;25071396					maternal	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2007-05-16	2	0
X	149483005	T	A	149483005	149483005	-	Haplotype	221203	RCV000204179	SCV000262516	222899	IDS	NM_000202.7:c.1394A>T	NP_000193.1:p.Gln465Leu	NM_000202.7:c.1394A>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	criteria provided, single submitter	May 16, 2007	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	LISIN Facultad de Ciencias Exactas, Universidad Nacional de La Plata	Mucopolysaccharidosis, MPS-II	18414213;20301451;21863056;25071396					maternal	GeneReviews:NBK1274;Genetic Alliance:Mucopolysaccharidosis+type+II/4913;MedGen:C0026705;OMIM:309900;Orphanet:580;SNOMED CT:70737009	2007-05-16	0	0
X	154534390	G	A	154534390	154534390	-	Haplotype	10392	RCV000011127	SCV000031354	25430	G6PD	NM_000402.4:c.682C>T	NP_000393.4:p.Arg228Cys	NM_001042351.2:c.592C>T:missense variant	other	pathogenic	1	0	0	0	0	no assertion criteria provided	no assertion criteria provided	May 24, 2017	OMIM	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664;4125296					germline	MedGen:C4016535	1992-08-01	0	0
X	154534438	G	A	154534438	154534438	-	Haplotype	10392	RCV000011127	SCV000031354	38393	G6PD	NM_000402.4:c.634C>T	NP_000393.4:p.Arg212Trp	NM_001042351.2:c.544C>T:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1992	OMIM	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664;4125296					germline	MedGen:C4016535	1992-08-01	0	0
X	154534440	T	A	154534440	154534440	-	Haplotype	10382	RCV000011109	SCV000031336	25421	G6PD	NM_000402.4:c.632A>T	NP_000393.4:p.Asp211Val	NM_000402.4:c.632A>T:missense variant	Pathogenic, other	other	0	0	0	0	0	criteria provided, multiple submitters, no conflicts	no assertion criteria provided	May 24, 2017	OMIM	OMIM	G6PD SANTAMARIA;G6PD SANTAMARIA	1978554;1999409;6433630;8956035					germline	OMIM:305900.0023	2017-05-24	2	0
X	154535277	T	C	154535277	154535277	-	Haplotype	10361;10382	RCV000011075;RCV000011109	SCV000031301;SCV000031336	25399	G6PD	NM_000402.4:c.466A>G	NP_000393.4:p.Asn156Asp	NM_001042351.2:c.376A>G:missense variant	Conflicting interpretations of pathogenicity, other	pathogenic;other	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Oct 18, 2017	OMIM	OMIM	Glucose 6 phosphate dehydrogenase deficiency;G6PD A-;G6PD SANTAMARIA	10734064;1303173;1978554;2253938;2503817;2572288;2836867;2912886;3393536;4388132;5448;5492291;669721;7106752;7291768;903703;1999409;6433630;8956035					germline	Genetic Alliance:G6pd+a-/8448;Genetic Alliance:Glucose+6+Phosphate+Dehydrogenase+Deficiency/3096;Genetics Home Reference:glucose-6-phosphate-dehydrogenase-deficiency;MedGen:C0017758;OMIM:305900.0002;OMIM:305900.0027;OMIM:305900.0028;Office of Rare Diseases:6520;OMIM:305900.0023	2000-03-31;2017-05-24	0	1
X	154535336	G	C	154535336	154535336	-	Haplotype	10392	RCV000011127	SCV000031354	25431	G6PD	NM_000402.4:c.407C>G	NP_000393.4:p.Ser136Cys	NM_001042351.2:c.317C>G:missense variant	-	pathogenic	1	0	0	0	0	no assertion for the individual variant	no assertion criteria provided	Aug 01, 1992	OMIM	OMIM	Chronic granuloma and hemolytic anemia;CHRONIC GRANULOMA AND HEMOLYTIC ANEMIA	1353664;4125296					germline	MedGen:C4016535	1992-08-01	0	0
X	154536002	C	T	154536002	154536002	-	Haplotype	10361	RCV000011075	SCV000031301	25400	G6PD	NM_000402.4:c.292G>A	NP_000393.4:p.Val98Met	NM_001042351.2:c.202G>A:missense variant	drug response	pathogenic	1	0	0	0	0	reviewed by expert panel	no assertion criteria provided	Oct 18, 2017	OMIM	OMIM	Glucose 6 phosphate dehydrogenase deficiency;G6PD A-	10734064;1303173;1978554;2253938;2503817;2572288;2836867;2912886;3393536;4388132;5448;5492291;669721;7106752;7291768;903703					germline	Genetic Alliance:G6pd+a-/8448;Genetic Alliance:Glucose+6+Phosphate+Dehydrogenase+Deficiency/3096;Genetics Home Reference:glucose-6-phosphate-dehydrogenase-deficiency;MedGen:C0017758;OMIM:305900.0002;OMIM:305900.0027;OMIM:305900.0028;Office of Rare Diseases:6520	2000-03-31	3	0
